Analyse der molekularen Wechselwirkungen von Streptococcus pyogenes des Serotyps M1 mit primären humanen Endothelzellen by Ochel, Anja
  
  
 
 
 
 
 
 
 
Analysis of the molecular interactions of tissue-invasive M1 
Streptococcus pyogenes with primary human endothelial cells 
 
 
 
 
 
 
Von der Fakultät für Lebenswissenschaften 
 
der Technischen Universität Carolo-Wilhelmina 
 
zu Braunschweig 
 
zur Erlangung des Grades einer 
 
Doktorin der Naturwissenschaften 
 
(Dr. rer. nat.) 
 
genehmigte 
 
D i s s e r t a t i o n 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
von Anja Ochel, geb. Grützner 
aus Bottrop 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Referentin:  Privatdozentin Dr. Simone Bergmann 
2. Referent:  Professor Dr. Michael Steinert 
eingereicht am: 23.09.2013 
mündliche Prüfung (Disputation) am: 16.01.2014 
 
 
 
Druckjahr 2014 
 
  
  
 
 
 
 
 
 
Vorveröffentlichungen der Dissertation 
 
Teilergebnisse aus dieser Arbeit wurden mit Genehmigung der Fakultät für 
Lebenswissenschaften, vertreten durch die Mentorin der Arbeit, in folgenden Beiträgen vorab 
veröffentlicht: 
 
 
 
Publikationen 
 
Ochel, A., Rohde, M., Chhatwal, G. S. & Talay, S. T. The M1 protein of Streptococcus 
pyogenes triggers an innate uptake mechanism into polarized human endothelial cells. 
Journal of Innate Immunity 2014 (DOI: 10.1159/000358085). 
 
 
 
Tagungsbeiträge 
 
Grützner, A., Chhatwal, G. S. & Talay, S. T. Analysis of the interaction of M1 Streptococcus 
pyogenes with human endothelial cells. (Poster) 4th International PhD Symposium, Helmholtz 
International Graduate School for Infection Research, Braunschweig (2010). 
Grützner, A., Chhatwal, G. S. & Talay, S. T. Analysis of the interaction of M1 Streptococcus 
pyogenes with human endothelial cells. (Poster) 2nd Public Retreat, Helmholtz International 
Graduate School for Infection Research, Hahnenklee (2011). 
Grützner, A., Rohde, M., Chhatwal, G. S. & Talay, S. T. Analysis of the interaction of invasive 
M1 Streptococcus pyogenes with human endothelial cells. (Poster) 5th International PhD 
Symposium, Helmholtz International Graduate School for Infection Research, Braunschweig 
(2011). 
Grützner, A., Rohde, M., Chhatwal, G. S. & Talay, S. T. Analysis of the interaction of invasive 
M1 Streptococcus pyogenes with human endothelial cells. (Talk) Jahrestagung der 
Vereinigung für Allgemeine und Angewandte Mikrobiologie (VAAM), Tübingen (2012). 
Ochel, A., Rohde, M., Chhatwal, G. S. & Talay, S. T. Analysis of the molecular interactions of 
invasive M1T1 Streptococcus pyogenes with primary human endothelial cells. (Talk) 3rd 
Public Retreat, Helmholtz International Graduate School for Infection Research, Bad 
Bevensen (2012). 
Ochel, A. Analysis of the interaction of M1 S. pyogenes with human endothelial cells. (Talk) 
Progress Seminar, Helmholtz Centre for Infection Research, Braunschweig (2012). 
 
Table of contents 
 
  
I 
Table of contents 
List of figures ............................................................................................................ V 
List of tables ............................................................................................................ VI 
List of abbreviations............................................................................................... VII 
1. Abstract ................................................................................................................. 1 
2. Introduction ........................................................................................................... 2 
2.1 The genus Streptococcus............................................................................................................... 2 
2.2 Streptococcus pyogenes ................................................................................................................ 2 
2.3 Epidemiology of GAS invasive diseases ...................................................................................... 5 
2.4 Pathogen-host interactions underlying invasive GAS diseases ................................................ 5 
2.4.1 Attachment to the host cell surface ............................................................................................ 6 
2.4.2 Resistance to host immune defence mechanisms ..................................................................... 8 
2.4.3 Extracellular virulence factors .................................................................................................... 9 
2.4.4 Invasion into eukaryotic cells .................................................................................................... 10 
2.5 Invasion mechanisms of S. pyogenes ........................................................................................ 11 
2.6 Streptococcal dissemination from the primary site of infection into deeper tissue .............. 14 
2.7 Aim of the study ............................................................................................................................ 16 
3. Materials and Methods ....................................................................................... 17 
3.1 Materials ......................................................................................................................................... 17 
3.1.1 Chemicals/solutions .................................................................................................................. 17 
3.1.2 Expendable material ................................................................................................................. 21 
3.1.3 Instruments ............................................................................................................................... 22 
3.1.4 Oligonucleotides ....................................................................................................................... 24 
3.1.5 Antibodies ................................................................................................................................. 26 
3.1.6 Vectors...................................................................................................................................... 27 
3.1.7 Restriction endonucleases ....................................................................................................... 27 
3.1.8 Antibiotics ................................................................................................................................. 28 
3.1.9 Kits ............................................................................................................................................ 29 
3.1.10 Buffers .................................................................................................................................... 29 
3.2 Bacterial strains, media and culture conditions ........................................................................ 31 
3.2.1 Bacterial strains ........................................................................................................................ 31 
Table of contents 
 
  
II 
3.2.2 Bacterial culture media ............................................................................................................. 33 
3.2.3 Cultivation of bacterial strains and culture conditions .............................................................. 35 
3.3 Molecular biological techniques .................................................................................................. 36 
3.3.1 Isolation of chromosomal DNA from S. pyogenes and L. lactis ............................................... 36 
3.3.2 Isolation of plasmid DNA .......................................................................................................... 37 
3.3.3 Agarose gel electrophoresis ..................................................................................................... 37 
3.3.4 Polymerase chain reaction (PCR) ............................................................................................ 38 
3.3.4.1 Standard PCR ................................................................................................................... 39 
3.3.4.2 16s RNA sequencing ......................................................................................................... 40 
3.3.4.3 Colony PCR ....................................................................................................................... 41 
3.3.5 Purification of PCR products and restriction digests ................................................................ 41 
3.3.6 Digestion of DNA with restriction endonucleases .................................................................... 42 
3.3.7 Ligation of DNA fragments ....................................................................................................... 42 
3.3.8 Transformation of bacteria........................................................................................................ 43 
3.3.8.1 Preparation of competent E. coli ....................................................................................... 43 
3.3.8.2 Transformation of competent E. coli .................................................................................. 44 
3.3.8.3 Preparation of competent S. pyogenes ............................................................................. 44 
3.3.8.4 Transformation of competent S. pyogenes ....................................................................... 45 
3.4 Cloning techniques ....................................................................................................................... 45 
3.4.1 Complementation of the S. pyogenes M1 knock out mutant.................................................... 45 
3.4.2 Generation of recombinant M1 protein ..................................................................................... 46 
3.5 Biochemical techniques ............................................................................................................... 46 
3.5.1 Overexpression of recombinant M1-HIS-fusion protein ........................................................... 46 
3.5.2 Purification of recombinant M1-HIS-fusion protein ................................................................... 47 
3.5.3 Dialysis and quantification of purified proteins ......................................................................... 47 
3.5.4 SDS polyacrylamide gel electrophoresis (SDS-PAGE) ............................................................ 47 
3.5.5 Staining of proteins in polyacrylamide gels .............................................................................. 49 
3.5.6 Coating of latex beads with recombinant proteins ................................................................... 50 
3.5.7 Analysis of the coating efficiency of M1-coated latex beads by flow cytometry ....................... 50 
3.5.8 Analysis of surface localization of M1 on S. pyogenes and L. lactis ........................................ 50 
3.5.9 Plasma absorbance assay ....................................................................................................... 51 
3.5.10 Binding assay with radioactively labelled IgG ........................................................................ 51 
3.6 Cell culture techniques ................................................................................................................. 52 
3.6.1 Primary endothelial cells........................................................................................................... 52 
3.6.2 Cell culture media ..................................................................................................................... 52 
3.6.3 Cultivation and sub-cultivation of primary endothelial cells ...................................................... 53 
3.6.3.1 Cultivation of HUVEC ........................................................................................................ 53 
3.6.3.2 Cultivation of HPMEC and HDLEC ................................................................................... 53 
3.6.3.3 Freezing and thawing of HUVEC and HPMEC ................................................................. 53 
3.7 Infection assays ............................................................................................................................. 54 
3.7.1 In vitro transwell infection system ............................................................................................. 54 
3.7.2 In vitro transwell infection assay of endothelial cells with S. pyogenes or L. lactis .................. 54 
3.7.3 Pre-incubation of HUVEC ......................................................................................................... 55 
3.7.3.1 Blocking of integrin subunits on HUVEC ........................................................................... 55 
3.7.3.2 Pre-incubation of HUVEC with various inhibitors to interfere with host cell signalling 
pathways ........................................................................................................................................ 55 
3.7.3.3 Pre-incubation of HUVEC with BSA-gold nano particles .................................................. 56 
3.7.4 Blocking of the M protein on streptococci................................................................................. 57 
3.7.5 Latex bead internalization assay on HUVEC ........................................................................... 57 
Table of contents 
 
  
III 
3.7.6 Quantification of intracellular viable bacteria in HUVEC (survival assay) ................................ 57 
3.7.7 Measurement of EC barrier function using the CellZscope® automated cell monitoring system
 ........................................................................................................................................................... 58 
3.7.8 Ex vivo infection assay of umbilical cord with S. pyogenes ..................................................... 59 
3.8 Microscopic techniques................................................................................................................ 59 
3.8.1 Fluorescence microscopy ......................................................................................................... 59 
3.8.1.1 Double-immunofluorescence staining ............................................................................... 59 
3.8.1.2 Staining of intra-/extracellular streptococci, lactococci or protein-coated latex beads ...... 60 
3.8.1.3 Staining of streptococci and the actin cytoskeleton .......................................................... 60 
3.8.1.4 Staining of streptococci and late endosomal/lysosomal compartments ............................ 60 
3.8.1.5 Staining of the Arp2/3 complex ......................................................................................... 61 
3.8.1.6 Staining of streptococci and the β1-integrin subunit .......................................................... 61 
3.8.1.7 Bacterial viability staining .................................................................................................. 61 
3.8.2 Electron microscopy (EM) ........................................................................................................ 61 
3.8.2.1 Field emission scanning electron microscopy (FESEM) ................................................... 61 
3.8.2.2 Transmission electron microscopy (TEM) ......................................................................... 62 
3.9 Statistical analysis ........................................................................................................................ 63 
4. Results ................................................................................................................. 64 
4.1 Analysis of the invasion potential of different serotype M1 S. pyogenes strains .................. 64 
4.1.1 Establishment of an in vitro transwell infection model to study streptococcal invasion ........... 64 
4.1.2 Different serotype M1 GAS clinical isolates invade EC ............................................................ 65 
4.2 Characterization of the invasion mechanism ............................................................................. 67 
4.2.1 M1 S. pyogenes triggers the formation of membrane protrusion and zipper-like uptake into EC
 ........................................................................................................................................................... 67 
4.2.2 M1 GAS entry is characterised by F-actin accumulation and aggregation of the Arp2/3 
complex in the vicinity of invading GAS ............................................................................................ 68 
4.3. M1 GAS mediates phagocytic-like uptake processes into HUVEC ......................................... 70 
4.3.1 M1 GAS mediates co-localization with the late endosomal/lysosomal compartment .............. 70 
4.3.2 M1 GAS phagosomes fuse with terminal lysosomes ............................................................... 71 
4.4. Intracellular survival of M1 GAS in HUVEC ............................................................................... 74 
4.4.1 Quantification of intracellular survival ....................................................................................... 74 
4.4.2 M1 GAS escapes from the phagolysosome into the cytoplasm ............................................... 75 
4.4.3 M1 GAS overcomes the endothelial cell barrier ....................................................................... 76 
4.5 Identification of the bacterial factor that determines EC interaction ....................................... 78 
4.5.1 Characterization of the GAS M1 knock out mutant strain ........................................................ 78 
4.5.2 The M1 protein of S. pyogenes is crucial for efficient invasion of GAS into HUVEC ............... 80 
4.5.3 The M1 protein mediates internalization of latex beads into HUVEC ...................................... 81 
4.5.4 The M1 protein mediates invasion of Lactococcus lactis into HUVEC .................................... 83 
4.5.5 Dead M1 GAS are also internalized into HUVEC .................................................................... 85 
4.6 Identification of host cell factors that mediate M1 GAS invasion into HUVEC ....................... 86 
4.6.1 Engagement of beta1-integrins during invasion of M1 GAS into HUVEC ................................ 86 
4.6.2. Involvement of phospholipase C, protein kinase C and intracellular calcium in the invasion of 
M1 GAS into HUVEC ......................................................................................................................... 87 
Table of contents 
 
  
IV 
4.7 Infection assays with lung and dermal endothelial cells .......................................................... 89 
4.7.1 Serotype M1 GAS invades into different primary human endothelial cell types ...................... 89 
4.7.2 Ex vivo infection of human endothelium with M1 GAS ............................................................. 91 
5. Discussion .......................................................................................................... 92 
5.1 Use of an in vitro EC barrier model to study serotype M1 S. pyogenes invasion .................. 92 
5.2 Serotype M1 GAS mediates zipper-like uptake into EC ............................................................ 93 
5.3 The M1 protein of GAS triggers internalization into EC via the engagement of β1-integrins 
on the endothelial cell surface ........................................................................................................... 95 
5.4 M1 GAS exploits the phagocytic uptake machinery to gain access to EC ............................. 97 
5.5 Serotype M1 GAS survival within EC is associated with phagolysosomal escape ............... 99 
5.6 Survival of serotype M1 GAS within endothelial cells and its ability to overcome the 
endothelial cell barrier ...................................................................................................................... 101 
5.7 Summary of the invasion process triggered by serotype M1 GAS ........................................ 103 
6. References ........................................................................................................ 104 
Acknowledgment .................................................................................................. 114 
 
  
  
V 
List of figures 
Figure 1: Schematic representation of the variety of virulence factors expressed by S. pyogenes to 
circumvent host cell immune defences ........................................................................................... 6 
Figure 2: Schematic representation of signalling pathways and corresponding uptake processes 
initiated by M1- and SfbI/F1- expressing S. pyogenes .................................................................. 12 
Figure 3: Schematic representation of the composition of a blood vessel ............................................ 15 
Figure 4: Schematic representation of the transwell system ................................................................. 54 
Figure 5: HUVEC cultivated on transwell inserts form confluent polarised cell layers .......................... 65 
Figure 6: Different clinical isolates of serotype M1 GAS invade confluent HUVEC layers ................... 66 
Figure 7: Invasion of M1 GAS into EC is accompanied by the formation of membrane protrusions .... 68 
Figure 8: Upon invasion M1 GAS triggers the accumulation of F-actin and the aggregation of the 
Arp2/3 complex at the port of entry ............................................................................................... 69 
Figure 9: Co-localization of M1 GAS with late endosomal/lysosomal compartments ........................... 71 
Figure 10: Co-localization of M1 GAS with gold particles indicates phagolysosomal fusion ................ 72 
Figure 11: M1 GAS containing phagosomes fuse with terminal lysosomes ......................................... 73 
Figure 12: Intracellular survival of M1 GAS within HUVEC ................................................................... 75 
Figure 13: M1 GAS escapes from the phagolysosomal compartment .................................................. 76 
Figure 14: M1 GAS transmigrate through the endothelial cell barrier ................................................... 77 
Figure 15: Serotype M1 GAS lacking the M1 surface protein fails to bind human plasma components
 ....................................................................................................................................................... 79 
Figure 16: The M1 knock out mutant is deficient for invasion of HUVEC ............................................. 81 
Figure 17: The M1 protein of S. pyogenes triggers invasion into HUVEC ............................................ 83 
Figure 18: The M1 protein of S. pyogenes mediates invasion of lactococci into HUVEC..................... 84 
Figure 19: Internalization of heat-killed M1 GAS into HUVEC .............................................................. 85 
Figure 20: Beta1-integrins are involved in the invasion of M1 GAS into HUVEC ................................. 87 
Figure 21: M1 GAS induces phagocytic-like uptake into HUVEC ......................................................... 89 
Figure 22: M1 GAS invades into HPMEC as well as HDLEC ............................................................... 90 
Figure 23: Attachment of M1 GAS to ex vivo derived human endothelium .......................................... 91 
Figure 24: Mechanisms of bacterial invasion ........................................................................................ 94 
 
  
  
VI 
List of tables 
Table 1: Chemicals and solutions used in this study............................................................................. 17 
Table 2: Expendable material used in this study ................................................................................... 21 
Table 3: Instruments and equipment used in this study ........................................................................ 22 
Table 4: Oligonucleotides used in this study ......................................................................................... 24 
Table 5: Primary antibodies used in this study ...................................................................................... 26 
Table 6: Secondary antibodies used in this study ................................................................................. 27 
Table 7: Vectors used in this study ....................................................................................................... 27 
Table 8: Antibiotics used in this study ................................................................................................... 28 
Table 9: Kits used in this study .............................................................................................................. 29 
Table 10: Buffers used in this study ...................................................................................................... 29 
Table 11: S. pyogenes strains used for infection studies, survival assays and cloning ........................ 31 
Table 12: E. coli strains used for protein biochemical studies .............................................................. 32 
Table 13: L. lactis strains used for infection studies .............................................................................. 33 
Table 14: Media used for the cultivation of S. pyogenes strains ........................................................... 33 
Table 15: Media used for the cultivation of E. coli strains ..................................................................... 34 
Table 16: Media used for the cultivation of L. lactis strains ................................................................... 35 
Table 17: Buffers and solutions used for isolation of chromosomal DNA ............................................. 36 
Table 18: Buffers and solutions used for gel electrophoresis ............................................................... 38 
Table 19: Standard PCR protocol.......................................................................................................... 39 
Table 20: Standard PCR program ......................................................................................................... 39 
Table 21: 16s RNA PCR protocol .......................................................................................................... 40 
Table 22: 16s RNA PCR program ......................................................................................................... 40 
Table 23: Colony PCR protocol ............................................................................................................. 41 
Table 24: Standard restriction digest protocol ....................................................................................... 42 
Table 25: Ligation protocol .................................................................................................................... 42 
Table 26: Buffers and media used for preparation of competent E. coli ............................................... 43 
Table 27: Buffers and solutions used for SDS-PAGE ........................................................................... 48 
Table 28: Composition of the Coomassie staining solution .................................................................. 49 
Table 29: Primary endothelial cells used in this study .......................................................................... 52 
Table 30: Inhibitors used in this study ................................................................................................... 56 
Table 31: Solutions and buffers used for electron microscopy ............................................................. 63 
 
 
Abbreviations 
 
  
VII 
List of abbreviations 
 
% percentage 
°C degree Celsius 
µF microfarad 
µg microgram 
µl microlitre 
µm micrometre 
µM micromol 
3’ three prime end 
5’ five prime end 
∞ infinitely 
A adenine 
ad ad (Latin ‘up to’) 
APS ammonium persulfate 
aq. aqueous 
Arp2/3 actin-related protein 2/3 
ATP adenosine-5’-triphosphate 
bp base pairs 
BSA bovine serum albumin 
C cytosine 
Ccl capacitance 
CD cluster of differentiation 
cfu colony forming units 
cm2 centimetre squared 
CO2 carbon dioxide 
compl. complemented 
C-terminus carboxy-terminus 
ctr control 
Abbreviations 
 
  
VIII 
DAG diacylglycerol 
dH2O deionized water 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
dNTP deoxyribonucleotide triphosphate 
DTT dithiotretol 
E. coli Escherichia coli 
e.g. exempli gratia (Latin ‘for example’) 
EBM endothelial basal medium 
ec extracellular 
EC endothelial cell 
ECM extracellular matrix 
EDTA ethylenediaminetetraacetic acid 
EEA1 early endosomal antigen 1 
EGM endothelial growth medium 
EM electron microscopy 
EsB energy selective backscattered electron 
et al et alii (Latin ‘and others’) 
FACS fluorescence activated cell sorting 
FAK focal adhesion kinase 
FbaB fibronectin binding protein of group A streptococci type B 
FCS fetal calf serum 
FESEM field emission scanning electron microscopy 
FHL-1 factor H-like protein 1 
FnBP fibronectin binding protein 
fwd forward 
G guanine 
g gram 
Abbreviations 
 
  
IX 
GA glutaraldehyde 
GAS group A streptococcus 
GST glutathione-S-transferase 
GTPase guanosine triphosphatase 
h hour 
HA hyaluronic acid 
HDLEC human dermal lymphatic endothelial cells 
HIS histidine 
HPMEC human pulmonary microvascular endothelial cells 
HUVEC human umbilical vein endothelial cells 
i.e. id est (Latin ‘that is’) 
ic intracellular 
IF immunofluorescence 
IFNγ interferon gamma 
IgG (H+L) immunoglobulin G (heavy and light chain) 
IL interleukin 
ILK integrin linked kinase 
IP3 inositol-3,4,5-trisphosphate 
IPTG isopropyl-β-D-thiogalactopyranoside 
kb kilobase 
kDa kilodalton 
kV kilovolt 
l litre 
L. lactis Lactococcus lactis 
Lamp-1 lysosomal associated membrane protein 1 
LB Luria Bertani 
LTA lipoteichoic acid 
M molarity 
mAB monoclonal antibody 
Abbreviations 
 
  
X 
MCS multiple cloning site 
mg milligram 
MHC major histocompatibility complex 
min minute(s) 
ml millilitre 
mm millimetre 
mM millimol 
MOPS 3-(N-morpholino)propanesulfonic acid 
MQ H2O milli-Q water 
MW molecular weight 
MWCO molecular weight cut off 
N nucleus 
n.s. non-significant 
NETs neutrophil extracellular traps 
ng nanogram 
nm nanometre 
N-terminus amino-terminus 
ø diameter 
O2 oxygen 
OD600 optical density at 600 nm 
p value probability value 
PBS phosphate buffered saline 
PBST phosphate buffered saline with Tween-20 
PCR polymerase chain reaction 
Pen penicillin 
PET polyethylene terephthalate 
PFA paraformaldehyde 
pH potentia Hydrogenii 
PI(4,5)P2 phosphatidylinositol-4,5-bisphosphate 
Abbreviations 
 
  
XI 
PI3K phosphatidylinositol-3-kinase 
PKC protein kinase C 
PLC phospholipase C 
PMNs polymorphonuclear neutrophils 
pmol picomol 
PrtF1 protein F1 
rev reverse 
RGD  arginine-glycine-aspartic acid 
RNase ribonuclease 
rpm rotations per minute 
S. pyogenes  Streptococcus pyogenes 
SD standard deviation 
SDS sodium dodecyl sulphate 
SDS-PAGE SDS-polyacrylamide gel electrophoresis 
sec second(s) 
SfbI streptococcal fibronectin binding protein I 
sic streptococcal inhibitor of complement-mediated lysis 
SLO streptolysin O 
SLS streptolysin S 
Spe streptococcal pyrogenic exotoxin 
Strep streptomycin 
STSS streptococcal toxic shock syndrome 
T thymine 
TA annealing temperature 
TAE Tris-acetate-EDTA 
TCH thiocarbocyanide 
TCR T cell receptor 
TE Tris/EDTA 
TE elongation time 
Abbreviations 
 
  
XII 
TEM transmission electron microscopy 
TEMED N,N,N,N-tetramethylethylenediamine 
TER transendothelial electric resistance 
TES Tris/EDTA/saline 
THB Todd Hewitt broth 
THY Todd Hewitt broth with yeast extract 
TNFα tumor necrosis factor alpha 
TSB tryptic soy broth 
TSBY tryptic soy broth with yeast  
™ trademark 
U units 
Uac uranyl acetate 
UV ultraviolet 
V volt 
v/v volume/volume 
w/v weight/volume 
WASP Wiskott-Aldrich Syndrome proteins 
WAVE WASP family verprolin-homologous proteins 
wt wild type 
α alpha 
β beta 
γ gamma 
∆ delta 
Ω ohm 
Abstract 
 
  
1 
1. Abstract 
Streptococcus pyogenes (S. pyogenes, GAS) is a major human pathogen that causes severe 
invasive diseases associated with high morbidity and mortality. Although various serotypes of 
S. pyogenes are associated with invasive tissue infections, serotype M1 S. pyogenes is 
frequently isolated from patients with necrotizing fasciitis. The development of an invasive 
disease implies that the pathogen has to be able to overcome tissue barriers, one of which is 
the endothelial cell (EC) lining separating the blood stream from the underlying soft tissue.  
This study demonstrates for the first time a direct interaction of serotype M1 GAS with human 
EC. Infection assays using a complex in vitro EC barrier model highlight that M1 GAS 
efficiently invades into human umbilical cord, dermal and lung endothelial cells. A tight 
confluent polarized EC layer proofed to be essential for efficient invasion. The M1 protein 
expressed by serotype M1 S. pyogenes is identified as a strong invasin which mediates 
internalization into EC. Heterologous expression of M1 as well as the use of a M1 knock out 
mutant clearly demonstrates that the M1 protein is sufficient to mediate uptake into EC via a 
phagocytosis-like mechanism. Activation of phospholipase C, protein kinase C and the 
release of intracellular calcium are crucial for efficient invasion of M1 GAS, as inhibition of 
either of those significantly reduces streptococcal uptake. On a cellular level the activation of 
these signalling molecules leads to the formation of membrane protrusions which tightly 
engulf the streptococcal chain resulting in zipper-like uptake of M1 GAS into EC. This 
process comprises a reorganization of the actin cytoskeleton, activation of the Arp2/3 actin 
nucleation complex and accumulation of F-actin at the entry port. Internalized streptococci 
are incorporated into phagosomes which traffic along the classical endocytic pathway, 
accumulate late endosomal/lysosomal markers and finally fuse with lysosomes. However, 
M1 GAS evades the phagolysosome to reside and persist within the cytoplasm of the host 
cell and subsequently crosses the EC lining and is released at the basolateral side of the EC 
layer, facing the underlying soft tissue. 
In conclusion, this study provides new major insights in the invasion of serotype M1 GAS into 
EC and strongly indicates that EC represent target cells for M1 GAS invasion. Invasion into 
EC represents one potential general mechanism of M1 GAS to efficiently evade innate host 
immune responses and to persist intracellular. Subsequent transmigration into underlying 
soft tissue might represent a crucial step in the dissemination into deep tissue and thus, 
would explain why M1 GAS is frequently associated with invasive diseases such as 
necrotizing fasciitis. 
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2. Introduction 
2.1 The genus Streptococcus 
The genus Streptococcus encompasses non-motile, gram-positive, non-spore-forming cocci 
0.6-1 µm in diameter which grow in pairs or chains. As facultative anaerobes with a 
fermentative metabolism, streptococci obtain energy from homolactic fermentation of sugars 
(e.g. glucose) to lactic acid rather than by electron transport and oxidative phosphorylation 
(Olsen et al., 2010).  
The genus Streptococcus comprises various human pathogenic strains including 
Streptococcus pyogenes, Streptococcus dysagalactiae subsp. equisimilis, Streptococcus 
agalactiae and Streptococcus pneumoniae. One major characteristic, which is wildly used for 
taxonomic classification, is the ability of streptococci to lyse red blood cells (Schottmüller, 
1903). According to the lysis capabilities streptococci are divided into α-, β- and γ-haemolytic 
species. The group of β-haemolytic streptococci creates a zone of complete clearing when 
grown on blood agar plates which is characterized by complete lysis of nearby erythrocytes. 
α-haemolysis, on the other hand, is characterized by an incomplete lysis of erythrocytes 
causing a greenish zone surrounding the streptococcal colonies. γ-haemolytic streptococci 
show no haemolysis pattern (Prescott et al., 2005, Salyers et al., 2002).  
 
2.2 Streptococcus pyogenes  
Streptococcus pyogenes (S. pyogenes), the β-haemolytic group A streptococcus (GAS), is 
an important human pathogen which is considered as the most pathogenic species of the 
genus streptococcus (Facklam, 2002). It is an exclusively human pathogen causing a large 
variety of diseases ranging from mild superficial infections to severe invasive diseases 
(Cunningham, 2000, Carapetis et al., 2005). When grown on blood agar plates it shows the 
typical zone of β-haemolysis around the colonies. This feature allows the clear discrimination 
of S. pyogenes from members of the α- and γ-haemolytic streptococci. Within the group of β-
haemolytic streptococci S. pyogenes is further distinguished from other members of this 
group e.g. Streptococcus agalactiae on the basis of serological typing of the group A specific 
surface carbohydrate antigen within the bacterial cell wall. This so called Lancefield grouping 
schema was developed by Rebecca Lancefield in 1933 and divides β-haemolytic 
streptococci into 20 serogroups designated A-H and K-V (Lancefield, 1933). In addition, the 
streptococcal M protein on the cell surface of S. pyogenes has been used for further 
differentiation of S. pyogenes strains. Serological typing of the M protein antigen, firstly 
introduced by Rebecca Lancefield, allows further differentiation of group A streptococci into 
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serotypes (Lancefield, 1928, Lancefield, 1962, Facklam, 2002). This technique is still used 
today and more than 100 different serotypes have been identified so far. Nowadays, 
sequence analysis of the hypervariable region of the emm gene (emm typing) is conducted 
alternatively to serological typing and allows additional classification of GAS into emm types. 
Over 120 emm types have been identified which correlate in most cases with serogroups 
obtained by serological analysis (Beall et al., 1996, Facklam, 2002). 
S. pyogenes is an extremely versatile organism and a major cause for morbidity and 
mortality worldwide (Carapetis et al., 2005). Since S. pyogenes colonizes the throat and the 
skin, superficial infections of the mucous and epithelial membranes such as pharyngitis, 
tonsillitis, impetigo and pyoderma are the most common diseases caused by GAS (Tart et 
al., 2007). The prevalence of GAS pharyngitis is estimated with 616 million cases per year. In 
addition, 111 million incidents of GAS pyoderma, an infection of the epidermis of the face or 
the extremities, have been reported each year (Carapetis et al., 2005). Although these are 
usually mild and uncomplicated infections, they provide a constant reservoir and represent a 
major burden on healthcare (Bisno, 2001, Carapetis et al., 2005, Tart et al., 2007). Post 
infection immune sequelae like rheumatic fever and post-streptococcal glomerulonephritis 
can develop as a complication of untreated upper respiratory tract or skin infections. 
Rheumatic fever mostly affects children with untreated pharyngitis and is the major cause for 
acquired cardiovascular conditions (Guilherme et al., 2000, Olivier, 2000). Although 
rheumatic fever today is relatively uncommon in the industrialized world, high frequencies are 
found in underdeveloped countries and populations with low access to medical health care 
institutions for example the native population in Northern Australia. In these populations 
among 100-200 children out of 100.000 children are affected by rheumatic fever each year 
(Olivier, 2000). Although the exact mechanism of the development of post streptococcal 
conditions remains unclear, there is evidence that molecular mimicry between streptococcal 
components (e.g. the M protein) and components of human tissue (e.g. heart) account for 
the development of these auto-immune conditions (Dale et al., 1985, Kaplan et al., 1964, 
Cunningham, 2000, Guilherme et al., 2000). In addition to superficial infections, GAS is able 
to cause severe invasive and life threatening diseases like sepsis, necrotizing fasciitis and 
streptococcal toxic shock syndrome (STSS). With over 500.000 deaths per year due to 
severe diseases, S. pyogenes is placed among the top ten global killers. It is estimated that 
the prevalence of invasive diseases is 663.000 new cases and 163.000 deaths annually 
(Carapetis et al., 2005). The pathogenesis of invasive streptococcal diseases is covered in 
further detail in chapters 2.3 and 2.4. 
For treatment of GAS infections Penicillin is still the antibiotic of choice. To date, GAS 
remains exquisitely sensitive to Penicillin and no resistances have been reported (Kaplan, 
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1997, Horn et al., 1998, Macris et al., 1998). However, in around 35% of the pharyngitis 
patients treated with Penicillin a failure in complete eradication of GAS is observed (Sela et 
al., 1999) suggesting that S. pyogenes has evolved mechanisms to evade the antimicrobial 
effect of Penicillin. An intracellular niche within tonsillar epithelial cells and the poor cell 
penetration of Penicillin as well as the presence of β-lactamase producing commensal 
bacteria (e.g. Bacillus fragilis) might account for protection and survival of S. pyogenes 
despite antibiotic treatment (Sela et al., 1999, Brook, 2010, Brook, 2013, Kaplan et al., 2006). 
Considering the significant global burden of GAS diseases, research has focused on the 
development of an efficient and safe vaccine which would ideally prevent both pharyngeal 
and skin colonization, invasive diseases as well as rheumatic fever and rheumatic heart 
disease (Dale et al., 2013). However, vaccine development is hindered by the diversity of 
conserved surface antigens, the varying geographic distribution of GAS diseases among 
industrialized and developing countries and the diverging global prevalence of emm types. 
Furthermore, the problem of vaccine safety and the issue of auto-immunity due to cross-
reactivity with human tissue are still major factors contributing to the problems impeding 
vaccine development (Cunningham, 2000, Dale et al., 2013). The streptococcal M protein 
has been the major target for vaccine development and several strategies have focused on 
the type-specific N-terminal region of the M protein which is known to induce type specific 
antibodies (Cunningham, 2000, Dale et al., 2013). A 26- and a 30-valent vaccine candidate 
containing peptides from multiple N-terminal regions of the M protein have turned out as 
promising candidates and are in various stages of clinical and pre-clinical trials (McNeil et al., 
2005, Dale et al., 2011, Dale et al., 2013). In addition, various conserved GAS antigens, 
including the C-terminal region of the M protein, known to be protective against multiple 
serotypes, as well as non-M protein based vaccine candidates (e.g. C5a peptidase, 
fibronectin-binding proteins, pili) and anchorless surface antigens have been considered as 
target antigens and are currently under investigation (Batzloff et al., 2003, Batzloff et al., 
2004, Bauer et al., 2012, Shet et al., 2003, Kawabata et al., 2001, Koller et al., 2010, 
Henningham et al., 2012, Cunningham, 2000, Dale et al., 2013). 
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2.3 Epidemiology of GAS invasive diseases 
In addition to superficial diseases, S. pyogenes infection may lead to severe invasive 
diseases like necrotizing fasciitis and streptococcal toxic shock syndrome, conditions causing 
substantial morbidity and mortality worldwide (Cunningham, 2000, Carapetis et al., 2005). 
The global burden of severe invasive diseases is estimated with 663.000 new cases and 
163.000 deaths per year and places S. pyogenes among the top ten pathogens responsible 
for global mortality (Carapetis et al., 2005). Necrotizing fasciitis is an infection of the 
subcutaneous tissue that is characterized by rapid destruction of the skin, subcutaneous and 
deep soft tissue and muscle. The disease progresses within hours from a seemingly 
harmless skin lesion to rapid tissue destruction and necrosis (Stevens, 2001, Olsen et al., 
2010). Invasive diseases may also be accompanied by streptococcal toxic shock syndrome, 
a disease characterized by massive release of pro-inflammatory cytokines in response to 
streptococcal superantigens resulting in hypotension, toxic shock and multi organ failure 
(Cunningham, 2000, Long et al., 2012).  
Since the late 1980s a resurgence of severe invasive streptococcal diseases has been 
observed worldwide. Various serotypes of S. pyogenes have been associated with invasive 
diseases, however serotype M1 and M3 GAS are most prevalent and together account for 
more than 50% of the severe invasive diseases (Stevens, 2001, Tart et al., 2007, Aziz et al., 
2008). For the development of an invasive disease, the pathogen has to gain access to 
naturally sterile tissue. S. pyogenes may gain access to deeper tissue through a break in the 
epithelial cell layer as a consequence of an injury (Olsen et al., 2009). In addition, risk factors 
include burns, insect bites, varicella, diabetes and intravenous drug abuse (Stevens, 2001). 
However, in a substantial number of cases invasive conditions develop in previously healthy 
individuals with no obvious port of entry (Johansson et al., 2010).  
 
2.4 Pathogen-host interactions underlying invasive GAS diseases 
The major characteristics of severe invasive GAS diseases are substantial tissue destruction, 
bacterial dissemination and systemic disease manifestations (Olsen et al., 2009). The key 
steps in the pathogenesis involve successful colonization of the host, adaptation to the host 
environment and expression of factors that allow subversion of host immune defences and 
vascular dissemination (Olsen et al., 2009). To ensure its survival within the host, 
S. pyogenes expresses an array of surface bound and secreted virulence factors which will 
be discussed in the following chapters (Figure 1, (Nizet, 2007)). 
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Figure 1: Schematic representation of the variety of virulence factors expressed by 
S. pyogenes to circumvent host cell immune defences  
Taken from (Nizet, 2007) 
 
2.4.1 Attachment to the host cell surface 
Adhesion to host cells represents the initial step in establishing a disease and allows the 
pathogen to attach to and subsequently colonize the host (Cunningham, 2000, Yamaguchi et 
al., 2012). To ensure colonization S. pyogenes expresses a large variety of adhesins that 
mediate initial attachment to the mucosal surfaces of the upper respiratory tract and the 
dermal epithelial cells of the skin. The expression of multiple adhesins might favour 
colonization of different tissue sites under varying host environmental conditions and at 
different stages of infection ensuring successful establishment of an infection (Cunningham, 
2000, Bisno et al., 2003, Schwarz-Linek et al., 2006). Binding of bacterial adhesins to cell 
surface receptors frequently involves engagement of extracellular host cell molecules in 
particular components of the extracellular matrix e.g. fibronectin, collagen, vitronectin, and 
laminin which are ubiquitously expressed within the host (Cunningham, 2000). Binding to 
fibronectin has been shown to play a major role for attachment of streptococci to epithelial 
and endothelial cells by acting as a molecular bridge between the bacterial and the host cell 
surface (Yamaguchi et al., 2012, Schwarz-Linek et al., 2006).  
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S. pyogenes expresses multiple adhesins that mediate attachment to various host cells. The 
streptococcal cell wall contains glycolipids such as lipoteichoic acid (LTA) which was 
identified as a streptococcal adhesin for buccal epithelial cells. LTA binds to fibronectin and 
thereby mediates attachment to epithelial cells. The use of anti-LTA antibodies inhibits 
adhesion of streptococci to epithelial cells (Beachey et al., 1976, Simpson et al., 1983, 
Courtney et al., 1983, Courtney et al., 1992, Cunningham, 2000). It has been proposed that 
LTA mediates the first contact of the bacterium to the host cell and that other adhesins are 
required to establish high affinity binding (Hasty et al., 1992, Bisno et al., 2003). 
A large group of GAS adhesins represents the family of fibronectin binding proteins (FnBPs) 
which mediate host pathogen interactions by recognition and binding of extracellular 
fibronectin (Schwarz-Linek et al., 2006, Yamaguchi et al., 2012). Binding of fibronectin to the 
bacterial surface triggers engagement of α5β1-integrins on the host cell surface and 
subsequently successful attachment to the target cell. To date, at least 11 fibronectin binding 
proteins have been described (Yamaguchi et al., 2012). These include SfbI/PrtF1, and 
related proteins SfbII, FBP54, protein 2 and PFBP (Bisno et al., 2003, Talay, 2005). SfbI and 
its allelic variant PrtF1 are the best characterised fibronectin binding proteins of GAS and 
have been shown to mediate adhesion to respiratory epithelial cells (Talay et al., 1992, 
Hanski et al., 1992, Schwarz-Linek et al., 2006). The sfbI (or prtF) gene can be found in more 
than 70% of clinical GAS isolates (Valentin-Weigand et al., 1994). 
In addition, the streptococcal M protein, pili and the hyaluronic acid capsule (HA) act as 
potent adhesins for various cell types. The M1 protein was identified as a potent adhesin on 
human lung epithelial cells. Several studies have shown that serotype M1 GAS mediates 
attachment and subsequent uptake into epithelial cells by binding of the M1 protein to 
fibronectin and subsequent engagement of α5β1-integrins on the host cell surface. Blocking of 
either the M1 protein on the bacterial surface or the host cell fibronectin binding receptor 
significantly decreased adherence and invasion of serotype M1 GAS into epithelial cells. 
(Cue et al., 1998, Dombek et al., 1999, Cue et al., 2000). Furthermore, the M protein of GAS 
has been demonstrated to recognize membrane cofactor protein CD46 thereby mediating 
attachment to keratinocytes in skin infections (Okada et al., 1995, Cunningham, 2000). The 
M3 protein of GAS was shown to target type I and type IV collagen fibres, a process which 
favours colonization (Dinkla et al., 2003). The hyaluronic acid capsule also acts as a potent 
adhesin either by binding of cell surface receptors via collagen or by directly binding to 
human CD44 the cell surface receptor of keratinocytes on epithelial cells (Schrager et al., 
1998, Dinkla et al., 2003).   
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2.4.2 Resistance to host immune defence mechanisms 
Professional phagocytic cells e.g. macrophages and polymorphonuclear neutrophils (PMNs) 
represent major cell types of the innate immune system which represent an important line of 
defence against invading pathogens. Professional phagocytes efficiently internalize and 
eliminate bacterial pathogens (Sarantis et al., 2012). However, S. pyogenes has evolved 
multiple mechanisms to circumvent phagocytosis which is important to ensure successful 
survival within the human host. 
Both, the M protein and the hyaluronic acid capsule of GAS, have been described to confer 
antiphagocytic properties (Moses et al., 1997, Wessels et al., 1991). The streptococcal M 
protein is composed of two polypeptide chains which form an alpha-helical dimer which 
protrudes from the streptococcal cell surface. The C-terminal region of the M protein is highly 
conserved among GAS strains and is anchored to the cell membrane via a LPXTG motif. 
The hypervariable N-terminal region extends from the cell surface and constitutes for the 
production of type specific antibodies (Phillips et al., 1981, Cunningham, 2000, Bisno et al., 
2003). The M protein of GAS is known to exert its antiphagocytic properties in non-immune 
individuals by interfering with the activation of the alternative complement pathway (Bisno, 
1979). Several mechanisms have been described so far. On the one hand the M protein 
binds to regulatory components of the complement pathway like factor H or factor H-like 
protein (FHL-1) (Horstmann et al., 1988, Bisno et al., 2003, Nizet, 2007). Binding of factor H 
to the C-terminal region of the M protein impedes the deposition of soluble complement 
factor C3b resulting in inhibition of the activation of the alternative complement pathway and 
in turn inhibition of phagocytosis (Cunningham, 2000, Bisno et al., 2003). On the other hand 
the M protein binds human fibrinogen to its surface. Binding of fibrinogen blocks the 
activation of the alternative complement pathway, again by diminishing the amount of C3b 
deposited on the bacterial cell surface and thereby inhibiting phagocytosis by 
polymorphonuclear leukocytes (Cunningham, 2000, Bisno et al., 2003). In addition, several 
other M related surface proteins (e.g. M49, Mrp, Enn-49, FcrA) of GAS have been identified 
and have been shown to contribute to the antiphagocytic properties of GAS (Podbielski et al., 
1996, Ji et al., 1998, Bisno et al., 2003). 
Another major streptococcal factor which promotes resistance to phagocytosis is the capsule 
(Nizet, 2007). It is composed of a polymer of hyaluronic acid similar to hyaluronate present in 
human connective tissue. Due to these similarities the hyaluronic acid capsule of GAS is a 
poor immunogen. Studies have shown that non-encapsulated strains are more susceptible to 
phagocytosis and are less virulent in mice than encapsulated strains. In addition, GAS 
strains which are highly encapsulated and produce high amounts of M protein are found to 
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be extremely virulent for humans and the cause of severe invasive diseases (Cunningham, 
2000, Bisno et al., 2003, Nizet, 2007).  
The recruitment of professional phagocytic cells from the vasculature to the site of infection is 
mediated by the release of chemoattractants for example the chemokine interleukin-8 (IL-8) 
and the complement factor C5a. S. pyogenes interferes with host cell chemotactic 
components by the production of factors with enzymatic activities e.g. SpyCEP and C5a 
peptidase. The streptococcal protease SpyCEP inactivates IL-8 by specific cleavage of the 
C-terminus, thereby impairing leucocyte recruitment (Nizet, 2007, Tart et al., 2007). 
Furthermore, the C5a peptidase of GAS which is anchored to the streptococcal cell wall 
cleaves complement factor C5a. By inactivating C5a streptococci inhibit the recruitment of 
polymorphonuclear neutrophils to the site of infection, hence promoting resistance to 
phagocytosis and aiding dissemination within the host (Wexler et al., 1985, Ji et al., 1996, 
Cunningham, 2000, Nizet, 2007). 
An additional streptococcal factor possibly contributing to GAS virulence is the streptococcal 
inhibitor of complement-mediated lysis (SIC) which blocks the assembly of the complement 
membrane attack complex thereby preventing lysis of the bacterium (Cunningham, 2000, 
Bisno et al., 2003). 
 
2.4.3 Extracellular virulence factors  
In addition to surface bound virulence factors, S. pyogenes produces several extracellular 
proteins which contribute to virulence favouring rapid tissue destruction, streptococcal spread 
and inducing the clinical manifestations observed in severe invasive diseases e.g. 
necrotizing fasciitis and STSS (Bisno et al., 2003).  
S. pyogenes produces two exotoxins streptolysin O (SLO) and streptolysin S (SLS) which 
are major virulence factors that contribute to the pathogenesis of invasive diseases (Nizet, 
2007, Tart et al., 2007). Both belong to the family of pore-forming cytolysins and have been 
shown to be toxic for a variety of cell types including erythrocytes, polymorphonuclear 
neutrophils, platelets and subcellular organelles such as lysosomes and mitochondria. SLO 
is an oxygen labile haemolysin produced by almost all GAS strains and which is, therefore, 
inhibited in an oxygen rich environment (Bisno et al., 2003, Nizet, 2002). 
In addition to their function as professional phagocytes, neutrophils are also able to capture 
and subsequently kill pathogens by their entrapment in a mesh of DNA and histone 
molecules so called neutrophil extracellular traps (NETs). The production of DNases (e.g. 
SdaI) which degrade DNA enables S. pyogenes to successfully escape from NETs (Nizet, 
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2007, Tart et al., 2007). Streptococcal tissue spread is further facilitated by degradation of 
hyaluronic acid components of human connective tissue by the streptococcal enzyme 
hyaluronidase (Bisno et al., 2003). Streptokinase, a plasminogen binding protein found in 
almost all GAS isolates, also plays an important role in GAS virulence. Streptokinase binds 
plasminogen and converts it to plasmin which in turn dissolves fibrin clots, a process 
favouring tissue spread (Cunningham, 2000, Bisno et al., 2003). Furthermore, S. pyogenes 
produces streptococcal pyrogenic exotoxin B (SpeB), a cysteine protease, which exerts 
multiple functions contributing to the tissue damage observed in invasive diseases 
(Cunningham, 2000, Bisno et al., 2003). Beside its role in the activation of human matrix 
metalloproteinases it is able to degrade several components of the extracellular matrix e.g. 
vitronectin and fibronectin (Kapur et al., 1993, Burns et al., 1996). On the other hand SpeB 
activates the pro-inflammatory cytokine interleukin 1 beta (IL-1β) by conversion of the 
precursor into its active form (Kapur et al., 1993) which suggests a role of SpeB in the 
pathogenesis of STSS (Bisno et al., 2003).   
In addition to SpeB, a large variety of streptococcal pyrogenic exotoxins (Spe’s) has been 
identified including SpeA, SpeC, SpeD, SpeF, SpeG, SpeH, SpeJ, SpeK, SpeL, SMEZ, 
SMEZ-2 and SSA. The family of Spe’s acts as bacterial superantigens which unspecifically 
bind to the T-cell receptor (TCR) and MHC class II molecules without prior processing by 
antigen-presenting cells. Binding results in activation and proliferation of large numbers of T-
cells which in turn release massive amounts of pro-inflammatory cytokines such as tumor 
necrosis factor alpha (TNFα), IL-1β, IL-2 and interferon gamma (IFNγ). This overshooting 
inflammatory response may lead to endocytic shock, fever, hypotension and multi organ 
failure representing the clinical characteristics of STSS (Cunningham, 2000, Bisno et al., 
2003). 
 
2.4.4 Invasion into eukaryotic cells 
Internalization into host cells represents another successful mechanism of S. pyogenes that 
might contribute to the pathogenesis of invasive diseases. Although traditionally viewed as 
an extracellular pathogen, various studies have shown that S. pyogenes is able to induce 
invasion into non-phagocytic cells with internalization rates comparable to those of classical 
intracellular pathogens (LaPenta et al., 1994, Greco et al., 1995, Molinari et al., 1997, 
Jadoun et al., 1998, Rohde et al., 2003, Nerlich et al., 2009, Amelung et al., 2011). The 
biological relevance of an intracellular state has been controversial but might represent 
several biological advantages. On the one hand an intracellular ‘lifestyle’ might provide a 
niche which allows streptococci to be protected from phagocytes, humoral antibodies and 
antibiotic treatment. This might promote carriage and streptococcal persistence within the 
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human host. On the other hand invasion into host cells might represent the first step in the 
dissemination from the primary site of infection into deep tissue (Cunningham, 2000, Bisno et 
al., 2003, Schwarz-Linek et al., 2006). A study of Osterlund and colleagues gave first 
evidence that an intracellular habitat of GAS might constitute a relevant mechanism for in 
vivo persistence. This study showed that viable GAS could be recovered from biopsies of 
infected tonsils from patients with recurrent pharyngotonsillits. This suggests that an 
intracellular niche constitutes an essential step for streptococcal persistence within the host 
and hence contributes to the pathogenesis of GAS infections (Osterlund et al., 1997).  
 
2.5 Invasion mechanisms of S. pyogenes 
Since various reports have shown that S. pyogenes is able to trigger its own uptake into host 
cells, research has focused on the identification of bacterial and host cell factors as well as 
the molecular mechanisms that contribute to the internalization process.  
The streptococcal surface proteins M1 and the major fibronectin-binding protein SfbI (and its 
allelic variant protein F1) not only mediate adhesion to host cells, as previously described, 
but also represent potent invasins mediating efficient internalization into epithelial cells 
(Molinari et al., 1997, Talay et al., 2000, Jadoun et al., 1998, Ozeri et al., 1998, Rohde et al., 
2003, Cue et al., 1998, Dombek et al., 1999). Studies of the invasion mechanism using 
different GAS strains have identified distinct invasion patterns dependent on the invasin 
expressed on the streptococcal surface (Molinari et al., 2000). M1-expressing and SfbI-
negative strains invade host cells by cytoskeletal rearrangements characterized by the 
formation of membrane protrusion that tightly engulf the streptococcal chain and subsequent 
zipper-like uptake of streptococci into epithelial cells (Dombek et al., 1999, Molinari et al., 
2000). On the other hand SfbI-expressing strains use the formation of large membrane 
invaginations for internalization into host cells (Molinari et al., 2000, Rohde et al., 2003).  
Studies on the cellular processes triggered by M1 or SfbI revealed common pathways as well 
as characteristic features initiated by each invasin. Figure 2 shows a schematic 
representation of the signalling pathways initiated by M1- and SfbI/F1 protein leading to 
S. pyogenes uptake into epithelial cells. A pre-requisite for both, M1- and SfbI-mediated 
invasion processes, is binding of the extracellular matrix protein fibronectin. Fibronectin acts 
as a bridging molecule by binding to α5β1-integrins on the host cell surface via its RGD 
(arginine, glycine, aspartic acid) motive (Cue et al., 1998, Molinari et al., 1997, Molinari et al., 
2000, Talay et al., 2000, Jadoun et al., 1998, Ozeri et al., 1998). Integrin engagement on the 
host cell surface leads to the formation of focal adhesions which function as signalling and 
docking sites for a variety of cytoskeletal proteins, thereby linking the extracellular matrix 
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(ECM) to the actin cytoskeleton (Brakebusch et al., 2003, Wang et al., 2007). Upon 
association with integrins both, M1 and SfbI, initiate the recruitment and phosphinositide 3-
kinase (PI3K) dependent activation of the integrin linked kinase (ILK) and subsequent 
phosphorylation and assembly of paxillin and the focal adhesion kinase (FAK) at the port of 
entry (Purushothaman et al., 2003, Wang et al., 2006, Wang et al., 2007, Ozeri et al., 2001). 
In the case of M1-expressing strains, phosphorylation of paxillin is absolutely essential for 
efficient uptake processes. It provides additional docking sites for cytoskeletal proteins 
promoting cytoskeletal rearrangements (Wang et al., 2007). In contrast to this, in SfbI/F1-
mediated entry processes paxillin phosphorylation is also induced but does not seem to be 
necessarily required for SfbI/F1-mediated entry processes. Instead, Wang et al speculated 
that in SfbI-mediated uptake paxillin acts as a scaffold for additional signalling molecules 
such as the src family kinases (Wang et al., 2007). Recruitment of src kinases causes the 
phosphorylation of caveolin-1 and the formation of membrane invaginations (Wang et al., 
2007). In addition, Ozeri and colleagues have observed involvement of the small GTPase 
Rac and Cd42 in internalization of SfbI/F1 expressing streptococci (Ozeri et al., 2001).  
 
 
Figure 2: Schematic representation of signalling pathways and corresponding uptake 
processes initiated by M1- and SfbI/F1- expressing S. pyogenes  
Both M1 and SfbI/F1 protein bind to soluble fibronectin and subsequently bind to α5β1-integrins on the host cell 
surface. Integrin engagement triggers an intracellular signalling cascade including assembly and activation of 
PI3K, ILK, paxillin and FAK. In the case of M1-mediated entry signalling cascades lead to actin cytoskeletal 
rearrangements and zipper-like uptake of M1-expressing strains. SfbI/F1-mediated signalling pathways trigger 
caveolae formation via the phosphorylation of caveolin-1 by src family kinases and subsequent uptake of S. 
pyogenes by caveolae-mediated endocytosis (Taken from (Wang et al., 2007)). 
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Initiation of different signalling cascades correlates with the observation of distinct uptake 
and intracellular trafficking processes of M1- and SfbI/F1-expressing streptococci. M1-
mediated internalization is characterized by great cytoskeletal rearrangements of the host 
cell membrane. The re-organization of the cytoskeleton is accompanied with actin 
polymerization and actin recruitment to the site of streptococcal entry. Membrane microvilli 
and pseudopod-like structures are formed which tightly engulf invading streptococci resulting 
in zipper-like uptake of M1-expressing streptococci into epithelial cells. Following uptake, 
internalized streptococci reside within membrane-bound phagocytic vacuoles which are 
positive for the late endosomal/lysosomal marker protein 1 (Lamp-1) indicating trafficking 
along the classical endosomal pathway with subsequent lysosomal fusion (Dombek et al., 
1999). The association of streptococci containing vacuoles with Lamp-1 is in line with 
previous observations of Greco and colleagues who showed fusion of phagocytic 
compartments with lysosomes (Greco et al., 1995). 
In contrast, in SfbI-expressing strains co-operative binding of fibronectin results in the 
presentation of multiple RGD binding sites in fibronectin, thus, triggering integrin clustering 
and subsequent accumulation of small omega shaped cavities in the vicinity of attached 
streptococci (Rohde et al., 2003). These cavities were identified as caveolae which have 
already been described as entry ports for other bacteria (e.g. FimH expressing Escherichia 
coli, Chlamydia trachomatis), viruses (e.g. echovirus, SV40 virus) as well as parasites (Shin 
et al., 2001c, Shin et al., 2001a, Shin et al., 2001b, Baorto et al., 1997, Norkin et al., 2001, 
Marjomaki et al., 2002, Pelkmans et al., 2001). At later stages caveolae aggregate and fuse 
forming large invaginations enabling uptake of SfbI-expressing streptococci. Subsequently 
streptococci are incorporated into caveosomes which are positive for caveolin-1 but lack 
markers of the classical endocytic pathway like Lamp-1 and Rab7. In addition, neither 
acidification of caveosomes nor lysosomal fusion events are detectable. Thus, by co-opting 
caveloae-mediated endocytosis, SfbI-expressing streptococci bypass the classical 
endosomal/lysosomal pathway, prevent fusion with lysosome and thereby ensure protection 
from host cell defence mechanisms (Rohde et al., 2003). 
The development of diverse uptake mechanisms, in spite of the initiation of similar signalling 
pathways triggered by binding of M1/SfbI to fibronectin and subsequent engagement of 
integrins on the host cells surface, demonstrates the high variability of S. pyogenes. Wang et 
al hypothesized that different binding properties and binding affinities of M1 and SfbI to 
fibronectin might account for the initiation of distinct uptake mechanisms (Wang et al., 2007). 
Furthermore, the expression of M1 and SfbI is tightly regulated. The M1 protein is expressed 
under high CO2 conditions while SfbI is expressed in O2-rich environments (Caparon et al., 
1992, Gibson et al., 1995, Wang et al., 2007). Thus, the initiation of different signalling and 
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uptake processes might favour streptococcal survival at different tissue sites under various 
host environmental conditions and at different stages of infection ensuring successful 
establishment of a disease (Wang et al., 2007). 
 
2.6 Streptococcal dissemination from the primary site of infection into deeper tissue 
A pre-requisite for the development of an invasive disease is the ability of the pathogen to 
overcome tissue barriers. Breaks of the epithelial cell layer, for example as a consequence of 
physical injury, burns and viral infections, provide entry ports for the transition of S. pyogenes 
into deep tissue and, thus, constitute risk factors for the development of invasive diseases 
(Olsen et al., 2009, Stevens, 2001). However, in a substantial number of cases invasive 
diseases develop in previously healthy individuals with no obvious port of entry. It has been 
suggested that the source of bacteria in these cases is a transient bacteremia originating 
from the oropharynx (Johansson et al., 2010). The transition of S. pyogenes from the blood 
stream into deeper tissue requires its ability to overcome the endothelium of the blood vessel 
which is one of the strongest cellular barriers in the human body. Thus, the endothelial cell 
lining of the vascular system might possibly represent target cells for S. pyogenes invasion. 
The endothelium constitutes the inner layer of the blood vessels of the entire vascular 
system within the human body (Figure 3). Endothelial cells form a continuous single layer 
lining the interior of the blood vessel wall thereby forming an active barrier between the blood 
and the underlying tissue, allowing selective transport of metabolites and nutrients (Sumpio 
et al., 2002). In addition to its barrier function, it also plays a major role in the regulation of 
homeostasis, the modulation of blood flow and vessel tone, coagulation, fibrinolysis as well 
as angiogenesis and vasculogenesis (Sumpio et al., 2002, Pries et al., 2006). In immune 
reactions and inflammatory responses the endothelium regulates the extravasation of 
leukocytes from the blood stream into the tissue to the site of infection (Sumpio et al., 2002).  
Staali and colleagues have demonstrated that serotype M1 GAS ensures its survival within 
human PMNs by impairing fusion of azurophilic granules with phagosomes containing 
intracellular streptococci thereby avoiding intracellular killing (Staali et al., 2003, Staali et al., 
2006). In addition, Medina and colleagues could re-isolate viable S. pyogenes from 
neutrophils after in vivo infection of mice (Medina et al., 2003). The ability of neutrophils to 
move from the blood stream into tissue together with the observation of intracellular survival 
of S. pyogenes within neutrophils led the authors to hypothesise that S. pyogenes might 
exploit neutrophils as vehicles for the transport across the endothelium (Trojan horse theory), 
a process which facilitates dissemination into deeper tissue (Medina et al., 2003). Recent 
studies have further highlighted the import role of the endothelium during the pathogenesis of 
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S. pyogenes deep tissue infections. Serotype M3 GAS has been shown to directly interact 
with and invade endothelial cells (Nerlich et al., 2009). The fibronectin-binding protein FbaB 
has been identified as the endothelial cell invasin which mediates phagocytosis-like uptake of 
S. pyogenes into endothelial cells of the umbilical cord (Amelung et al., 2011). It has been 
shown that after transcytosis viable serotype M3 GAS are released at the basement 
membrane via lysosomal exocytosis (Talay, unpublished data). 
 
 
Figure 3: Schematic representation of the composition of a blood vessel  
(http://www.siumed.edu/~dking2/crr/cvguide.htm) 
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2.7 Aim of the study 
S. pyogenes has been the cause for severe life-threatening invasive infections including 
sepsis, necrotizing fasciitis and streptococcal toxic shock syndrome (Cunningham, 2000). 
Although various serotypes have been associated with these severe invasive infections, 
serotype M1 is frequently isolated from patients with necrotizing fasciitis (Stevens, 2001, Tart 
et al., 2007). A pre-requisite for the development of invasive infections is the ability of the 
pathogen to disseminate from the primary site of infection, a process which requires crossing 
of cellular and tissue barriers, one of which is the endothelial cell lining of the blood vessels. 
Studies have already identified a role of invasion of endothelial cells in the pathogenesis of 
serotype M3 S. pyogenes. However, despite the well characterized interaction of the most 
invasive serotype M1 S. pyogenes with epithelial cells, nothing is known about its interaction 
with endothelial cells. Thus, the focus of this study is the characterization of the molecular 
interactions of tissue-invasive serotype M1 S. pyogenes with human endothelial cells of the 
umbilical cord. By using a complex in vitro infection model, i.e. the establishment of an 
artificial EC barrier model, the invasion potential, in particular the mode of internalization, 
intracellular trafficking as well as the mechanism of survival of serotype M1 GAS within 
endothelial cells was to be elucidated. The use of defined M1 GAS knock out mutants, 
heterologous expression of M1 GAS factors and blocking experiments aimed to identify 
relevant bacterial and host cell factors that determine endothelial cell interaction as well as 
underlying signalling cascades in endothelial cells.  
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3. Materials and Methods 
3.1 Materials 
3.1.1 Chemicals/solutions 
 
Table 1: Chemicals and solutions used in this study 
Chemical/solution Company 
10x coral load PCR buffer Qiagen 
5x phusion high fidelity PCR  buffer Thermo Scientific 
6x loading dye (agarose gel electrophoresis) Fermentas 
Acetic acid Merck 
Acrylamide 30% (Rotiphorese Gel 30) Roth 
Agar-Agar, Kobe I Roth 
Agarose Broad range (NEEO Ultra quality) Roth 
Ammoniumpersulfate (APS) Serva 
Ampicillin Applichem 
Bacto™ Tryptic Soy Broth (TSB) Becton Dickinson 
Bacto™ Tryptone Becton Dickinson 
Bacto™ Yeast Extract Becton Dickinson 
BAPTA-AM Calbiochem 
Bovine serum albumin (BSA) Sigma Aldrich 
Bromophenol blue Sigma Aldrich 
Calcium chloride (CaCl2) Merck 
Calphostin C Enzo 
Chloroform Sigma Aldrich 
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Colloidal gold nanoparticles BBInternational 
Columbia blood agar plates Becton Dickinson 
Coomassie Brilliant Blue R-250 Sigma Aldrich 
Cu grids  Plano 
Difco™ M17 broth Becton Dickinson 
Dimethylsulfoxid (DMSO) Sigma Aldrich 
Di-sodiumhydrogenphosphat (Na2HPO4) Merck 
dNTPs Fermentas 
Edelfosine (ET-18-OCH3) Calbiochem 
Erythromycin Sigma Aldrich 
Ethanol J. T. Baker 
Ethidium bromide Applichem 
Ethylenediaminetetraacetic acid (EDTA) Gibco 
Fetal calf serum (FCS) PAA 
Gelatine Sigma Aldrich 
Gene ruler™ DNA ladder mix, 100-1000 bp Fermentas 
Gentamycin Sigma Aldrich 
Glucose Roth 
Glutaraldehyde 25% Merck 
Glutathion S-Transferase (GST) protein Abcam 
Glycerol Roth 
Glycine Roth 
HEPES-BSS Promocell 
Immersol 518N Zeiss 
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Isopropyl alcohol Merck 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Applichem 
Kanamycin Roth 
Lactose Roth 
LysoTracker® Red DND-99 Invitrogen 
Lysozyme Sigma 
Magnesium chloride (MgCl2)  Qiagen 
Manganese chloride Riedel-de Haën 
Methanol J. T. Baker 
MOPS (3-(N-morpholino)propanesulfonic acid) Roth 
Mutanolysine Sigma  
Osmium tetroxide 1%, aqueous Roth 
Page Ruler™ Plus Pre-stained Protein Ladder Fermentas 
Paraformaldehyde (PFA) solution, 4% in PBS USB Corporation 
Pb citrate (ultrastain 2) Leica 
Penicillin G Sigma Aldrich 
Penicillin/Streptomycin Pan Biotech GmbH 
Paraformaldehyde, 25% in H2O Sigma Aldrich 
Phusion® Hot Start II High fidelity DNA Polymerase Thermo Scientific 
Potassium acetate (KAc) Sigma 
Potassium carbonate (K2CO3) Merck 
Potassium chloride (KCl) Riedel- de Haën 
Potassium dihydrogenphosphate (KH2PO4) Roth 
ProLong® Gold antifade reagent Invitrogen 
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ProLong® Gold antifade reagent with DAPI Molecular probes 
Proteinase K Fluka 
RNase (DNase-free) Applichem 
Roti®-Phenol Roth 
Rubidium chloride Applichem 
Saponin Fluka 
Sodium acetate  Fluka 
Sodium chloride (NaCl) Roth 
Sodium dodecyl sulphate (SDS) Sigma Aldrich 
Sodium hydroxide (NaOH) Merck 
Spectinomycin Sigma Aldrich 
Spurr resin Sigma/Fluka 
Sucrose Fluka 
T4 DNA ligase  New England Biolabs 
Taq DNA polymerase Qiagen 
TEMED Biorad 
Todd Hewitt Broth (THB) Roth 
Tris Sigma Aldrich 
Triton-X-100 Sigma Aldrich 
Trizma Base Sigma Aldrich 
Trypsin/EDTA Promocell 
Tween 20 Applichem 
Uranyl acetate (Uac) 4%, (w/v) Serva 
β-mercaptoethanol Serva 
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3.1.2 Expendable material 
 
Table 2: Expendable material used in this study 
Material Company 
Cell culture insert, transparent PET membrane, 
 24 well (0.4 µm and 3.0 µm pore size) 
Becton Dickinson 
Cell Star® 15 ml tubes  Greiner bio-one 
Cell Star® 50 ml tubes  Greiner bio-one 
Coverslips (ø 12 mm) Thermo Scientific 
Cryo tube™ vial Nunc™ 
Cuvettes polystyrene 10x 4x 45 mm Sarstedt 
Electroporation cuvettes, 2 mm electrode gap Peqlab Biotechnologie GmbH 
Gelatine capsules, operculatae No.2 Pharmapol 
Latex beads (ø 3 µm) Sigma Aldrich 
Micro tube 1.5 ml Sarstedt 
Microscope slides 76x 26 mm Thermo Scientific 
PCR tubes 0.2 ml Starlab 
Petri dish  Greiner bio-one 
Safe seal micro tube 2 ml Sarstedt 
Servpor® dialysis tubing (MWCO 12-14000) Serva 
TPP Tissue culture dish 100, growth area 60.1 cm2 Sigma Aldrich 
TPP Tissue culture test plate 24 well Sigma Aldrich 
TPP Tissue culture test plate 96 well Sigma Aldrich 
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3.1.3 Instruments 
 
Table 3: Instruments and equipment used in this study 
Instrument Company 
Agarose gel chambers  Horizon™ 58 
Autoclave-steam sterilizer Biomedis 
Biofuge primo Heraeus 
CellZscope® Nano Analytics 
Centrifuge 5417R Eppendorf 
Centrifuge 5804R Eppendorf 
CO2 water jacketed incubator Forma Scientific 
Critical point dryer (CPD030, CPD300) BalTec, Leica 
Cryo 1°C freezing container  Nalgene™ 
FACS Calibur BD Becton Dickinson 
FESEM DSM 982 Gemini Zeiss 
FESEM Merlin Zeiss 
French® pressure cell press (SLM Aminco, 40.000 PSI) Thermo Fisher 
Gene Pulser™ and pulse controller BioRad 
HERA Cell 150i CO2 Incubator  Thermo Scientific 
Incubator Kelvitron® Heraeus Instruments  
Infors HT multitron shaking incubator Tuttnauer 
Kodak IS2000R gel documentation unit Intas 
Megafuge 1.0 Heraeus 
Microwave Pro 825 Whirlpool 
Materials and Methods 
  
23 
Mini Protean II™ system  BioRad 
Nano Drop® Thermo Scientific 
Novaspec II spectophotometer Amersham Pharmacia Biotech 
pH-meter 766  Calimatic Knick 
Power pack 200 BioRad 
Power pack 300 BioRad 
Roller mixer SRT6 Stuart 
Rotor TLA 100.2 Beckmann 
Shaking device Unimax 2010 Heidolph Instruments 
Sorvall® RC 6 Plus, rotor SLA-3000 Thermo Electron Corporation 
Sorvall® RC 6 Plus, rotor SS-34 Thermo Electron Corporation 
Special accuracy weighing machine AE 260 Delta Range® Mettler 
Sputter coater SCD 500 BalTec 
TEM EM 910 Zeiss 
Thermocycler Biometra 
Thermomixer Comfort Eppendorf 
Transferpette® S-8 (multichannel pipet) Brand 
Ultra centrifuge TL-100 Beckmann 
Ultramicrotome, Reichert ultracut Leica 
Ultratrimm, Reichert Leica 
UV-transilluminator Herolab UVT 2020 
Vortex Genie 2™ Bender + Hobein AG 
Wallac 1470 Wizard gamma counter Perkin Elmer 
Waterbath GFL 
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Weighing machine PC 2000 Mettler 
Zeiss Axio Cam MRm camera Zeiss 
Zeiss Axio Imager A2 Zeiss 
Zeiss AxioCam HRc digital camera Zeiss 
Zeiss Axiophot Zeiss 
Zeiss Microscope ID03 Zeiss 
 
3.1.4 Oligonucleotides  
 
Table 4: Oligonucleotides used in this study 
Name Sequence 5’-3’ Annotation/ 
reference 
 
Primer for amplification of emm1 
(complementation of M1 knock out mutant) 
 
M1_fwd_KpnI GCGGTACCCCTGAAAATGAGGGTTTCTTC KpnI restriction site 
M1_rev_XbaI GCGTCTAGACTCCTTAACCTCATTCTTCTATAC XbaI restriction site 
 
Primer for amplification of emm1 
(expression of recombinant M1-HIS fusion 
protein) 
 
His_M1_fwd 
 
GCCGCCATGGGATTAAAAACAGGAACGGCTTC
AGTAGCG 
NcoI restriction site 
His_M1_rev 
 
GCCGGGATCCCTGTCTCTTAGTTTCCTTCATTG
GTGC 
BamHI restriction 
site 
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Name Sequence 5’-3’ Annotation/ 
reference 
 Primer for colony PCR 
and sequencing of pDCerm 
 
pDC_MCS_fw GCCATACCACAGATGTTCCA provided by S. 
Amelung (HZI, 
Braunschweig) 
pDC_MCS_rev GCTTTTTCAGATTCAGTTGCCTTC provided by S. 
Amelung (HZI, 
Braunschweig 
 Primer for colony PCR and sequencing of 
pQE60 
 
pQE60_5’ CCGTGAGCGGATAACAATTTCACACAGGG provided by K. 
Branitzki-
Heinemann (HZI, 
Braunschweig) 
pQE60_3’ CCGATGGAGTTCTGAGGTCATTACTGGGG provided by K. 
Branitzki-
Heinemann (HZI, 
Braunschweig) 
 Primer for 16s RNA sequencing 
 
16s_fwd AGAGTTTGATCCTGGCTC provided by A. 
Babbar (HZI, 
Braunschweig) 
16s_rev GGTTACTTGTTACGACTT provided by A. 
Babbar (HZI, 
Braunschweig) 
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3.1.5 Antibodies 
 
Table 5: Primary antibodies used in this study 
Antibody/serum Dilution 
immunofluorescence 
Source/company 
Rabbit anti-S. pyogenes serum, 
polyclonal (anti-GAS) 
1:100 (Molinari et al., 1997) 
Rabbit anti-Lactococcus lactis 
serum 
1:100 Kindly provided by Dr. S. 
Talay (HZI, Braunschweig) 
Mouse anti-human beta 1 integrin 
labelling antibody (MAB 2079Z) 
5 µg/well Chemicon International 
Mouse anti-human beta 1 integrin 
blocking antibody (MAB 1987Z) 
1:100 Millipore 
Mouse anti-human alpha 1 integrin 
blocking antibody (MAB 1973Z) 
1:100 Chemicon International 
Mouse anti-human alpha 2 integrin 
blocking antibody (MAB 1950Z) 
1:100 Chemicon International 
Mouse anti-Arp2/3 (p16 #323H3) 1:50 Kindly provided by Dr. C. 
Erck (Research Group 
Cellular Proteome 
Research, HZI, 
Braunschweig)  
Mouse anti-human CD107a 
(Lamp-1) 
1:50 BD Pharmingen™ 
Rabbit anti-GST (ab 9085) 1:100 Abcam 
Rabbit anti-M1  1:100 Kindly provided by Dr. S. 
Talay (HZI, Braunschweig) 
ALEXA Fluor® 488 phalloidin  1:100 Invitrogen 
ALEXA Fluor® 568 phalloidin  1:100 Invitrogen 
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Table 6: Secondary antibodies used in this study 
Antibody Dilution Source/company 
ALEXA Fluor® 488 goat-anti-rabbit IgG (H+L) 1:200 Invitrogen 
ALEXA Fluor® 568 goat-anti-rabbit IgG (H+L) 1:300 Invitrogen 
ALEXA Fluor® 488 goat-anti-mouse IgG (H+L) 1:200 Invitrogen 
 
3.1.6 Vectors 
 
Table 7: Vectors used in this study 
Vector Vector size Selection conditions Reference/source 
pDCerm 4690 bp 500 µg ml-1 erythromycin Kindly provided by Prof. V. Nizet, 
UCSD, San Diego 
pQE60 3431 bp 100 µg ml-1 ampicillin Qiagen 
 
3.1.7 Restriction endonucleases 
All enzymes and corresponding enzyme buffers were purchased from New England Biolabs. 
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3.1.8 Antibiotics 
 
Table 8: Antibiotics used in this study 
Name  Application Final 
concentration 
Source/company 
Ampicillin Culturing of Escherichia coli 
(E. coli) carrying pQE60 and 
its derivatives  
100 µg ml-1 Applichem 
Erythromycin E. coli carrying pDCerm and 
its derivatives 
S. pyogenes carrying 
pDCerm derivatives 
Lactococcus lactis (L. lactis)  
carrying pLM1 or pP59 
500 µg ml-1 
 
2 µg ml-1 
5 µg ml-1 
Sigma Aldrich 
Gentamycin Killing of extracellular 
bacteria during survival 
assays 
100 µg ml-1 Sigma Aldrich 
Kanamycin Culturing of E. coli M15 
Culturing of S. pyogenes 
mutant strain A528 
25 µg ml-1 
150 µg ml-1 
Roth 
Penicillin G Killing of extracellular 
bacteria during survival 
assays 
5 µg ml-1 Sigma Aldrich 
Penicillin/Streptomycin Cell culture  100 U 
Penicillin/ml 
0.1 mg 
Streptomycin/ml 
PAN™ Biotech 
GmbH 
Spectinomycin Culturing of S. pyogenes 
mutant strains A585 and 
A591 
80 µg ml-1 Sigma Aldrich 
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3.1.9 Kits 
 
Table 9: Kits used in this study 
Kit Company 
QIAprep® Spin Miniprep Kit Qiagen 
PCR Extract & Gel Extract Mini Kit 5Prime 
QIAquick PCR Purification Kit Qiagen 
Protino® Ni-TED 150 Purification of  
polyhistidine-tagged proteins Kit 
Macherey-Nagel 
Live/Dead® Baclight™ Bacterial Viability Kit Invitrogen 
    
3.1.10 Buffers 
 
Table 10: Buffers used in this study 
10x PBS  
NaCl 80 g 
KCl 2 g 
Na2HPO4·2H2O 7.6 g 
KH2PO4 2 g 
Adjust pH 7.4 with NaOH   
dH2O ad 1 l 
Autoclave 15 min at 121°C. 
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1x PBS  
10x PBS (pH 7.4) 100 ml 
dH2O ad 1 l 
 
PBST  
PBS  
Tween 20 0.05% (v/v) 
 
Tris/EDTA buffer (TE),  
10 mM Tris/0,1 mM EDTA 
 
1M Tris pH 7.5 2.5 ml 
0.5 M EDTA pH 8.0 50 µl 
MQ H2O ad 250 ml 
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3.2 Bacterial strains, media and culture conditions 
3.2.1 Bacterial strains 
 
Table 11: S. pyogenes strains used for infection studies, survival assays and cloning  
Strain Serotype  Phenotype Origin/condition Reference/source 
S. pyogenes A527 
(KTL3) 
M1 wild type Blood isolate  Strain collection 
Department of 
Medical Microbiology, 
HZI, Braunschweig 
S. pyogenes A302 
(SF370) 
M1 wild type Genome 
sequenced M1 S. 
pyogenes strain; 
wound isolate 
Strain collection 
Department of 
Medical Microbiology, 
HZI, Braunschweig; 
(Ferretti et al., 2001) 
S. pyogenes A270 
(CanA) 
M1T1 wild type Blood isolate Strain collection 
Department of 
Medical Microbiology, 
HZI, Braunschweig 
S. pyogenes A271 
(CanB) 
M1T1 wild type Blood isolate Strain collection 
Department of 
Medical Microbiology, 
HZI, Braunschweig 
S. pyogenes A766 
(90-226) 
M1 wild type Blood isolate (Cue et al., 1997) 
S. pyogenes A767 
(90-226 ∆emm1) 
M1 ∆M1 Blood isolate (Zimmerlein et al., 
2005) 
S. pyogenes 
complemented 
∆M1 A767 
M1pDCerm (clone 
2-4) 
M1 ∆M1/M1 
complemente
d 
2 µg ml-1 
erythromycin 
This study 
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Strain Serotype  Phenotype Origin/condition Reference/source 
S. pyogenes A528 
(KTL3 grab ko) 
M1 ∆GRAB 150 µg ml-1 
kanamycin 
Strain collection 
Department of 
Medical Microbiology, 
HZI, Braunschweig 
S. pyogenes A585 
(KTL3 prtS::spc) 
M1 ∆PrtS 80 µg ml-1 
spectinomycin 
Strain collection 
Department of 
Medical Microbiology, 
HZI, Braunschweig 
S. pyogenes A591 
(KTL3 slo::spc) 
M1 ∆SLO 80 µg ml-1 
spectinomycin 
Strain collection 
Department of 
Medical Microbiology, 
HZI, Braunschweig 
S. pyogenes A592 
(KTL3 pJRS 233-
∆sagA) 
M1 ∆SagA 1 µg ml-1 
erythromycin 
Strain collection 
Department of 
Medical Microbiology, 
HZI, Braunschweig 
 
Table 12: E. coli strains used for protein biochemical studies 
Strain Plasmid Insert Culture conditions Reference/source 
E. coli DH5α - - - Strain collection 
Department of 
Medical 
Microbiology, HZI, 
Braunschweig 
E. coli Top 10 pQE60 - 100 µg ml-1 ampicillin Qiagen 
E. coli MC1061 pDCerm - 500 µg ml-1 erythromycin Provided by Prof. V. 
Nizet, UCSD, San 
Diego 
E. coli DH5α pDCerm emm1 500 µg ml-1 erythromycin  This study 
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Strain Plasmid Insert Culture conditions Reference/source 
E. coli M15 
pRep4 
- - 25 µg ml-1 kanamycin Qiagen 
E. coli M15 
pRep4 
pQE60 emm1 100 µg ml-1 ampicillin 
and 25 µg ml-1 
kanamycin 
This study 
 
Table 13: L. lactis strains used for infection studies 
Strain Plasmid Insert/characteristics Culture conditions Reference 
L. lactis  pLM1 Replacement of emm6 
within pVE5508 with 
emm1 (pLM1) 
5 µg ml-1 
erythromycin; 30°C 
(Cue et al., 
2001) 
L. lactis pP59 Deletion of emm6 from 
pVE5508 
5 µg ml-1 
erythromycin; 30°C 
(Cue et al., 
2001) 
 
3.2.2 Bacterial culture media 
Prior to usage media were sterilized by autoclaving in a steam sterilizer for 15 min at 121°C 
and 1 bar high pressure. For cultivation of bacteria on agar plates 16 g of agar were added 
per litre of medium prior to autoclaving.  
 
Table 14: Media used for the cultivation of S. pyogenes strains 
TSB broth  
Tryptic Soy Broth  30 g  
dH2O ad 1 l  
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THB broth  
Todd Hewitt Broth  30 g  
dH2O ad 1 l  
 
THY broth  
Todd Hewitt Broth  30 g  
Bacto™ Yeast Extract 5 g  
dH2O ad 1 l  
 
TSBY broth  
Tryptic Soy Broth  30 g  
Bacto™ Yeast Extract 5 g  
dH2O ad 1 l  
 
Table 15: Media used for the cultivation of E. coli strains 
Luria Bertani medium (LB)  
Bacto™ Tryptone 10 g 
NaCl 10 g 
Bacto™ Yeast Extract 5 g  
dH2O ad 1 l 
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Table 16: Media used for the cultivation of L. lactis strains 
M17 medium  
Difco™ M17 broth powder 37.25 g 
dH2O 950 ml 
Heat with frequent agitation  
Boil 1 min to completely dissolve the powder  
Autoclave 15 min at 121°C  
Cool to 50°C  
10% Lactose 50 ml 
 
3.2.3 Cultivation of bacterial strains and culture conditions 
S. pyogenes strains were cultured in TSB medium and supplemented with antibiotics if 
needed (see Table 8). Bacterial were cultured in a Falcon tube with the lid slightly opened. 
Cultivation was carried out overnight at 37°C, 5% C O2 without agitation. For isolation of 
chromosomal DNA from GAS, bacteria were grown in THY medium overnight at 37°C, 5% 
CO2 in a Falcon tube with the lid slightly opened. For the preparation of competent GAS as 
well as transformation, GAS were grown in TSBY medium or were plated on TSBY agar 
plates. E. coli strains were routinely grown in LB medium in the presence of antibiotics where 
appropriate (see Table 8, Table 12) overnight at 37°C shaking (120 rpm). To prepare 
competent E. coli cells bacteria were grown in SOB medium at 37°C wi th agitation. L. lactis 
strains were cultured in M17 medium supplemented with 0.5% glucose and 5 µg ml-1 
erythromycin at 30°C without agitation. For long te rm storage of bacteria 750 µl overnight 
cultures of GAS cultured in THY medium, E. coli grown in LB medium and L. lactis cultivated 
in M17 + 0.5% glucose were mixed with 250 µl sterile glycerol. Stocks were stored at -80°C.  
 
 
 
Materials and Methods 
  
36 
3.3 Molecular biological techniques 
3.3.1 Isolation of chromosomal DNA from S. pyogenes and L. lactis 
For isolation of chromosomal DNA from S. pyogenes an overnight culture in 100 ml THY 
medium was inoculated (37°C, 5% CO 2). L. lactis strains were cultured in M17 medium 
containing 0.5% glucose. On the following day bacterial cultures were centrifuged for 10 min 
at 10000 rpm and the pellet was resuspended in 3 ml sucrose/TES-buffer. Afterwards 1 ml 
lysozyme (5 mg/ml) and 100 µl mutanolysine (5000 U/ml) were added and the suspension 
was incubated for 1 h at 37°C. Following addition o f 100 µl RNase (5 mg/ml) and incubation 
for 15 min at 37°C, 500 µl of proteinase K (5 mg/ml ) were added and samples were 
incubated for 15 min at 37°C. After the addition of  500 µl 10% sarcosyl/250 mM EDTA-buffer, 
the tubes were inverted gently and incubated for 1 h at 37°C. Subsequently 2 ml of phenol 
were added, the samples were mixed and centrifuged for 10 min at 4000 rpm. The upper 
aqueous phase was removed and transferred to a new eppendorf tube. 2 ml of 
phenol/chloroform (25:24) were added and the sample was centrifuged for 10 min at 12000 
rpm. The supernatant, which contains the DNA, was removed carefully and mixed with 1/10 
of the volume of 3M NaAc and 1 volume of isopropanol and precipitated 1 h at room 
temperature or overnight at -20°C. Following precip itation, the sample was centrifuged for 
10 min at 12000 rpm. The supernatant was removed and the pellet was washed with 70% ice 
cold ethanol. Following a final centrifugation step (5 min at maximum speed), ethanol was 
removed and the pellet was air dried at room temperature. The dry pellet was then 
resuspended in 500 µl TE-buffer and analysed by agarose gel electrophoresis (see section 
3.3.3).     
 
Table 17: Buffers and solutions used for isolation of chromosomal DNA 
TES-buffer (Tris/EDTA/saline-buffer), pH 8.0 
50 mM Tris-HCl 
5 mM EDTA 
10 mM NaCl 
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TE-buffer (Tris/EDTA buffer), pH 8.0 
10 mM Tris/0,1 mM EDTA 
 
1M Tris pH 7.5 2.5 ml 
0.5 M EDTA pH 8.0 50 µl 
MQ H2O ad 250 ml 
 
Sucrose-TES 
20% sucrose in TES-buffer, pH 8.0 
 
RNase  
5 mg/ml in TES-buffer (boil for 15 min to inactivate residual DNase) 
 
Sarcosyl solution 
10% sarcosyl in 250 mM EDTA 
 
3.3.2 Isolation of plasmid DNA 
Plasmid DNA from E. coli was isolated with the QIAprep® Spin Miniprep kit according to the 
manufacturer’s protocol. DNA was eluted in MQ H2O and stored at -20°C until used. Isolated 
plasmid DNA was analysed by agarose gel electrophoresis (see section 3.3.3). 
 
3.3.3 Agarose gel electrophoresis 
Agarose gel electrophoresis is used for qualitative and quantitative analysis of DNA 
molecules, for example after plasmid DNA isolation or to analyse fragment sizes after 
restriction digest or polymerase chain reaction. It is based on the migration of different sized 
DNA fragments in an electric field. Small DNA molecules run faster through a mesh of 1% 
agarose than larger molecules and this allows the separation of DNA fragments according to 
their sizes. Samples were mixed with 6x loading dye and separated in a 1% (w/v) agarose 
gel (in 1x TAE buffer) for 30 min at 120 V. 1x TAE buffer was used as running buffer. Gene 
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Ruler™ DNA ladder mix served as a molecular weight standard. Following gel 
electrophoresis, gels were incubated in an ethidium bromide solution (1 µg/ml in H2O) for 
10 min. DNA bands were then visualised with an UV-transilluminator and a Kodak IS2000R 
gel documentation unit (Intas).  
 
Table 18: Buffers and solutions used for gel electrophoresis 
50x TAE  
Trizma base 242 g 
Acetic acid 51.12 ml 
EDTA (0.5 M, pH 8) 100 ml 
dH2O ad 1 l  
 
1x TAE  
50x TAE 20 ml 
dH2O ad 1 l 
 
1% (w/v) agarose  
Agarose 1 g  
1x TAE 
Boil until agarose is completely melted 
100 ml 
 
3.3.4 Polymerase chain reaction (PCR) 
Polymerase chain reaction is used for in vitro amplification of defined DNA fragments and 
was described by Mullis and Faloona 1987 (Mullis et al., 1987). PCR is a cyclic reaction in 
which the DNA template is amplified exponentially. It encompasses the steps denaturation, 
annealing of short oligonucleotides (primers) and the synthesis of new DNA fragments by a 
polymerase (elongation).  
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3.3.4.1 Standard PCR 
The amplification of the emm1 gene of S. pyogenes was performed in a Thermocycler 
according to the standard PCR protocol described below (see Table 19, Table 20). For 
standard PCR the Phusion high fidelity polymerase was used.  
 
Table 19: Standard PCR protocol 
10-100 ng Template DNA 
10 µl 5x Phusion PCR buffer 
5 µl dNTPs [2 mM] 
1 µl forward primer [10 pmol/µl] 
1 µl reverse primer [10 pmol/µl] 
0.5 µl  Phusion high fidelity DNA 
polymerase [2 U/µl] 
ad 50 µl MQ H2O 
 
Table 20: Standard PCR program 
95°C 2:00 min Denaturation 
95°C 0:30 min Denaturation 
TA°C 0:30 min Annealing 
72°C T E min Elongation 
72°C 5:00 min Final polymerisation 
4°C ∞  
TA: Annealing temperature, primer specific 
TE: Elongation time, dependent on the processivity of the polymerase used (Phusion 
polymerase ~1 kb/30 sec, Taq polymerase ~1 kb/1 min) 
 
25x 
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3.3.4.2 16s RNA sequencing 
To verify the provided L. lactis strains, 16s RNA was sequenced using a PCR based method. 
Chromosomal DNA from L. lactis was isolated as described above (see 3.3.1) and served as 
a template for PCR.  
 
Table 21: 16s RNA PCR protocol 
10-100 ng Template DNA 
2 µl 10x PCR buffer 
0.5 µl dNTPs [2 mM] 
0.5 µl forward primer [10 pmol/µl] 
0.5 µl reverse primer [10 pmol/µl] 
0.2 µl  Taq DNA polymerase [3 U/µl] 
ad 20 µl MQ H2O 
 
Table 22: 16s RNA PCR program 
94°C 5:00 min Denaturation 
94°C 0:30 min Denaturation 
54°C 0:45 min Annealing 
72°C 0:45 min Elongation 
72°C 10:00 min Final polymerisation 
4°C ∞  
 
 
 
 
27x 
Materials and Methods 
  
41 
3.3.4.3 Colony PCR 
Using the colony PCR method positive bacterial clones, carrying the desired insert after 
transformation, were identified. A single bacterial colony was resuspended in 15 µl MQ H2O. 
Subsequently samples were boiled for 10 min at 95°C  to lyse bacteria and to release the 
DNA. 5 µl of this bacterial suspension was then used as template for PCR. PCR was 
performed according to the protocol described below (Table 23) using the standard PCR 
program (Table 20).  
 
Table 23: Colony PCR protocol 
5 µl Template DNA  
5 µl 10x CL PCR buffer 
5 µl MgCl2 
5 µl dNTPs [2 mM] 
1 µl forward primer [10 pmol/µl] 
1 µl reverse primer [10 pmol/µl] 
0.5 µl  Taq DNA polymerase [5 U/µl] 
ad 50 µl MQ H2O 
 
Following PCR, 5 µl of the samples were mixed with 1 µl of 6x loading dye and analysed by 
agarose gel electrophoresis (see 3.3.3).  
 
3.3.5 Purification of PCR products and restriction digests 
PCR products and restriction digests were purified using the PCR Extract Mini Kit or the 
QIAquick PCR Purification Kit according to the manufacturer’s protocol. Samples were eluted 
in 30 µl of MQ H2O. 
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3.3.6 Digestion of DNA with restriction endonucleases 
PCR amplification products and plasmid DNA vectors were digested with specific restriction 
endonucleases. Restriction digests were performed using the protocol stated below (Table 
24) for 3 h, or alternatively overnight, at 37°C. Aft erwards samples were purified with the 
QIAquick PCR Purification Kit and either directly used for ligation or stored at -20°C.  
 
Table 24: Standard restriction digest protocol 
20 µl DNA (purified PCR product or plasmid DNA) 
5 µl 10x NEB buffer 
5 µl 10x BSA 
1 µl Restriction endonuclease I [20 U/µl] 
1 µl Restriction endonuclease II [20 U/µl] 
ad 50 µl MQ H2O 
 
3.3.7 Ligation of DNA fragments 
Ligation is a method in which a free 3’-hydroxygroup of one DNA strand is covalently linked 
to a free 5’-phosphate group of a second DNA strand resulting in a continuous DNA double 
strand. This reaction is catalysed by T4 ligase and is dependent on ATP. Ligation of digested 
PCR amplification products and vectors was performed overnight at 16°C according to the 
protocol described below (Table 25). Following ligation, samples were either directly used for 
transformation of competent bacteria or stored at -20°C. 
Table 25: Ligation protocol 
1 µl Vector 
6 µl Insert 
2 µl 10x T4-Ligase buffer 
1 µl T4 DNA Ligase [400 U/µl] 
ad 20 µl MQ H2O 
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3.3.8 Transformation of bacteria 
3.3.8.1 Preparation of competent E. coli  
E. coli DH5α and E. coli M15 pRep4 were grown in SOB medium overnight at 37°C and 120 
rpm agitation. On the following day bacterial cultures were diluted 1:100 in fresh SOB 
medium and incubated at 37°C with agitation until e xponential growth phase (OD578nm 0.4-
0.6). Bacterial cultures were collected and cooled on ice for 15 min followed by centrifugation 
for 10 min at 5000 rpm (4°C). The bacterial pellet was resuspended in 15 ml Tfb1 and again 
centrifuged for 10 min (as above). After removal of the supernatant, the bacterial pellet was 
resuspended in 4 ml Tfb2 und cooled for 15 min on ice. Competent bacteria were distributed 
in pre-cooled eppendorf tubes, immediately shock-frozen in liquid nitrogen and stored at         
-80°C.    
Table 26: Buffers and media used for preparation of competent E. coli 
SOB medium 
 
20 g Bacto™ Tryptone (= 2%) 
5 g Bacto™ Yeast Extract (= 0.5%) 
0.6 g NaCl (= 10 mM) 
2.5 ml 1M KCl (= 2.5 mM) 
ad 1 l dH2O  
 
TfbI 
 
588.84 mg Potassium acetate (= 30 mM) 
2.4 g Rubidium chloride (= 100 mM) 
294 mg Calcium chloride (= 10 mM) 
1.62 g Manganese chloride (= 50 mM) 
30 ml Glycerol 
ad 200 ml dH2O  
Adjusted to pH 5.8, sterile filtered 
and stored at 4°C 
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TfbII  
46.24 mg MOPS (= 10 mM) 
220.53 mg Calcium chloride (= 74 mM) 
24.184 mg Rubidium chloride (= 10 mM) 
3 ml Glycerol 
ad 20 ml dH2O  
Adjusted to pH 6.5, 
sterile filtered and stored at 4°C 
 
 
3.3.8.2 Transformation of competent E. coli 
10 µl ligation reaction were carefully mixed with 50 µl competent E. coli and incubated for 
30 min on ice which allows adsorption of DNA to the bacterial cell surface. Afterwards 
samples were subjected to a heat shock (90 sec at 42°C). Following heat shock, samples 
were incubated with 250 µl LB medium for at least 1 h at 37°C shacking (120 rpm). Bacterial 
cultures were then selected on LB agar containing antibiotics. Bacterial colonies carrying the 
desired insert were analysed by colony PCR (see 3.3.4.3). To verify the right DNA sequence 
of the insert, plasmid DNA was isolated (see 3.3.2) and send for DNA sequencing 
(Department of Genome Analytics, HZI, Braunschweig).   
 
3.3.8.3 Preparation of competent S. pyogenes 
In order to prepare competent S. pyogenes, strain ∆M1 GAS (A767) was grown in TSBY 
medium overnight at 37°C and 5% CO 2. On the following day the overnight culture was 
diluted 1:10 in fresh TSBY medium containing 1% glycine and further incubated at 37°C until 
OD600nm 0.1-0.2 was reached. Following centrifugation (10 min at 5000 rmp, 6°C), the 
bacterial pellet was washed twice with 25 ml ice-cold MQ H2O and resuspended in 2 ml ice-
cold MQ H2O. After a final centrifugation step (2 min, 13.000 rpm) the bacterial pellet was 
resuspended in 1 ml ice-cold MQ H2O. Competent S. pyogenes were then directly used for 
transformation.     
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3.3.8.4 Transformation of competent S. pyogenes 
For transformation of competent S. pyogenes, 200 µl competent cells were carefully mixed 
with 5 µl plasmid DNA and incubated on ice for 30 min. After electroporation at 1.6 kV, 200 Ω 
using the Gene Pulser™ system, 10 ml pre-warmed TSBY medium was added and cultures 
were incubated for at least 4 h at 37°C and 5% CO 2. Following incubation, cultures were 
filled up to 50 ml with TSBY medium and incubated in the presence of 1 µg ml-1 erythromycin 
overnight at 37°C and 5% CO 2. On the following day cultures were collected by centrifugation 
(10 min at 5000 rmp). The bacterial pellet was resuspended in 1 ml TSBY and plated on 
TSBY agar containing 2 µg ml-1 erythromycin. Plates were incubated for 24-48 h at 37°C and 
5% CO2. Bacterial colonies carrying the desired insert were analysed by colony PCR (see 
3.3.4.3).  
 
3.4 Cloning techniques 
3.4.1 Complementation of the S. pyogenes M1 knock out mutant 
The full length emm1 gene (including 51 nucleotides upstream of the start codon and 84 
nucleotides downstream from the stop codon) was amplified according to the standard PCR 
protocol using chromosomal DNA of M1 GAS strain SF370 as template (see 3.3.1 and 
3.3.4.1). The primer pair M1_fwd_KpnI  and M1_rev_XbaI was used for amplification (Table 
4). The emm1 gene was then cloned into the KpnI and XbaI restriction sites of the shuttle 
vector pDCerm (Jeng et al., 2003) and the resulting plasmid M1pDCerm transformed into E. coli 
DH5α (see 3.3.8.1 and 3.3.8.2). Transformants were selected on LB agar plates containing 
500 µg ml-1 erythromycin. Positive clones were confirmed by colony PCR (see 3.3.4.3), 
restriction enzyme analysis and DNA sequencing (Department of Genome Analytics, HZI, 
Braunschweig). Plasmid DNA was then subcloned into electro-competent S. pyogenes ∆M1 
90-226 (A767), transformants (complemented ∆M1 GAS A767 M1pDCerm clone 2-4) were 
selected on TSBY agar plates containing 2 µg ml-1 erythromycin (see 3.3.8.3 and 3.3.8.4). 
The presence of the emm1 gene was verified by colony PCR (see 3.3.4.3). Surface 
expression of the M1 protein was assessed by immunofluorescence staining using a M1 
specific primary antibody and a fluorescently labelled secondary antibody (see 3.5.8). 
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3.4.2 Generation of recombinant M1 protein 
In order to express C-terminally 6x Histidine tagged recombinant M1 protein in E. coli, the 
emm1 gene, omitting the sequence of the signal peptide and the membrane anchor, was 
cloned into the NcoI and BamHI restriction sites of the plasmid pQE60. Chromosomal DNA 
from GAS strain SF370 and the primer pair His_M1_fwd and His_M1_rev were used for 
amplification (see 3.3.1, 3.3.4.1 and Table 4). The resulting plasmid M1pQE60 was 
transformed into E. coli M15pRep4 and transformants were selected on LB plates containing 
100 µg ml-1 ampicillin and 25 µg ml-1 kanamycin (see 3.3.8.1 and 3.3.8.2). Positive clones 
carrying the emm1 gene were verified by colony PCR (see 3.3.4.3), restriction enzyme 
analysis and DNA sequencing (Department of Genome Analytics, HZI, Braunschweig).  
 
3.5 Biochemical techniques 
3.5.1 Overexpression of recombinant M1-HIS-fusion protein 
E. coli transformants carrying the emm1 gene were incubated in LB medium containing 
100 µg ml-1 ampicillin and 25 µg ml-1 kanamycin overnight at 37°C with agitation (120 rp m). 
On the following day overnight cultures were diluted 1:100 in fresh LB medium (500 ml) and 
were further incubated (37°C, 120 rpm) in the prese nce of 100 µg ml-1 ampicillin and 25 µg 
ml-1 kanamycin until late exponential growth phase (OD600nm 0.8). For SDS-PAGE analysis, 
1 ml of the culture was removed, centrifuged (10 min at 5000 rpm) and the bacterial pellet 
was resuspended in 200 µl of PAGE sample buffer. Samples were boiled for 10 min at 95°C 
and then stored at -20°C. For the induction of prot ein expression, 500 ml LB medium 
containing IPTG (final concentration 1 mM) was added to the remaining E. coli culture and 
samples were further incubated overnight at 37°C an d 120 rpm. 1 ml of the induced E. coli 
culture was removed, centrifuged and stored in PAGE sample buffer at -20°C as described 
above. Cultures were harvested by centrifugation (10 min at 8000 rpm) and the pellet 
resuspended in 20 ml LEW buffer (Protino® Ni-TED Kit). Following an additional 
centrifugation step (10 min at 8000 rpm), the bacterial pellet was resuspended in 10 ml LEW 
buffer und kept on ice. Bacterial lysates were prepared using the French-pressure cell at a 
pressure of 1000 bar. To remove cell debris bacterial lysates were centrifuged for 15 min at 
15.000 rpm. The supernatant was kept in a fresh eppendorf tube and stored at -20°C. 100 µl 
of the lysate was mixed with PAGE sample buffer, boiled for 10 min at 96°C and also stored 
at -20°C until SDS-PAGE analysis (see 3.5.4).          
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3.5.2 Purification of recombinant M1-HIS-fusion protein 
Recombinant M1-HIS fusion protein was purified from E. coli lysates using the Protino® Ni-
TED purification of polyhistidine-tagged proteins kit according to the manufacturer’s manual. 
Samples of the flow through, the wash steps and the eluted proteins were taken, mixed with 
SDS-PAGE sample buffer, boiled 10 min at 96°C and s tored at -20°C until SDS-PAGE 
analysis (see 3.5.4).  
 
3.5.3 Dialysis and quantification of purified proteins 
Purified M1-HIS fusion protein was dialyzed against PBS overnight at 4°C in dialysis tubes 
with a molecular weight cut off of 12.000-14.000. The protein concentration was measured 
with the Nano Drop (Thermo Scientific). This technique is based on the measurement of the 
absorption at a wavelength of 280 nm. According to the Lambert-Beer law the protein 
concentration of a sample is proportional to the absorbance of light (Hellenthal, 2002). Since 
the protein was dialyzed against PBS, PBS was used as a blank. Aliquots of the dialyzed 
protein was stored at -20°C.  
 
3.5.4 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS polyacrylamide gel electrophoresis is a method used to separate proteins in an electric 
field according to their molecular weight. This method was first described by Laemmli in 1970 
(Laemmli, 1970) and is frequently used in protein biochemistry. Samples are mixed with 
SDS, an anionic detergent, which denatures and dissociates protein structures and also 
imparts a negative charge to proteins in proportion to their molecular mass. Addition of β-
mercaptoethanol or dithiotretol (DTT) further denatures all disulphide bonds present within 
the molecule. Thus, due to the negative charge of SDS, proteins migrate towards the anode 
and are separated based on their molecular weight and independent of their charge. Large 
proteins are retained within the gel matrix and run slower as small molecules. Protein 
samples were mixed with SDS-PAGE sample buffer, boiled 10 min at 96°C and are applied 
to the gel matrix. Proteins are first concentrated in a low percentage stacking gel with a pH of 
6.8, then they migrate into a higher percentage resolving gel (10%) with a pH of 8.8 in which 
they are separated according to size. SDS gel electrophoresis was carried out using the Mini 
Protean II system with 0.75 mm spacer and 1x SDS running buffer. As a molecular weight 
standard Page ruler™ plus pre-stained protein ladder was used.    
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Table 27: Buffers and solutions used for SDS-PAGE 
2x SDS-PAGE sample buffer  
Tris-HCl (0.5 M, pH 6.8) 1 ml 
Glycerol 0.8 ml 
10% SDS 2 ml 
H2O 3.6 ml 
0.05% Bromophenol blue 400 µl of a 1% stock solution 
β-mercaptoethanol 0.4 ml 
Filter sterilize (ø 0.22 µm)  
 
10x SDS running buffer  
Trizma base 60 g 
Glycine 300 g 
SDS (ultrapure) 20 g 
H2O ad 2 l 
 
Stacking gel Volume for 1 gel 
H2O 0.68 ml 
30% Acrylamide/Bisacrylamide 0.17 ml 
1.0 M Tris (pH 6.8) 0.13 ml 
10% SDS 0.01 ml 
10% APS 0.01 ml 
TEMED 0.001 ml 
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Resolving gel 10% (volume for 1 gel) 12% (volume for 1 gel) 
H2O 1.9 ml 1.6 ml 
30% Acrylamide/Bisacrylamide 1.7 ml 2.0 ml 
1.5 M Tris (pH 8.8) 1.3 ml 1.3 ml 
10% SDS 0.05 ml 0.05 ml 
10% APS 0.05 ml 0.05 ml 
TEMED 0.002 ml 0.002 ml 
 
3.5.5 Staining of proteins in polyacrylamide gels 
After SDS gel electrophoresis, proteins were stained with Coomassie R250 Brilliant Blue 
(Table 28). Gels were boiled in the staining solution for 30 sec in a microwave and were 
further incubated in the staining solution for 30 min at room temperature with shaking. Gels 
were destained by repeated boiling in dH2O and incubation at room temperature with 
agitation until protein bands became visible and the gel background was clear.  
 
Table 28: Composition of the Coomassie staining solution  
Coomassie staining solution  
Coomassie Brilliant Blue R-250 0.1% (v/v) 
Methanol 50% (v/v) 
Acetic acid 10% (v/v) 
Added to dH2O  
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3.5.6 Coating of latex beads with recombinant proteins 
In order to investigate the invasion potential of recombinant proteins, latex beads were 
coated with purified recombinant M1 protein and GST protein as a negative control. Latex 
beads (1x108) with a diameter of 3 µm were used and were washed three times with 500 µl 
PBS prior to usage. In between the wash steps samples were centrifuged for 10 min at 1500 
rpm. Latex beads were then coated with 5 µg of purified M1 or GST protein overnight at 4°C 
with rolling. Following two washing steps with PBS (as above), coated beads were blocked 
with bovine serum albumin [10 mg/ml] in PBS for 1 h at room temperature. After blocking 
beads were washed once, resuspended in PBS and stored at 4°C until used.  
 
3.5.7 Analysis of the coating efficiency of M1-coated latex beads by flow cytometry 
The coupling efficiency of protein coated latex beads was assessed by flow cytometry. Latex 
beads were incubated with a polyclonal antibody against M1 or GST for 45 min at room 
temperature followed by incubation with a goat-anti-rabbit ALEXA Fluor® 488-labelled 
secondary antibody (30 min at room temperature, Table 5, Table 6). Labelled samples were 
then measured by flow cytometry using the FACS Calibur BD and cell quest software (BD). 
FACS measurements of stained samples were kindly performed by Dr. O. Goldmann 
(Research Group Infection Immunology, HZI Braunschweig). 
 
3.5.8 Analysis of surface localization of M1 on S. pyogenes and L. lactis 
To analyse surface expression of M1 on S. pyogenes or L. lactis, strains were grown 
overnight in TSB medium or M17 medium (supplemented with 0.5% glucose) respectively. 
One drop of the overnight culture was distributed on a glass coverslip, dried and 
subsequently fixed with 4% paraformaldehyde for at least 30 min at 4°C. The M1 protein on 
the bacterial surface was labelled with a specific anti-M1 antibody (1:100 in PBS) for 45 min 
at room temperature. After washing samples were incubated with a species specific ALEXA 
Fluor® 488 conjugated secondary antibody (goat-anti-rabbit IgG, 1:200 in PBS) for 30 min at 
room temperature. After another washing step in PBS stained samples were analysed by 
fluorescence microscopy using a Zeiss Axio Imager A2 microscope. Strains which express 
the M1 protein showed green fluorescence.  
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3.5.9 Plasma absorbance assay 
Overnight cultures (50 ml in THY medium) of S. pyogenes were collected by centrifugation 
(10 min at 5000 rpm), washed once with PBS and the pellet was resuspended in 500 µl 
PBST (PBS + 0.05% Tween). 50 µl of this suspension was added to 350 µl PBST and 
incubated with 100 µl of human plasma (kindly provided by Dr. H. Garritsen, Institute for 
Transfusion Medicine, Hospital Celler Strasse, Braunschweig) for 1 h at 37°C. During the 
incubation period samples were inverted occasionally. Following incubation, bacterial pellets 
were washed twice with 1 ml PBST. In order to elute bound plasma protein from the bacteria 
cell surface, samples were incubated with 100 µl glycine/HCl (100 mM, pH 2) for 15 min at 
room temperature. Following a final centrifugation step the supernatant, containing eluted 
plasma proteins, was collected and mixed with SDS-sample buffer. To neutralize samples 
10% 1.5 M Tris buffer (pH 8.8) was added. Samples were then denatured at 95°C for 5 min 
and analysed by SDS-PAGE gel electrophoresis on a 12% gel (refer to 3.5.4 and 3.5.5). 
 
3.5.10 Binding assay with radioactively labelled IgG 
Overnight cultures of S. pyogenes (50 ml in TSB medium) were collected by centrifugation 
for 10 min at 5000 rpm and washed once with 20 ml PBST (PBS + 0.05% Tween). 
Afterwards bacterial pellets were resuspended in 500 µl PBST and suspensions were 
adjusted in PBST to 10% transmission. 250 µl of this bacterial suspension was then mixed 
with radioactive IgG (100.000 units per sample) and incubated for 1 h at room temperature. 
Following incubation, unbound radioactive IgG was removed by washing with 1 ml PBST 
followed by centrifugation. Finally, the radioactive radiation emitted from the bacterial pellets 
was measured with a Wallac 1470 Wizard gamma counter (Perkin Elmer). The experiment 
was performed in triplicates. As a positive control with 100% binding FCS (20 µl) was used. 
FCS was mixed with the same amount of radioactively labelled IgG as used for the samples 
and precipitated with 1 ml trichloroacetic acid. The percental binding activity of the 
streptococcal strains was assessed in comparison to the total amount of radioactive protein 
used in the experiment (100% binding). The radioactive binding assays were performed in 
collaboration with Dr. M. Fulde (Department of Medical Microbiology, HZI, Braunschweig).  
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3.6 Cell culture techniques 
3.6.1 Primary endothelial cells 
 
Table 29: Primary endothelial cells used in this study 
Cells Culture medium Culture 
conditions 
Company/source 
Human umbilical vein 
endothelial cells (HUVEC) 
EGM-2 + 
SupplementMix + 
Pen/Strep [100 U ml-1]/ 
[0.1 mg ml-1] 
37°C, 5% CO 2 Lonza 
Human pulmonary 
microvascular endothelial 
cells (HPMEC) 
EGM MV + 
SupplementMix + 
Pen/Strep [100 U ml-1]/ 
[0.1 mg ml-1] 
37°C, 5% CO 2 Promocell 
Human dermal lymphatic 
endothelial cells (HDLEC) 
EGM-2 + 
SupplementMix + 5% 
FCS + Pen/Strep [100 
U ml-1]/[0.1 mg ml-1] 
37°C, 5% CO2 Promocell 
 
3.6.2 Cell culture media 
Endothelial cell growth medium 2 (EGM-2) used for the cultivation of HUVEC was purchased 
from Promocell and was supplemented with the SupplementMix provided by the 
manufacturer. In addition, Penicillin/Streptomycin (100 U ml-1 Penicillin; 0.1 mg ml-1 
Streptomycin) were added. After addition of the supplements the shelf life of the complete 
endothelial cell growth medium is 6 weeks at 4°C. A liquots of the complete medium were 
stored at 4°C. Endothelial cell basal medium (EBM-2 ), which was used during the infection of 
HUVEC with streptococci, was purchased from Promocell. Aliquots were stored at 4°C. 
Endothelial cell growth medium MV (EGM MV) was used for the cultivation of HPMEC and 
was purchased from Promocell. EGM MV was supplemented with the SupplementMix 
provided by the manufacturer. Penicillin and Streptomycin was also added and the complete 
medium was stored as described above for EGM-2 medium. Endothelial cell basal medium 
MV was also purchased from Promocell. 
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3.6.3 Cultivation and sub-cultivation of primary endothelial cells 
Prior to cultivation all media and solutions were pre-warmed at 37°C. Endothelial cells were 
cultured in cell specific medium as described in Table 29 at 37°C and 5% CO 2. The medium 
was replaced every 3 days.  
 
3.6.3.1 Cultivation of HUVEC 
HUVEC were sub-cultured when 80% confluence was reached. For sub-cultivation, cells 
were washed once with 5 ml HEPES-BSS to remove dead cells, cell debris and medium 
components. Then 3 ml Trypsin/EDTA were added to detach cells from the cell culture dish. 
Trypsin treatment was stopped by the addition of 7 ml EGM-2. Detached cells were carefully 
washed from the petri dish, centrifuged 9 min at 900 rpm and resuspended in 4 ml fresh 
EGM-2. Approximately 4x105 cells were seeded per 10 cm cell culture dish and incubated at 
37°C and 5% CO 2. HUVEC were cultured until passage 5.  
 
3.6.3.2 Cultivation of HPMEC and HDLEC 
HPMEC and HDLEC were sub-cultured in the appropriate cell culture medium (Table 29) 
according to the protocol described for HUVEC (see 3.6.3.1). Cells were collected by 
centrifugation and resuspended in 3 ml EGM-MV. HPMECs were cultured up to passage 5.  
 
3.6.3.3 Freezing and thawing of HUVEC and HPMEC 
For long term conservation, endothelial cells were stored in liquid nitrogen. HUVEC and 
HPMEC were washed and detached from the cell culture dish as described above (see 
3.6.3.1 and 3.6.3.2). After centrifugation the pellet of one cell culture dish was resuspended 
in 1 ml of the corresponding cell culture medium supplemented with 20% FCS and 10% 
DMSO. 500 µl HUVEC cell suspension and 1 ml HPMEC cell suspension were frozen per 
cryo vial and stored in an isoproponal filled freezing container for 24 h at -80°C which 
ensures controlled cooling of 1°C per minute to pre vent accumulation of cell damaging ice 
crystals. After 24 h vials were transferred into liquid nitrogen. For thawing, the cells from one 
cryo vial were seeded in a 10 cm cell culture dish containing pre-warmed cell culture 
medium. Cells were incubated at 37°C with 5% CO 2. To diminish the cytotoxic effects of 
DMSO, the medium was replaced after cells had attached to the cell culture dish (after 4-
5 h). 
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3.7 Infection assays 
3.7.1 In vitro transwell infection system 
For infection assays, an in vitro transwell system was used in which endothelial cells were 
grown on a semi-permeable membrane of cell culture inserts with a pore size of 3.0 or 0.4 
µm. This system allows the cultivation of a polarised endothelial cell barrier to study the 
interaction and transmigration of streptococci. Prior to seeding of endothelial cells, transwell 
inserts were coated with 1% gelatine for 1 h at 37°C. Gelatine was subsequently cross-linked 
with 0.5% glutaraldehyde for 25 min at room temperature. Cross-linked gelatine served as a 
substrate to generate a semi-artificial basement membrane (Smeets et al., 1992). 3x104 
endothelial cells were seeded per transwell insert, cultivated at 37°C, 5% CO 2 and grown to 
confluence. Confluent cell layers were then infected with streptococci or lactococci as 
described in section 3.7.2.  
 
 
Figure 4: Schematic representation of the transwell system  
Taken from (Saunders, 2009) 
 
3.7.2 In vitro transwell infection assay of endothelial cells with S. pyogenes or L. lactis 
To study the interaction of S. pyogenes with endothelial cells, HUVEC, HPMEC or HDLEC 
were cultivated on cell culture transwell inserts as described in section 3.7.1. One day prior 
to infection cell layers were washed three times with endothelial basal medium and were 
further incubated in antibiotic free endothelial cell growth medium at 37°C and 5% CO 2. For 
infection assays, streptococcal strains were grown in TSB overnight and on the day of 
infection sub-cultured in a 1:10 ratio in TSB until exponential growth phase (OD600 0.4). Prior 
to infection streptococci were harvested by centrifugation at 5000 rpm for 10 min. The pellet 
of a 50 ml bacterial culture was resuspended in 500 µl PBS and the suspension adjusted to 
10% transmission in PBS. The bacterial solution was subsequently diluted 1:8 in basal 
medium containing 2.5% FCS. To start the infection, 25 µl of the bacterial suspension were 
added per transwell containing 400 µl medium (final dilution 1:128). Infection was performed 
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for different time intervals ranging from 1 h till overnight infections. To stop the infection, cell 
layers were washed three times with endothelial basal medium and fixed with 4% PFA in 
PBS (immunofluorescence analysis). For electron microscopic analysis samples were fixed 
with EM-fixans (see Table 31). Invasion rates were determined after immunofluorescence 
staining of intra- and extracellular bacteria (see 4.8.1) by enumerating intracellular bacteria. 
Invasion rates are expressed as intracellular bacteria per 10 cells or % invasion. 
Infection assays of HUVEC with L. lactis strains were performed as described above for 
S. pyogenes except that L. lactis strains were cultured in M17 medium supplemented with 
5% glucose and 5 µg/ml erythromycin.  
 
3.7.3 Pre-incubation of HUVEC 
3.7.3.1 Blocking of integrin subunits on HUVEC 
In order to identify the cellular receptor which mediates entry of M1 GAS into HUVEC, 
blocking experiments of the alpha and beta integrin subunits on HUVEC were performed. 
HUVEC were pre-incubated with specific monoclonal antibodies against the α1-, α2- and β1-
integrin subunit diluted 1:100 in cell culture medium for 75 min. Following blocking, cell layers 
were washed twice with EBM-2 and infected with M1 GAS A527 for 2 ½ h according to the 
standard infection protocol described above (see 3.7.2). Invasion rates were determined by 
enumerating intracellular streptococci. Invasion rates are depicted as % invasion compared 
to an untreated control with 100% invasion. 
 
3.7.3.2 Pre-incubation of HUVEC with various inhibitors to interfere with host cell 
signalling pathways 
To analyse the involvement of host cell signalling molecules of the phagocytic uptake 
machinery in M1 GAS invasion into HUVEC, function interfering experiments were 
performed. A key component of classical phagocytic uptake processes is the protein kinase 
which was inhibited by calphostin C in the infection experiments. Activation of protein kinase 
leads to the release of intracellular calcium, which was inhibited by the calcium chelator 
BAPTA-AM. Treatment with edelfosine inhibits phospholipase C gamma, another essential 
host cell signalling molecule required for the phagocytic uptake machinery. HUVEC, 
cultivated in transwell inserts, were pre-treated with the inhibitors specified in Table 30 for 30 
min. To exclude toxic effects of the solvent on HUVEC and subsequently on bacterial 
invasion, cells were also pre-incubated with the corresponding concentration of DMSO alone. 
All inhibitors were diluted in cell culture medium to the concentration stated in Table 30. 
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Following pre-incubation, infection of HUVEC cell layers were performed for 3 h according to 
the standard infection protocol described in section 3.7.2. Inhibitors were present during the 
whole infection period. Invasion rates were determined by enumerating intracellular 
streptococci. Invasion rates are depicted as % invasion compared to the DMSO treated 
control with 100% invasion. 
 
Table 30: Inhibitors used in this study  
Inhibitor Concentration Solvent 
Calphostin C 2 µM DMSO 
Edelfosine 20 µM DMSO 
BAPTA-AM 25 µM DMSO 
 
3.7.3.3 Pre-incubation of HUVEC with BSA-gold nano particles 
Coating of 15 nm gold particles with BSA 
10 ml of a colloidal gold solution containing 15 nm nano gold particles were adjusted to pH 
6.0-6.5 using 1.1 M K2CO3. Subsequently the gold solution was incubated with 100 µl of a 
BSA stock solution (100 mg/ml) for 15 min at room temperature. In this step the positively 
charged BSA is linked to the negatively charged gold particles by van der Waals forces and, 
therefore, retaining biological activity, especially not influencing the interaction with the cell 
receptor. The stability of the BSA-gold complexes was tested by incubation of the BSA-gold 
solution with 10% NaCl in a 1:1 ratio. A red colour indicates stable BSA-gold complexes, in 
contrast, colour change from red to blue indicates unstable complexes. Following 
centrifugation of the BSA-gold solution (15 min at 20.000 rpm and 4°C), the red pellet was 
collected and used for pre-incubation of HUVEC.   
 
Co-incubation of HUVEC with BSA-gold particles 
To pre-load HUVEC lysosomes, HUVEC were fed with BSA-gold particles 18 h prior to 
infection. HUVEC cultivated in transwell inserts were incubated with 75 µl of the BSA-gold 
solution per well under standard conditions. On the following day cell layers were washed 
once with basal medium and infected with streptococci as described in section 3.7.2.  
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3.7.4 Blocking of the M protein on streptococci 
In order to analyse the involvement of the M1 protein of S. pyogenes in invasion into 
HUVEC, GAS A527 cultures were adjusted to 10% transmission as described for the 
standard infection model (see 3.7.2). Diluted streptococcal suspensions were then pre-
treated with increasing concentrations (0 µg/ml, 10 µg/ml, 25 µg/ml, 50 µg/ml and 75 mg/ml) 
of a rabbit anti-M1 antibody or a control antibody (75 µg/ml) 1 h prior to infection. Following 
pre-incubation, HUVEC were infected with pre-treated streptococci according to the standard 
infection protocol (see 3.7.2). Internalization rates were expressed as % invasion compared 
to the internalization rates of an untreated control with 100% invasion. 
 
3.7.5 Latex bead internalization assay on HUVEC 
To assess the invasion potential of the M1 protein of S. pyogenes, latex beads were coated 
with recombinant M1 protein and GST as negative control (see 3.5.6). HUVEC seeded on 
coverslips or transwell inserts (see 3.7.1) were co-incubated with 2x106 M1- or GST-coated 
latex beads 1-5 h for immunofluorescence analysis, 60-120 min for field emission scanning 
electron microscopy (FESEM) or 12 h for transmission electron microscopy (TEM). Cell 
layers were washed three times with basal medium and fixed with 1% PFA 
(immunofluorescence analysis) or EM-fixans (electron microscopy, see Table 31). 
Internalization rates were assessed by immunofluorescence staining of intra- and 
extracellular beads (see 3.8.1). Internalization rates were determined by enumerating 
intracellular beads. 
 
3.7.6 Quantification of intracellular viable bacteria in HUVEC (survival assay) 
HUVEC cultivated on transwell inserts (see 3.7.1) were infected with M1 GAS A527 
according to the standard infection procedure (see 3.7.2). Infection was performed for an 
initial period of three hours (t0). Subsequently infected cell layers were washed three times 
with EBM-2 to remove unbound bacteria.  Afterwards samples were incubated for defined 
time periods in EBM-2 medium supplemented with 2.5% FCS, 5 µg ml-1 penicillin G and 100 
µg ml-1 gentamycin to kill all remaining extracellular bacteria. After 2 h, 4 h, 6 h and 9 h 
infected cell layers were washed with EBM-2 at least five times to ensure complete removal 
of antibiotics. Cells were detached from the transwell membrane with 100 µl 0.025% 
Trypsin/0.01% EDTA per well for 5 min at 37°C. Deta ched cells were subsequently 
permeabilized with 400 µl 1% saponin in PBS for 20 min at 37°C. Finally, cell suspensions 
were diluted in EBM-2. 25 µl of the corresponding serial dilutions were plated on THY agar 
plates and incubated at 37°C and 5% CO 2 for up to 48 h. The number of viable intracellular 
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streptococci was evaluated by counting bacterial colonies and calculating the colony forming 
units (cfu) per ml.  
 
3.7.7 Measurement of EC barrier function using the CellZscope® automated cell 
monitoring system 
Analysis and monitoring of cell cultures, in particular cell layer formation and polarization, 
was determined with the CellZscope® automated cell monitoring system by measuring the 
transendothelial impedance of cells grown on permeable membranes. In addition to the 
transendothelial resistance (TER), the cell layers electric capacitance (Ccl) was measured 
which gives information about the properties of a cell layer, e.g. expression of microvilli. 
Measurement of the transendothelial resistance and the cell layers capacitance provides 
valuable parameters to assess the current state of a cell layer. Confluent polarized cell layers 
exhibit high TER values and low capacitance, while permeability correlates with low TER 
values and high capacitance (NanoAnalytics, 2009).  
HUVEC were cultivated on gelatinised transwell membranes with a pore size of 0.4 µm as 
described above (see 3.7.1). Transwells were then placed in the cavities of the CellZscope® 
system and incubated at 37°C and 5% CO 2. Two electrodes on either side of the transwell 
membrane and the application of a small voltage allow the measurement of the electric 
resistance of the cell layer. The TER and the Ccl was measured automatically every hour 
over a period of several days. The resulting data was evaluated based on the algorithm of 
the CellZscope® system and customized Cellzscope® software. After 4-5 days of cultivation 
HUVEC cell layers exhibited TER values higher than 15 Ω x cm2 and Ccl values lower than 
1 µF/cm2 indicating that HUVEC cell layers had grown to confluence and were polarized. To 
assess the influence of streptococcal infection on HUVEC barrier function and integrity, 
HUVEC cell layers were infected with several M1 GAS strains according to the standard 
infection protocol (see 3.7.2). Throughout the whole infection period the TER and Ccl were 
measured and compared to the values of an uninfected control well.  
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3.7.8 Ex vivo infection assay of umbilical cord with S. pyogenes 
Human umbilical cord was obtained post-delivery from the Hospital Celler Strasse in 
Braunschweig. The vein (thrombus free) endothelium was infected with 1x108 M1 
S. pyogenes A527 suspended in EGM-2 medium for 4 ½ h at 37°C a nd 5% CO2. Afterwards 
samples were washed three times with PBS followed by fixation with EM-fixans (see Table 
31). Following fixation, several pieces of the vein were processed and analysed by FESEM 
(see 3.8.2.1). To exclude any effects due to physical damage during the infection process, 
samples were collected from an area distant from the injection point. 
 
3.8 Microscopic techniques 
3.8.1 Fluorescence microscopy 
Immunofluorescence staining and immunofluorescence microscopy is a standard technique 
to visualize target proteins on the cell surface or to localize specific structures within cells or 
subcellular compartments. This method uses antibodies labelled with specific fluorochromes 
that specifically, either directly or indirectly, bind to a target antigen. Using light with a specific 
wavelength the fluorochrome of the sample is excited and emits light with a longer wave 
length which is detected in the fluorescent microscope (Campbell et al., 2003). Samples 
were stained as described below and were examined using a Zeiss Axiophot with an 
attached Zeiss AxioCam HRc digital camera and Zeiss Axiovision software 4.8 or a Zeiss 
Axio Imager A2 with a Zeiss Axio Cam MRm camera and ZEN 2011 software. Contrast and 
brightness of images were adjusted using Adobe Photoshop CS3 Extended (Version 10.0).     
  
3.8.1.1 Double-immunofluorescence staining 
Irrespective of the different staining set ups described below, fixed samples were washed 
three times with PBS and first blocked with PBS containing 10% FCS for 30 min at room 
temperature to prevent unspecific binding of the antibodies. Afterwards streptococci and 
specific cellular structures were stained according to the protocols described below. For 
detailed information regarding the antibodies and dilutions used, refer to Table 5 and Table 6. 
In between each staining step samples were washed three times with PBS. All incubation 
steps were performed at room temperature in a wet chamber. After the last washing step 
stained transwell membranes were cut out of the transwell insert and mounted on glass 
cover slides using ProLong® Gold antifade reagent containing DAPI. Samples were sealed 
with clear nail polish and stored at 4°C in the dar k until fluorescence microscopic analysis. 
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3.8.1.2 Staining of intra-/extracellular streptococci, lactococci or protein-coated latex 
beads 
First extracellular streptococci were stained with a rabbit polyclonal antibody recognizing 
S. pyogenes (anti-GAS) (Molinari et al., 1997) for 45 min  followed by 30 min incubation with 
an anti-rabbit ALEXA Fluor® 488 coupled secondary antibody. To visualize intracellular 
streptococci cells were permeabilized with 0.1% Triton-X-100 for 5 min. Following 
permeabilization, streptococci were again labelled with the anti-GAS primary antibody (see 
above) and subsequently stained with a secondary anti-rabbit ALEXA Fluor® 568 labelled 
secondary antibody for 30 min. According to their respective label intracellular bacteria 
appear red and extracellular streptococci green to yellow. 
Intra- and extracellular lactococci were stained according to the protocol described for 
streptococci except that a rabbit-anti-L. lactis antibody was used as primary antibody. 
Staining of intra- and extracellular protein-coated latex beads was performed according to 
the protocol described above for streptococci except that a rabbit anti-M1 or rabbit-anti-GST 
primary antibody was used.  
Following immunofluorescence staining, internalization rates of bacteria or coated latex 
beads were determined by enumerating intracellular bacteria or latex beads. A minimum of 
100 cells was analysed and internalization rates were expressed as intracellular 
bacteria/beads per 10 cells or % invasion. 
 
3.8.1.3 Staining of streptococci and the actin cytoskeleton 
To visualize streptococci as well as cellular components like the actin cytoskeleton, cells 
were washed three times with PBS and then directly permeabilized with 0.1% Triton-X-100 
for 5 min. Following permeabilization, streptococci were labelled with a rabbit anti-GAS 
antibody (45 min) and subsequently stained with a goat-anti-rabbit ALEXA Fluor® 568 or 
alternatively A488 coupled secondary antibody for 30 min. Finally, the actin cytoskeleton was 
stained by incubation with either phalloidin ALEXA Fluor® 488 or phalloidin ALEXA Fluor® 
568 for 30 min.  
 
3.8.1.4 Staining of streptococci and late endosomal/lysosomal compartments 
In order to analyse co-localization of streptococci with the Lamp-1 positive late 
endosomal/lysosomal compartment, cells were directly permeabilized with 0.1% Triton-X-100 
(5 min), washed with PBS and streptococci stained with a rabbit anti-GAS antibody (45 min) 
and a species specific ALEXA Fluor® 568 coupled secondary antibody (30 min). The late 
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endosomal/lysosomal compartment was labelled with a mouse anti-human Lamp-1 
(CD107a) primary antibody (1 h) and subsequently stained with a goat-anti-mouse ALEXA 
Fluor® A488 secondary antibody (30 min).  
Following immunofluorescence staining, streptococci residing within the Lamp-1 positive 
compartment were enumerated and related to the total number of intracellular streptococci.   
 
3.8.1.5 Staining of the Arp2/3 complex 
Following permeabilization with 0.1% Triton-X-100 for 5 min, the Arp2/3 complex was 
labelled with a mouse-anti-Arp2/3 (p16 #323H3) antibody for 1 h followed by incubation with 
a goat-anti-mouse ALEXA Fluor® 488 coupled secondary antibody (30 min).  
 
3.8.1.6 Staining of streptococci and the β1-integrin subunit 
For visualisation of the β1-integrin subunit, unpermeabilized cells were incubated with an anti-
β1-integrin antibody (5 µg per well) for 1 h followed by a goat-anti-mouse ALEXA Fluor® 488 
coupled secondary antibody (30 min). Subsequently streptococci were labelled with a rabbit 
anti-GAS antibody (45 min) and a goat-anti-rabbit ALEXA Fluor® 568 coupled secondary 
antibody (30 min).  
 
3.8.1.7 Bacterial viability staining 
Viability testing of intracellular streptococci was performed using the LIVE/DEAD® Baclight™ 
Bacterial Viability Kit according to the manufacturer’s protocol. 
 
3.8.2 Electron microscopy (EM) 
3.8.2.1 Field emission scanning electron microscopy (FESEM) 
In addition to immunofluorescence analysis, the interaction of M1 S. pyogenes as well as 
M1-coated latex beads with HUVEC or HPMEC was analysed by FESEM. Infected cell 
layers were washed with EBM-2 or TE-buffer and fixed with EM-fixans for at least 30 min at 
4°C. Samples were then washed twice with TE-buffer and dehydrated in a grade series of 
ethanol (10%, 30%, 50%, 70%, 90%). Each step was performed for 10 min on ice. Samples 
were incubated twice in 100% ethanol for 15 min at room temperature. Following 
dehydration, samples underwent critical point drying with liquid CO2. Finally, samples were 
sputter coated with a thin gold-palladium film or alternatively with carbon for visualization of 
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intracellular gold particles. Processed samples were then examined in a field emission 
scanning electron microscope Zeiss DSM 982 Gemini with an acceleration voltage of 5 kV or 
a field emission scanning electron microscope Merlin, Zeiss. Sample analysis was carried 
out by Apl. Prof. Dr. M. Rohde (Department of Medical Microbiology, HZI Braunschweig). 
Brightness and contrast were adjusted with Adobe Photoshop CS3 Extended (Version 10.0). 
 
3.8.2.2 Transmission electron microscopy (TEM) 
Following fixation of infected HUVEC cell layers, transwell membranes were washed twice 
with 0.1 M cacodylate buffer. Transwell membranes were cut out of the transwell insert and 
again washed several times with 0.1 M cacodylate buffer. Membranes were again fixed and 
simultaneously contrasted with 1% aqueous osmium tetroxide for 1 h at room temperature. 
Afterwards samples were washed with 0.1 M cacodylate buffer and dehydrated in a grade 
series of ethanol (10%, 30%, 50%, 70%, 90%) with 30 min on ice for each step. Following 
incubation with 100% ethanol for 30 min at room temperature, samples were embedded in 
Spurr resin (Spurr, 1969) and polymerized at 70°C f or 16 h. After polymerization ultra-thin 
section of infected cell layers were cut with a diamond knife. Sections were collected onto 
butvar-coated Cu-grids, contrasted with 4% uranyl-acetate (UAc) for 3 min at room 
temperature and lead-citrate for 15 sec at room temperature. Following a final washing step 
with H2O, sections were air dried and examined with a TEM EM 910. Images were recorded 
digitally with a Slow-Scan CCD-Camera (ProScan, 1024 x 1024) with ITEM-Software 
(Olympus Soft Imaging Solutions). Samples analysis was carried out by Apl. Prof. Dr. M. 
Rohde (Department of Medical Microbiology, HZI Braunschweig). Contrast and brightness of 
images were adjusted with Adobe Photoshop CS3 Extended (Version 10.0). 
In order to stain cellular membranes, samples were subjected to ferrocyanide osmium 
fixation with thiocarbocyanide (TCH) on the day of infection, immediately after fixation with 
0.1 M cacodylate buffer + 5% paraformaldehyde + 2% glutaraldehyde. All solutions were 
prepared fresh on the day of use. Following fixation, samples were washed twice with 0.1 m 
cacodylate buffer and then incubated with 1.5% potassiumferrocyanide in 1% aqueous 
osmium tetroxide for 30 min at room temperature. Afterwards the cell layer was treated with 
1% aqueous thiocarbocyanide for 5 min at room temperature followed by another incubation 
with 1.5% potassiumferrocyanide in 1% aqueous osmium tetroxide for 5 min at room 
temperature. Finally, samples were washed with 0.1 M cacodylade buffer, dehydrated and 
processed as described above.      
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Table 31: Solutions and buffers used for electron microscopy 
Fixans for EM analysis  
Glutaraldehyde (GA) 2% (w/v) 
Paraformaldehyde (PFA) 5% (w/v) 
HEPES buffer 0.1 M 
 
HEPES buffer  
HEPES  23.83 g 
H2O ad 1 l 
Adjust pH 7.4 with NaOH  
 
Cacodylate buffer  
Cacodylate 100 mM 
Sucrose 90 mM 
MgCl2 10 mM 
CaCl2 10 mM 
 
3.9 Statistical analysis 
Data was analysed using Microsoft Office Excel 2010 software. Each assay was repeated at 
least three times on different days. A minimum of 100 cells was analysed per assay. 
Statistical comparison was performed using the Student’s paired t-test. Results represent 
mean values ± SD of one representative experiment, unless otherwise stated. p values of 
0.05 or less were considered significant.
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4. Results 
4.1 Analysis of the invasion potential of different serotype M1 S. pyogenes strains 
4.1.1 Establishment of an in vitro transwell infection model to study streptococcal 
invasion 
Since a direct interaction of the most invasive serotype M1 GAS with an endothelial cell layer 
(EC) has not been studied before, the invasion potential of M1 GAS was tested by infection 
of primary human endothelial cells of the umbilical cord (HUVEC). Infection studies were first 
performed according to a standard infection protocol, in which HUVEC were cultivated on 
glass coverslips, since previous work within the Department demonstrated successful 
invasion of serotype M3 GAS into endothelial cells using this infection system (Nerlich et al., 
2009, Amelung et al., 2011). Surprisingly, in subsequent immunofluorescence microscopic 
analysis all clinical M1 isolates appeared non-invasive (data not shown). Thus, in order to 
characterise the interaction of M1 GAS with EC in more detail, a new in vitro transwell 
infection model had to be established and applied. HUVEC were grown on an artificial semi-
permeable membrane of a transwell insert, thereby creating an apical and a basolateral 
chamber representing the blood stream on the apical side and the tissue side on the 
basolateral side. Since endothelial cells in vivo form functional barriers to ensure the 
physiological properties of tissues, it was speculated that the confluence status of the EC cell 
layer is also crucial for streptococcal invasion. Therefore, cell layer formation and polarization 
were determined with the CellZscope® system by continuously measuring the 
transendothelial resistance (TER) of cells grown on permeable membranes. In addition to the 
transendothelial impedance, the CellZscope® allows measurement of the electric capacitance 
(Ccl) of EC cell layers. Measurement of both, the transendothelial resistance and the cell 
layers capacitance, provides valuable parameters to assess the current state of a cell layer. 
Confluent polarized cell layers exhibit high TER values and low capacitance while cell layer 
permeability correlates with low TER values and high capacitance (NanoAnalytics, 2009).  
Directly after seeding HUVEC cell layers exhibit low TER values of ~ 8 Ω/cm2 (Figure 5a, 
upper panel). On day three of cultivation the TER value continuously rises and reaches 
values above 22 Ω/cm2 by day five (Figure 5a, upper panel). In contrast to the 
transendothelial resistance, the capacitance of HUVEC layers shows high values (14 µF/cm2) 
directly after seeding (Figure 5a, lower panel). As the transendothelial resistance rises, the 
capacitance continuously decreases to values below 1 µF/cm2 at day five of cultivation. In 
addition to the measurement of the impedance of HUVEC layers, the confluence was also 
assessed by electron microscopy. As shown in Figure 5b after five days of cultivation HUVEC 
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have formed a confluent tight cell layer which correlates with high transendothelial 
resistance.  
Taken together, this in vitro transwell system allows the cultivation of a confluent polarised 
HUVEC cell layer which was subsequently used to analyse the invasion potential of M1 GAS 
into HUVEC in further detail. 
 
 
 
Figure 5: HUVEC cultivated on transwell inserts form confluent polarised cell layers 
HUVEC were cultivated on artificial semi-permeable transwell membranes at 37°C and 5% CO 2 over a period of 5 
days.  
a. The transendothelial electric resistance TER (upper panel) and capacitance Ccl (lower panel) of HUVEC layers 
were continuously measured in 60 min intervals using the CellZscope® system. The diagram shows mean values 
of two independent wells of uninfected HUVEC during the course of cultivation. After 52 h of cultivation the cell 
culture medium was replaced (arrow medium change).  
b. Electron microscopic analysis (FESEM) of the cell layer after 5 days of cultivation confirms the formation of a 
tight confluent HUVEC cell layer. Bar represents 20 µm.  
   
4.1.2 Different serotype M1 GAS clinical isolates invade EC 
Using this transwell system the invasion potential of different clinical isolates of serotype M1 
GAS on HUVEC was assessed. Confluent HUVEC cell layers cultivated on transwell inserts 
were infected with four different M1 GAS isolates (A527, A302, A270 and A271) from 
patients with invasive diseases. After immunofluorescence staining of intra- (red) and 
extracellular (green-yellow) bacteria, the number of intracellular streptococci was assessed. 
Immunofluorescence images of infected HUVEC cell layers show that all M1 GAS isolates 
tested are able to efficiently invade into EC and intracellular streptococci are localized within 
the perinuclear region of the cell (Figure 6a-d). Quantification of invasion show that three of 
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the strains tested exhibit similar invasion rates with more than 100 intracellular bacteria per 
10 cells 4 h post infection (Figure 6e). Only strain A271 shows lower infection rates. As all M1 
GAS strains display comparable invasion potentials, the following experiments were 
performed with strain A527 only.  
Taken together, these results demonstrate the invasiveness of M1 GAS on EC. Furthermore, 
a polarized endothelial cell layer proofed to be essential for M1 GAS invasion, since infection 
assays on glass coverslips using the standard protocol were not successful. Thus, the 
transwell infection model represents a suitable system to study the invasion mechanisms of 
M1 GAS in further detail. 
 
 
Figure 6: Different clinical isolates of serotype M1 GAS invade confluent HUVEC layers 
a-d. Analysis of the invasion potential of M1 GAS clinical isolates on HUVEC layers by immunofluorescence. 
Confluent HUVEC layers were infected with four clinical isolates of serotype M1 GAS A527 (a), A302 (b), A270 (c) 
and A271 (d). Following infection, intracellular streptococci are stained in red and extracellular bacteria are 
visualised in green-yellow. The actin cytoskeleton is depicted in green. Bars represent 5 µm (a-d).  
e. Quantification of the invasion potential of M1 GAS strains A527, A302, A270 and A271 on HUVEC 4 h post 
infection. The graph represents mean values ± SD from one out of three independent experiments.  
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4.2 Characterization of the invasion mechanism 
It has already been shown that several S. pyogenes strains efficiently adhere to and invade 
into different cell types including epithelial and endothelial cells, a process which ensures 
streptococcal survival and protection from the host cells immune response (LaPenta et al., 
1994, Greco et al., 1995, Molinari et al., 1997, Jadoun et al., 1998, Rohde et al., 2003, 
Nerlich et al., 2009). Depending on the invasin expressed on the surface of GAS, distinct 
invasion mechanisms are triggered. Serotype M3 GAS, expressing the fibronectin binding 
protein FbaB, induces the formation of membrane protrusions which engulf the bacteria and 
mediate a zipper-like uptake into EC (Nerlich et al., 2009, Amelung et al., 2011). Similarly, 
M1 GAS mediates a zipper-like uptake into epithelial cells (Dombek et al., 1999). In contrast, 
SfbI-expressing S. pyogenes strains trigger the aggregation of caveolae and streptococcal 
uptake via large membrane invaginations (Molinari et al., 2000, Rohde et al., 2003).  
 
4.2.1 M1 S. pyogenes triggers the formation of membrane protrusion and zipper-like 
uptake into EC 
After establishing an in vitro infection system, the invasion mechanism and especially the 
mode of internalization of serotype M1 GAS into HUVEC were assessed in further detail. 
Therefore, HUVEC were infected with M1 GAS strain A527 and samples were analysed by 
FESEM. 
Following adherence to the apical side of the host cell (Figure 7a), M1 GAS induces actin 
cytoskeletal rearrangements and the formation of membrane protrusions (Figure 7b). These 
tightly engulf the streptococcal chain (Figure 7c) until bacteria are completely surrounded by 
the host cell membrane and internalized into the cell (Figure 7d). Notably, invasion was 
apparent predominantly at the interfaces between cells in the monolayer and not at the very 
centre of the cells (data not shown).  
These results demonstrate a zipper-like uptake of M1 GAS into endothelial cells which 
visually parallels the FbaB-mediated uptake of serotype M3 GAS into EC (Amelung et al., 
2011). In contrast, this invasion mechanism is morphologically distinct from the caveolae-
mediated uptake induced by SfbI-expressing GAS strains (Rohde et al., 2003).   
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Figure 7: Invasion of M1 GAS into EC is accompanied by the formation of membrane 
protrusions 
Analysis of the invasion mechanism of M1 GAS into EC by field emission scanning electron microscopy. Upon 
infection of HUVEC, M1 GAS adheres to the host cell surface (a) and induces the formation of membrane 
protrusions (b, c), which subsequently leads to complete internalization of the streptococcal chain into the host 
cell (d). Bars represent 1 µm (a), 600 nm (b) and 2 µm (c, d). 
 
4.2.2 M1 GAS entry is characterised by F-actin accumulation and aggregation of the 
Arp2/3 complex in the vicinity of invading GAS 
On the cellular level, the basis for the formation of membrane protrusions are cytoskeletal 
rearrangements and, in particular, a reorganization of the actin cytoskeleton. The actin 
related protein complex 2/3 (Arp2/3) has been shown to play a crucial role in actin 
cytoskeletal remodelling processes. It acts as a nucleation factor that initiates the formation 
of new actin filaments and, in particular, the assembly of branched actin fibres (Goley et al., 
2006, Campellone et al., 2010). Since electron microscopic analysis revealed cytoskeletal 
rearrangements during the invasion of M1 GAS into EC, the role of actin remodelling and the 
involvement of the Arp2/3 complex in these processes was investigated.  
Therefore, confluent HUVEC layers were infected with M1 GAS. Following infection, F-actin 
and the Arp2/3 complex were labelled and the samples were analysed by 
immunofluorescence microscopy.  
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Upon invasion of M1 GAS into HUVEC, an accumulation of F-actin is induced in the vicinity 
of invading streptococci. Figure 8a shows a streptococcal chain in the process of invasion. F-
actin (stained in green) closely accumulates around the initial three cocci of the streptococcal 
chain (labelled in red). In contrast, no co-localization with F-actin is observed for the 
remaining cocci, suggesting that only the front part of the streptococcal chain is already 
internalized into the cell and the rest of the chain is still localized outside of the cell. In 
addition to F-actin accumulation at the port of entry, the Arp2/3 complex aggregates around 
invading bacteria whereas it is statistically distributed within neighbouring cells or within parts 
of the cell where no bacterial invasion occurs (Figure 8b). 
Taken together, upon infection M1 GAS induces actin polymerization at the port of entry, a 
process which seems to be mediated by Arp2/3 actin filament branching. These cellular 
processes are the basis for cytoskeletal rearrangements, the formation of membrane 
protrusion and subsequent internalization of streptococci into the host cell as previously seen 
by scanning electron microscopy (Figure 7).  
 
Figure 8: Upon invasion M1 GAS triggers the accumulation of F-actin and the aggregation of 
the Arp2/3 complex at the port of entry 
HUVEC were infected with M1 GAS strain A527 for 60 min. Following infection, samples were stained for 
immunofluorescence microscopy. M1 GAS (red) invasion into HUVEC induces F-actin accumulation (green) at 
the site of entry (a). In addition, the Arp2/3 (green) complex aggregates around invading streptococci (blue) (b). 
Inserts show enlarged sections of split channels of the indicated area in the merged image. Bars represent 5 µm 
(a,b).   
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4.3. M1 GAS mediates phagocytic-like uptake processes into HUVEC 
Invasion into host cells represents one successful mechanism of S. pyogenes to evade host 
immune defences and to ensure streptococcal survival. It is already known that depending 
on the mode of internalization S. pyogenes strains take distinct intracellular trafficking routes. 
Strains that trigger invasion by cytoskeletal rearrangements, for example serotype M3 GAS, 
are localized within phagosomes which traffic along the classical endocytic route and fuse 
with lysosomes (Amelung et al., 2011) (Talay, unpublished data). In contrast, SfbI-expressing 
S. pyogenes strains showing caveolae-mediated invasion reside within caveosomes and 
prevent fusion with lysosomes thereby bypassing the endocytic machinery (Rohde et al., 
2003). 
Thus, the intracellular trafficking route of M1 GAS within EC was analysed in further detail. 
 
4.3.1 M1 GAS mediates co-localization with the late endosomal/lysosomal 
compartment 
A characteristic of the classical endocytic machinery is fusion of phagosomes containing 
foreign material, e.g. bacteria, with late endosomal and lysosomal compartments. A marker 
for late endosomal and lysosomal compartments is the lysosomal associated membrane 
protein 1 (Lamp-1). To analyse the intracellular trafficking route of M1 GAS within endothelial 
cells, HUVEC were infected with M1 GAS for different time periods ranging from 1 h to 
overnight infection. Following fixation, the late endosomal lysosomal compartment as well as 
streptococci were stained differentially and analysed by immunofluorescence microscopy. 
Immunofluorescence analysis of infected HUVEC cell layers reveals co-localization of 
intracellular streptocooci (red) with the Lamp-1 positive late endosomal/lysosomal 
compartments (green) of the cell (Figure 9a). 1 h until 5 h post infection the majority of the 
intracellular streptococci is localized within Lamp-1 positive compartments (Figure 9b). In 
contrast, after overnight infection the number of streptococci co-localizing with Lamp-1 
declines to approximately 50% (Figure 9b).  
These data suggest that following internalization M1 GAS travels along the endocytic route 
and acquires late endosomal and lysosomal markers. However, since the number of 
streptococci residing within these compartments is declining over time, it can be speculated 
that this is a transient time dependent step in the intracellular trafficking process. This 
question was addressed in subsequent experiments (refer to chapter 4.4.2). 
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Figure 9: Co-localization of M1 GAS with late endosomal/lysosomal compartments 
a. M1 GAS strain A527 (red) co-localizes with Lamp-1 (green), a marker for late endosomal/lysosomal 
compartments. The inserts show split channels for GAS (red) and Lamp-1 (green) of the indicated area in the 
merged image. Bar represents 5 µm. 
b. Quantification of Lamp-1 association. The graph shows mean values ± SD of one out of three independent 
experiments. ic cocci: intracellular streptococci. 
 
4.3.2 M1 GAS phagosomes fuse with terminal lysosomes 
The results shown above indicate trafficking of M1 GAS along the endocytic route. However, 
due to the limitation of the Lamp-1 stain, one cannot distinguish between late endosomes 
and terminal lysosomes. This raised the question if this process eventually ends in fusion of 
phagosomes with terminal lysosomes. Therefore, HUVEC were pre-incubated with BSA-gold 
particles 18 h prior to infection. These are internalized into the cell by receptor-mediated 
endocytosis and, after trafficking along the endocytic route, are delivered into terminal 
lysosomes. After infection of HUVEC with M1 GAS, the samples were processed for FESEM. 
Gold-loaded lysosomes are detectable as white material localized within the perinuclear 
region of HUVEC (Figure 10a, left image white arrow heads; right image shows specific 
detection of nano gold particles with the EsB-detector due to higher material contrast of nano 
gold particles). At early infection points, gold-loaded lysosomes are clearly separated from 
invading streptococci (Figure 10a, white arrow heads indicate gold particles, white arrows 
indicate invading streptococci) whereas at later time points invading streptococci co-localize 
with gold-particles (Figure 10b, c left images). Furthermore, electron microscopic images 
reveal that invading streptococci move from the border of the cell towards the gold-loaded 
lysosomes which are still surrounding the nucleus of HUVEC (Figure 10b). 
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Figure 10: Co-localization of M1 GAS with gold particles indicates phagolysosomal fusion 
Analysis of phagolysosomal fusion by FESEM. Prior to infection with M1 GAS, HUVEC lysosomes were pre-
loaded with gold particles. Following infection, samples were analysed by FESEM. Right images show 
corresponding images of the EsB-detector channel used for specific detection of intracellular gold particles.  
a. At early time points after infection intracellular streptococci (white arrows) are separated from gold particles 
(white arrow heads) which accumulate around the cell nucleus (N). Bars represent 2 µm. 
b. At later time points invading M1 GAS (white arrows) co-localize with gold particles (white arrow heads). N: 
HUVEC nucleus. Bars represent 2 µm. 
c. Co-localization of M1 GAS (white arrow) with gold particles (white arrow head) at higher magnification. Bars 
represent 200 nm.  
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Fusion of streptococci containing phagosomes with terminal lysosomes was further verified 
by transmission electron microscopy (Figure 11). Again HUVEC lysosomes were pre-loaded 
with gold particles followed by infection with M1 GAS. Within the cell gold particles are 
detectable as black and round electron dense material (Figure 11, white arrows). Ultra-thin 
sections of infected HUVEC layers show fusion events of streptococci with gold particles. At 
early time points streptococci are still separated from gold-loaded lysosomes (Figure 11, left 
image). Streptococci then move towards the gold particles (Figure 11, middle image) and at 
later time points a close co-localization of bacteria with gold particles is detectable (Figure 11, 
right image, white arrow). 
Taken together, the results shown above demonstrate that, after invasion and incorporation 
into phagosomes, M1 GAS travels along the classical endocytic route and is finally fusing 
with terminal lysosomes. Thus, this process shows parallels to FbaB-mediated uptake and 
trafficking of serotype M3 GAS within endothelial cells (Amelung et al., 2011). This is of 
specific interest since M1 GAS does not harbour the FbaB protein, which is responsible for 
M3 GAS invasion into HUVEC.    
 
 
Figure 11: M1 GAS containing phagosomes fuse with terminal lysosomes 
HUVEC lysosomes were pre-loaded with BSA-gold particles 18 h prior to infection. Following infection, ultrathin 
sections of infected HUVEC layers were prepared and analysed by TEM. Electron microscopic images show 
fusion of the M1 GAS containing phagosome with gold-loaded terminal lysosomes (white arrows). At earlier time 
points GAS and gold particles are clearly separated (left image). With increasing infection time, GAS and gold 
particles are found within close proximity (middle image) and finally closely associated and co-localized (right 
image). Bars represent 1 µm (left and middle image) and 500 nm (right image).   
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4.4. Intracellular survival of M1 GAS in HUVEC 
Classical endocytic uptake processes lead to the delivery of foreign material into lysosomes 
followed by subsequent degradation and elimination by hydrolytic enzymes, like lipases and 
proteases (Flannagan et al., 2012). To evade those host defence mechanisms, S. pyogenes 
developed several strategies to ensure its survival. SfbI-expressing streptococci invade 
target cells by caveolae aggregation and reside in caveosomes which exhibit no fusion with 
lysosomes and thereby ensure better streptococcal survival (Rohde et al., 2003). Serotype 
M3 GAS, in contrast, traffics along the phagolysosomal route but induces its release at the 
basolateral side of the cell by a lysosomal exocytosis process, thereby escaping from the 
acidic degrading environment of the lysosomes (Talay, unbublished data). Since serotype 
M1 GAS is one of the most invasive serotypes causing the majority of severe tissue based 
diseases, the question of intracellular survival and the possible strategy of survival were 
investigated in further detail. 
 
4.4.1 Quantification of intracellular survival 
Bacterial viability staining of HUVEC layers after infection with M1 GAS indicates 
streptococcal survival within the cell. Immunofluorescence images of infected cell layers 
reveal live bacteria 5 h post infection (Figure 12a, left image, live bacteria labelled in green). 
Also after longer infection periods (10 h) at least 50% of the intracellular bacteria are viable 
(Figure 12a, right image). To quantify intracellular survival, HUVEC were infected with M1 
GAS for an initial period of 3 h followed by killing of extracellular bacteria by the addition of 
antibiotics. After defined time points infected HUVEC were lysed and intracellular viable 
bacteria were plated. Quantification of survival rates by plating of HUVEC lysates confirms 
intracellular survival of M1 GAS within HUVEC (Figure 12b).  However, one has to note that 
the bacterial counts are gradually declining over time, yielding 2x104 cfu/ml 2 h post infection, 
1,5x104 cfu/ml 4 h post infection, 1x104 cfu/ml 6 h post infection and 5x103 cfu/ml after 9 h of 
infection (Figure 12b).  
Taken together, both, viability staining and plating of HUVEC lysates, indicate that M1 GAS 
has evolved a strategy to ensure bacterial survival despite the innate defence mechanisms 
within the host cell.  
 
Results 
 
  
75 
 
Figure 12: Intracellular survival of M1 GAS within HUVEC 
a. Immunofluorescence analysis of the viability of M1 GAS following infection of HUVEC at varying time points. 
Viable bacteria are stained in green and dead bacteria are labelled in red. HUVEC nuclei also absorb the stain 
used and, therefore, also appear green. Immunofluorescence images demonstrate viability of intracellular 
streptococci at 5 h (left image) as well as at 10 h (right image) post infection. Bars represent 5 µm. 
b. Quantification of survival rates of M1 GAS. Following infection and killing of extracellular bacteria, HUVEC 
lysates were plated after defined time points. Survival rates were calculated by enumerating viable bacteria. The 
graph shows mean values ± SD of triplicates from one representative experiment. 
 
4.4.2 M1 GAS escapes from the phagolysosome into the cytoplasm 
The capability of serotype M1 GAS to prevent its degradation within phagolysosomes raised 
the question how the bacteria mediate this process. To this end HUVEC layers were infected 
with M1 GAS for different time periods and ultrathin sections of infected HUVEC layers were 
analysed by transmission electron microscopy. Microscopic images reveal that M1 GAS 
escapes from the phagolysosomal compartments (Figure 13a, white arrow; Figure 13b) and 
resides free within the cytoplasm of the host cell (Figure 13a, c). This observation 
corroborates the findings of the Lamp-1 fluorescent staining which shows that only 50% of 
the intracellular streptococci co-localize with Lamp-1 after prolonged infection periods, also 
suggesting escape from phagolysosomal compartments (Figure 9b). In order to verify the 
cytoplasmic localization of M1 GAS, a staining technique was applied which specifically 
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visualises cellular membranes. The combined ferrocyanide and osmium tetroxide staining 
confirms the absence of any cellular membranes surrounding intracellular M1 GAS, giving 
further evidence of its cytoplasmic localization e.g. in direct proximity to the endoplasmic 
reticulum (Figure 13c). The electron microscopic images further support viability of 
intracellular GAS since streptococci seem morphologically intact and bacterial replication is 
evident.  
These results demonstrate that M1 GAS ensures its survival by escaping from the acidic 
environment of the phagolysosomal compartment into the cytoplasm of the cell, thereby 
being protected from host cell defence processes. 
 
 
Figure 13: M1 GAS escapes from the phagolysosomal compartment 
After infection of HUVEC cell layers with M1 GAS, ultrathin sections were prepared for TEM analysis.  
a, b. TEM images of infected HUCEC cell layers show that streptococci escape from the membrane bound 
compartment of the phagolysosome (a, white arrow). Bars represent 1 µm (a) and 200 nm (b). 
c. Free M1 GAS are localized within the cytoplasm (white arrows) of HUVEC in close proximity to the 
endoplasmic reticulum (black arrow). Bar represents 500 nm.   
 
4.4.3 M1 GAS overcomes the endothelial cell barrier 
The data shown above indicate successful survival of M1 GAS within endothelial cells. Since 
serotype M1 GAS is the leading cause of invasive diseases, the fate of intracellular 
streptococci had to be addressed next. The development of an invasive disease implies that, 
at some point, the pathogen is able to overcome endothelial cellular barriers. On this account 
it was speculated that M1 GAS transmigrates within HUVEC and emerges from the cell at 
the basolateral side ensuring its spread into deeper tissue layers. Thus, bacteria should be 
found within the lower compartment of the transwell insert. To test this hypothesis, confluent 
HUVEC layers were infected with M1 GAS. At defined time points after infection the medium 
of the lower well was plated and the colony forming units were calculated. Against the 
expectations plating experiments reveal that no streptococci are present in the lower well 
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even after 72 h of infection (Figure 14a). Electron microscopic analysis of HUVEC layers 
confirms the presence of intracellular streptococci (Figure 14b, white arrows). In order to 
further test the hypothesis of M1 GAS transmigration, infected HUVEC layers were removed 
from the transwell membrane and the bottom of the cell layer as well as the surface of the 
transwell membrane itself were analysed for the presence of streptococci. As shown in Figure 
14c M1 GAS are present directly attached to the transwell membrane entangled within a 
mesh of gelatine and extracellular matrix components (Figure 14c, white arrows indicating M1 
GAS, white arrow heads label the pores of the transwell membrane). In addition, it became 
apparent that, as infection progresses, increasing numbers of dead HUVEC are detectable 
within the intact HUVEC layer (Figure 14d). This observation gives reason for speculation that 
M1 GAS escape is accompanied with cell lysis.  However, since these are preliminary 
observations the exact mechanism of escape has to be addressed in further detail in 
subsequent studies.     
Taken together, survival of M1 GAS within endothelial cells can be demonstrated. 
Furthermore, the results indicate that M1 GAS possesses the potential to transmigrate over 
the endothelial cell barrier via the basolateral side of the HUVEC cells.  
 
Figure 14: M1 GAS transmigrate through the endothelial cell barrier 
a. Plating of streptococci within the lower compartment of the transwell at different time points after infection.  
b. Following infection, the presence of intracellular streptococci (white arrows) is confirmed by FESEM 
demonstrating successful invasion of M1 GAS into HUVEC. Bar represents 2 µm. 
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c. After removal of the HUVEC layer, M1 GAS (white arrows) are found directly bound to the transwell membrane 
indicating escape from the cell at the basolateral side. White arrow heads indicate the pores of the transwell 
membrane. Bar represents 2 µm. 
d. FESEM image reveals the presence of dead HUVEC within the cell layer suggesting that M1 GAS escape is 
accompanied by cell lysis. Bar represents 10 µm.  
 
4.5 Identification of the bacterial factor that determines EC interaction  
The data described in the previous chapters show that serotype M1 GAS has evolved 
strategies to ensure its survival within endothelial cells. Although traditionally viewed as an 
extracellular pathogen, it successfully invades into endothelial cells, prevents its degradation 
by hydrolytic enzymes within lysosomes and transmigrates through the endothelial cell 
barrier to reach deeper tissue layers. However, the bacterial factor or factors that mediate 
this invasion process remained unidentified. Unlike serotype M3 GAS, in which the 
fibronectin-binding protein FbaB was identified as the EC invasin (Amelung et al., 2011), 
serotype M1 GAS lacks this specific protein on its cell surface. Therefore, a series of pre-
existing knock-out mutants (GAS 90-226 ∆emm1; KTL3 grab ko; KTL3 prtS::spc; KTL3 
slo::spc; KTL3 pJRS 233-∆sagA) was tested in loss of function assays (data not shown). 
These assays identified the M1 surface protein as a promising candidate. Its role during 
invasion into EC was analysed in further detail in the following. Previously, Dombek and 
colleagues have demonstrated that the M1 knock out mutant is deficient in invasion of 
epithelial cells (Dombek et al., 1999). 
 
4.5.1 Characterization of the GAS M1 knock out mutant strain 
Prior to the functional analysis of the M1 protein as the EC invasin, the existing S. pyogenes 
(90-226 ∆M1) M1 knock out mutant strain (Zimmerlein et al., 2005) was characterised and 
verified for lack of expression of the M1 protein. 
First, the expression of the M1 protein on the surface of the M1 knock out mutant strain (90-
226 ∆emm1) was analysed in comparison to the corresponding wild type M1 GAS strain (90-
226 wt). By immunofluorescence staining with a specific α-M1 primary antibody and a 
labelled secondary antibody the M1 protein is visualised on the surface of the M1 wt GAS 
stain (Figure 15a, left images). In contrast, as expected, the M1 knock out mutant fails to 
express the M1 protein on its surface (Figure 15a, right images). 
As it is known that the M1 protein of GAS binds several human plasma components, the 
expression of the M1 protein can be assessed indirectly by analysis of the binding 
capabilities of the M1 wild type and the M1 knock out mutant strain in a plasma absorbance 
assay. Following incubation of both strains with human plasma, bound plasma proteins were 
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eluted with glycine/HCl and were analysed by SDS-PAGE. Figure 15b shows the coomassie 
stained SDS-gel. The M1 expressing wild type GAS strain binds human albumin, the heavy 
chain of IgG, fibrinogen and plasminogen, whereas the M1 knock out mutant fails to bind any 
of these plasma proteins, indicating lack of the M1 protein on its surface (Figure 15b).  
As binding of the M1 wild type strain with the light chain of human IgG is not detectable in the 
SDS-gel, IgG binding was assessed additionally in a radioactive IgG binding assay. 
Following incubation of the M1 wild type and the M1 knock out mutant with radioactively 
labelled human IgG, the potential binding was assessed by measuring the radioactive 
radiation emitted from the bacterial pellets. As shown in Figure 15c the M1 wild type GAS 
strain binds 75% of the radioactive labelled IgG. In contrast, binding of human IgG is 
significantly reduced in the mutant strain lacking the M1 protein on its surface.   
The results shown above verify the absence of the M1 protein in the M1 knock out mutant 
which was then used for functional analysis of the M1 protein as a potential invasin.    
 
Figure 15: Serotype M1 GAS lacking the M1 surface protein fails to bind human plasma 
components 
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a. Analysis of the expression of surface bound M1 on GAS by immunofluorescence staining of the M1 protein. In 
contrast to the wild type strain (M1 wt GAS, left images), the M1 knock out mutant strain (∆M1 GAS; right images) 
shows no expression of the M1 protein (green) on its surface. Bars represent 5 µm.  
b. Plasma absorbance assay analysing the binding capacities of GAS strains to human plasma components. The 
M1 wild type strain (M1 wt) binds plasminogen (faint band with a molecular weight of 95 kDa), albumin, IgG and 
fibrinogen (arrows). In contrast, the M1 knock out mutant (∆M1) shows no binding to these plasma proteins. MW: 
molecular weight 
c. Radioactive IgG binding assay. In comparison to the M1 wt strain IgG binding is significantly reduced in the M1 
knock out mutant strain. The graph shows mean values ± SD of one experiment done in triplicates.  
 
4.5.2 The M1 protein of S. pyogenes is crucial for efficient invasion of GAS into HUVEC 
After verification that the M1 knock out mutant could be used to analyse whether the M1 
protein represents the invasin of serotype M1 streptococci, loss of function/gain of function 
infection assays with HUVEC cells were performed. The invasion potential of the M1 protein 
on EC was analysed by infection of HUVEC with the M1 expressing wild type GAS strain and 
its isogenic M1 knock out mutant strain. After infection, cell layers were stained differentially 
for extra- (green-yellow) and intracellular (red) streptococci and samples were assessed by 
immunofluorescence microscopy.  
Figure 16 shows the results of the infection assay on HUVEC. S. pyogenes, expressing the 
M1 protein on its surface, efficiently invades HUVEC with invasion rates of 179 intracellular 
streptococci per 10 cells 4 h post infection (Figure 16b, M1 wt). In contrast, the invasion of the 
M1 knock out strain, lacking the M1 protein, is significantly reduced (Figure 16b, ∆M1). By 
complementation of the deleted emm1 gene by episomal expression of the M1 protein, the 
wild type phenotype is restored, yielding internalization rates comparable to that of the wt M1 
GAS strain (Figure 16b, compl. ∆M1). Likewise immunofluorescence images of infected 
HUVEC layers show that the M1 knock out mutant strain is deficient for invasion of HUVEC 
(Figure 16a, middle image ∆M1 GAS). In comparison both, the M1 wild type GAS strain and 
the complemented M1 knock out mutant, successfully invade HUVEC (Figure 16a, left and 
right image respectively).  
To further verify the essential role of the M1 protein during the invasion process of GAS into 
HUVEC, blocking experiments were performed. Prior to infection of HUVEC, streptococci 
were pre-incubated with increasing concentrations of an α-M1 specific antibody or a control 
antibody. Following infection, the samples were stained for intra- and extracellular 
streptococci. In comparison to untreated control bacteria or streptococci treated with a non-
M1 specific control IgG, pre-incubation of bacteria with a M1 specific antibody significantly 
reduces invasion in a concentration dependent manner (Figure 16c).   
The data of the infection and blocking assays identified the M1 surface protein of GAS as a 
crucial factor during the invasion process into endothelial cells. However, it remains to be 
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clarified if it is the sole factor that mediates streptococcal uptake into EC. In the following its 
role as a potential invasin on EC was analysed in further detail. 
 
 
Figure 16: The M1 knock out mutant is deficient for invasion of HUVEC 
a. Fluorescence images of HUVEC infected with the M1 wt stain (left image), the ∆M1 knock out mutant (middle 
image) and the complemented ∆M1 knock out mutant (right image) for 4 h. Intracellular bacteria are depicted in 
red, extracellular bacteria are shown in green-yellow. HUVEC nuclei are depicted in blue. Bars indicate 20 µm. 
b. Internalization rates of the M1 wt GAS strain (strain A766), its isogenic M1 knock out mutant ∆M1 GAS (A767) 
and the ∆M1 mutant complemented with an emm1 carrying plasmid (compl. ∆M1 GAS) into HUVEC (4 h post 
infection). Compared to the M1 wt strain, the ∆M1 knock out mutant is deficient for invasion of HUVEC. After 
complementation of the ∆M1 GAS strain with emm1, bacterial uptake into HUVEC is restored. The graph 
represents mean values ± SD of one representative out of three independent experiments. 
c. Pre-incubation of HUVEC with a polyclonal α-M1 specific antibody significantly reduces invasion of M1 GAS 
into HUVEC in a concentration dependent manner. Untreated HUVEC and HUVEC treated with a non-M1 control 
antibody (ctr IgG) served as negative controls. The graph shows mean values ± SD of one out of three 
independent experiments. 
 
4.5.3 The M1 protein mediates internalization of latex beads into HUVEC 
To exclude the involvement of any endogenous streptococcal factors in the invasion process, 
the invasive properties of the M1 protein were further characterised by latex bead 
internalization assays. Latex beads with a size of 3 µm are non-invasive and are naturally not 
internalized into HUVEC. In the following it should be tested if the presence of purified M1 
protein on the surface of latex beads promotes uptake of latex beads into HUVEC.  
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Therefore, the emm1 gene, omitting the sequence of the signal peptide and the membrane 
anchor, was amplified, cloned and transformed into E. coli. Following overexpression of M1 
in E. coli, recombinant M1 protein was purified and coated onto latex beads. Latex beads 
coated with GST protein served as a negative control. The coating efficiency was verified by 
FACS analysis to ensure successful coating of latex beads with recombinant M1 and GST 
protein (data not shown). Coated latex beads were then incubated with HUVEC for varying 
time periods. Following fixation, intra- and extracellular latex beads were stained and the 
invasion potential of M1 was assessed by immunofluorescence microscopy.  
Microscopic samples show that M1-coated latex beads are internalized into HUVEC in a time 
dependent manner (Figure 17a) and are detectable within the cell surrounding the nucleus 
(Figure 17b, white arrows). In contrast, GST-coated latex beads are not internalized (Figure 
17a). As seen for the M1 wt GAS strain, M1-coated latex beads induce the formation of 
membrane protrusions which enclose the latex beads (Figure 17c, white arrow heads) until 
they are completely engulfed by the host cell membrane and internalized into the host cell 
(Figure 17d). Internalized M1-coated latex beads, like the M1 wt GAS strain, follow the 
endocytic pathway. M1-coated latex beads induce the accumulation of the late 
endosomal/lysosomal marker protein Lamp-1 (Figure 17e). Due to the acidic environment 
within the phagolysosome, the M1 protein on the surface of latex beads is degraded, thus, 
intracellular latex beads lose their red immunofluorescence stain and appear green. Finally, 
phagosomes containing M1-coated latex beads fuse with terminal lysosomes as 
demonstrated by co-localization with gold particles (Figure 17f).  
Taken together, the results of the gain of function experiments demonstrate that the M1 
protein is sufficient for effective invasion into HUVEC and, therefore, represents the M1 
serotype invasin into endothelial cells.  
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Figure 17: The M1 protein of S. pyogenes triggers invasion into HUVEC 
Analysis of the invasion potential of M1 by latex bead internalization assays. HUVEC were co-incubated with M1-
coated latex beads as well as GST-coated latex beads as negative control. Following infection, the samples were 
processed for immunofluorescence or electron microscopic analysis.  
a. Quantification of internalization of M1- and GST-coated latex beads into HUVEC at varying time points. In 
contrast to the negative GST-control beads, M1-coated latex beads are internalized into HUVEC in a time 
dependent manner. The graph shows mean values ± SD of one representative out of three independent 
experiments. 
b. Phase contrast showing HUVEC containing intracellular M1-coated latex beads (white arrows) 60 min post 
infection. Bar represents 10 µm. 
c. FESEM image demonstrating that M1-coated latex beads trigger actin cytoskeletal rearrangements and 
engulfment of latex beads by host cell membranes 90 min post infection (white arrow heads). Bar represents 5 
µm.  
d. FESEM of one M1-coated latex bead completely internalized into HUVEC (90 min post infection). Bar 
represents 2 µm. 
e. M1-coated latex beads (red) co-localize with Lamp-1 (green) 4 h post infection. Within the acidic environment 
of phagolysosome the M1 protein on the surface of latex beads is degraded, thus, intracellular latex beads lose 
their red immunofluorescence stain and appear green. Bar represents 10 µm. 
f. TEM analysis of ultrathin section of HUVEC pre-incubated with BSA-gold particles followed by co-incubation 
with M1-coated latex beads. Latex beads closely associate with gold particles (white arrows) 12 h post infection 
indicating fusion of the phagosome with terminal lysosomes. Bar indicates 1 µm.  
 
4.5.4 The M1 protein mediates invasion of Lactococcus lactis into HUVEC 
Finally, the invasive properties of the M1 protein were further analysed in a bacterial 
heterologous expression system. L. lactis served as a suitable model organism as it is a 
gram-positive, non-pathogenic bacterium and naturally does not invade human endothelial 
cells. In the following it should be tested whether the expression of the M1 protein on the 
surface can convert L. lactis into an invasive strain. Two L. lactis strains, one expressing the 
M1 protein heterologous on its surface and the parental wt strain lacking the M1 protein were 
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kindly provided by Prof. Dr. P. Cleary, Minneapolis, USA (Cue et al., 2001). 16 s rRNA 
sequencing confirmed that both strains were indeed L. lactis strains (data not shown). 
Furthermore, immunofluorescence analysis confirmed the expression of the M1 protein in the 
L. lactis strain carrying the emm1 gene whereas in the parental wt strain no expression of M1 
was detectable (data not shown). Following verification, both strains were used in infection 
assays on HUVEC. Infected HUVEC layers were stained for intracellular lactococci by 
immunofluorescence.  
Immunofluorescence analysis of infected HUVEC cell layers confirms that the parental 
L. lactis strain is non-invasive in HUVEC (Figure 18, right bar labelled -M1). In contrast, 
expression of the M1 protein significantly increases the invasiveness of L. lactis, yielding 
invasion rates of around 60 bacteria per 10 cells (Figure 18, left bar labelled +M1).  
These data, together with the results of the experiments described above, clearly identify the 
M1 protein as a major streptococcal invasin on endothelial cells. In addition, these results 
demonstrate that the M1 protein alone is sufficient to mediate efficient uptake into HUVEC.    
 
 
Figure 18: The M1 protein of S. pyogenes mediates invasion of lactococci into HUVEC 
Quantification of invasion rates of L. lactis strains in HUVEC 3 h post infection. Following infection, intra- and 
extracellular lactococci were stained differentially. L. lactis expressing the M1 protein invades into HUVEC. In 
contrast, the parental wt strain, which lacks the M1 protein on its surface, is non-invasive in HUVEC. The graph 
shows mean values ± SD of one out of three independent experiments. 
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4.5.5 Dead M1 GAS are also internalized into HUVEC 
In addition to infections with live M1 GAS, infection assays with dead bacteria were also 
performed. Prior to infection of HUVEC, M1 GAS were heated for 30 min at 95°C to kill all 
streptococci. Then HUVEC were infected with heat-killed M1 GAS for varying time periods 
ranging from 2 h to 5 h. The internalization of M1 GAS into HUVEC was assessed by 
immunofluorescence microscopy and determination of the number of intracellular bacteria. 
As depicted in Figure 19, heat-killed M1 GAS are also internalized into HUVEC in a time 
dependent manner with invasion rates of 180 intracellular streptococci per 10 cells 5 h post 
infection.  
The uptake of dead streptococci indicates that the cellular uptake process of M1 GAS does 
not require live bacteria or secretion of any effector molecules. In addition, HUVEC, as non-
professional phagocytic cells, are able to efficiently internalize M1 GAS depicting the strong 
potential of M1 as an invasin even in its denatured state.    
 
 
Figure 19: Internalization of heat-killed M1 GAS into HUVEC 
HUVEC were infected with heat-killed M1 GAS. Uptake of streptococci into HUVEC was assessed by 
immunofluorescence staining of intra- and extracellular bacteria. As seen for live bacteria heat-killed M1 GAS 
strains are also internalized into HUVEC in a time dependent manner. The graph shows mean values ± SD of one 
representative experiment performed in triplicate.  
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4.6 Identification of host cell factors that mediate M1 GAS invasion into HUVEC 
The basis for actin cytoskeletal rearrangements as triggered by M1 GAS during invasion of 
HUVEC is the engagement of a cellular receptor and the activation of specific signalling 
cascades within the host cell which lead to engulfment and internalization of M1 GAS into 
HUVEC. Next, experiments were performed which aimed to identify cellular factors in 
particular the cellular receptor and intracellular signalling molecules involved in the invasion 
process of M1 GAS into HUVEC.  
   
4.6.1 Engagement of beta1-integrins during invasion of M1 GAS into HUVEC 
One known host cell receptor involved in invasion of M1 GAS is the family of integrins (Cue 
et al., 1998). Integrins are heterodimeric glycoprotein receptors consisting of one alpha and 
one beta subunit. To date, 18 alpha and 8 beta integrin subunits have been identified. 
Integrins are involved in signal transduction of various cellular processes including 
organization of the actin cytoskeleton, cell survival, cell proliferation and cell motility 
(Schwartz et al., 1995, Cary et al., 1999, Hynes, 2002) which makes them an attractive 
receptor for M1 protein mediated streptococcal uptake. 
Next the involvement of integrins in the invasion of M1 GAS into HUVEC was assessed. 
HUVEC were pre-incubated with monoclonal antibodies against specific alpha and beta 
integrin subunits. Following pre-incubation, HUVEC were infected with M1 GAS for 2 ½ h 
and samples were processed for immunofluorescence microscopy. Figure 20a shows the 
effect of integrin subunit blocking on M1 GAS invasion into HUVEC. Blocking of the α1- or α2-
integrin subunit has no significant effect on the invasion of M1 GAS into EC. In comparison to 
the untreated control, invasion rates of more than 90% are observed in these samples. 
Blocking of the β1-integrin subunit, however, significantly reduces streptococcal invasion to 
56% (Figure 20a). Immunofluorescence images show that β1-integrins are evenly distributed 
across the surface of HUVEC (Figure 20b, β1-integrin labelled in green). In contrast, upon 
streptococcal invasion, clustering of the β1-integrins is detectable in the close vicinity of 
invading streptococci, giving evidence for an outside-inside signalling event (Figure 20b, white 
box).  
The results of the integrin blocking experiments, together with the observation of β1-integrin 
subunit clustering around invading streptococci, indicate that M1 GAS induces the activation 
of host cell integrins. However, further experiments need to be done to clarify which integrin 
heterodimer is engaged during this process.    
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Figure 20: Beta1-integrins are involved in the invasion of M1 GAS into HUVEC 
Analysis of the involvement of specific integrin subunits in the invasion of M1 GAS into EC.  
a. Quantification of M1 GAS invasion following blocking of the α1-, α2- or β1-integrin subunits by pre-incubation of 
HUVEC with specific monoclonal antibodies. Blocking of the β1 subunits significantly reduces streptococcal 
invasion to 50%. In contrast, neither the α1 nor α2 subunit seem to be engaged during M1 GAS invasion as 
blocking either of those has no effect on invasion rates. n.s.: non-significant  
b. Immunofluorescence staining of β1-integrins on the surface of HUVEC. M1 GAS (red) induces the accumulation 
of the β1-integrin subunit (green) around invading streptococci. Inserts show enlarged sections of split channels 
(GAS in red and β1-integrin in green) of the indicated area in the merged image. EC nuclei are depicted in blue. 
Bar represents 5 µm. 
 
4.6.2. Involvement of phospholipase C, protein kinase C and intracellular calcium in 
the invasion of M1 GAS into HUVEC 
The results of the experiments described in the previous chapters highlight that M1 GAS 
entry into HUVEC comprises features of the classical phagocytic uptake machinery, in 
particular actin cytoskeletal rearrangements and accumulation of F-actin. During phagocytic 
uptake of foreign material, receptor engagement leads to the activation of membrane bound 
phospholipase C which hydrolyses phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) to 
diacylglycerol (DAG) and inositol-3,4,5-trisphosphate (IP3) (Steinberg et al., 2008, Flannagan 
et al., 2012, Sarantis et al., 2012). IP3 in turn induces the release of calcium from intracellular 
stores like the endoplasmic reticulum (Nunes et al., 2010, Sarantis et al., 2012). Intracellular 
calcium acts as a second messenger and in turn activates protein kinase C and additional 
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downstream signalling molecules for example small GTPases. These either directly or 
indirectly induce the re-organization of the actin cytoskeleton and engulfment of foreign 
material into membrane-bound compartments (Steinberg et al., 2008, Botelho et al., 2011, 
Flannagan et al., 2012). 
Next, it was investigated whether host cell signalling molecules of the phagocytic uptake 
machinery are also involved in M1 protein mediated streptococcal invasion. Therefore, 
HUVEC were pre-treated with different chemicals specifically inhibiting single signalling 
molecules. To specifically impair phospholipase C, HUVEC were pre-incubated with 
edelfosine. The amount of intracellular calcium within HUVEC was reduced by incubation of 
HUVEC with the calcium chelating agent BAPTA-AM. A third inhibitor, calphostin C, was 
used to specifically target protein kinase C. All inhibitors were diluted in DMSO. To exclude 
any negative effects of the solvent on M1 GAS invasion, HUVEC were also pre-treated with 
DMSO alone. After pre-treatment HUVEC were infected with M1 GAS for 3 h and afterwards 
intra- and extracellular streptococci were stained differentially.  
Pre-treatment of HUVEC with edelfosine, inhibiting phospholipase C, significantly reduces 
the invasion of M1 GAS to 16% (Figure 21a). In addition, incubation of HUVEC with the 
calcium chelator BAPTA-AM completely abolished streptococcal invasion. Inhibition of 
protein kinase C with calphostin C also significantly reduces the invasion of M1 GAS by 80% 
(Figure 21a). Immunofluorescence analysis further confirms that, compared to the DMSO 
treated control (Figure 21b), inhibition of protein kinase C (Figure 21c) and reduction of 
intracellular calcium (Figure 21d) results in reduced numbers of intracellular streptococci. 
The data demonstrate that phospholipase C, intracellular calcium and protein kinase C are 
involved in the invasion process of M1 GAS into EC since inhibiting either of those 
significantly reduces or completely abolishes streptococcal internalization. In addition, the 
results indicate that M1 GAS exploits the phagocytic uptake machinery of EC to ensure 
internalization into the host cell and protection from the immune system of the host. 
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Figure 21: M1 GAS induces phagocytic-like uptake into HUVEC 
Specific inhibitors were used to interfere with host cell signalling molecules known to be involved in classical 
phagocytosis. HUVEC were pre-treated with edelfosine [20 µM], BAPTA-AM [25 µM] and calphostin C [2 µM] for 
30 min to inhibit phospholipase C, release of intracellular calcium and protein kinase C respectively. Pre-treated 
HUVEC were then infected with M1 GAS for 3 h.  
a. Quantification of invasion rates. Pre-treatment of HUVEC with edelfosine, BAPTA-AM and calphostin C 
significantly reduces or completely abolishes M1 GAS mediated uptake into EC. The graph shows mean values ± 
SD of one representative experiment out of a total of three independent experiments. 
b-d. Fluorescence images show less intracellular streptococci in HUVEC when treated with calphostin C (c) and 
BAPTA-AM (d) when compared to DMSO treated control cells (b). Intracellular bacteria are depicted in red, 
extracellular bacteria are shown in green-yellow. HUVEC nuclei are depicted in blue. Bars represent 5 µm. 
 
4.7 Infection assays with lung and dermal endothelial cells 
4.7.1 Serotype M1 GAS invades into different primary human endothelial cell types 
The loss of function/gain of function experiments demonstrate the potential of M1 to act as 
an invasin on primary endothelial cells. This raised the question whether invasion is 
restricted to endothelial cells of the human umbilical cord or if invasion into other human 
endothelial cells might constitute a common mechanism employed by serotype M1 GAS.  
Therefore, infection experiments were performed using primary human lung endothelial cells 
(HPMEC) as well as primary human dermal lymphatic endothelial cells (HDLEC). These cells 
were infected with M1 GAS as previously described for HUVEC. Afterwards, infected cell 
layers were processed for immunofluorescence as well as field emission scanning electron 
microscopy.  
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The results of the microscopic analysis are depicted in Figure 22. M1 GAS is also able to 
efficiently invade into human lung endothelial cells (Figure 22a). Similar to invasion into 
HUVEC, M1 GAS triggers the formation of membrane protrusions tightly engulfing 
streptococci and subsequent zipper-like uptake into HPMEC (Figure 22a, left FESEM image, 
white arrow heads indicate membrane ruffles). Immunofluorescence staining of infected cell 
layers confirms the presence of intracellular streptococci within EC (Figure 22a, right 
immunofluorescence (IF) image). In addition, also primary human dermal lymphatic 
endothelial cells represent potential target cells for M1 GAS, as infection assays using these 
cells also demonstrate invasion of M1 GAS in a time dependent manner (Figure 22b). 
In conclusion, the results of the infection experiments described above demonstrate that 
endothelial cells in general represent target cells for M1 GAS invasion. Thus, invasion into 
endothelial cells possibly constitutes a common mechanism of M1 GAS to evade the host 
immune system and reside intracellular. 
 
Figure 22: M1 GAS invades into HPMEC as well as HDLEC 
Analysis of the invasion potential of M1 GAS on different EC by immunofluorescence microscopy (IF) and 
FESEM.  
a. Upon infection M1 GAS induces rearrangements (left image, white arrow heads) of the actin cytoskeleton and 
zipper-like uptake into HPMEC. Immunofluorescence staining of intra- (red) and extracellular (green-yellow) 
streptococci confirms invasion of M1 GAS into HPMEC (right image). The actin cytoskeleton is depicted in green. 
Bars represent 2 µm (left image) and 10 µm (right image). 
b. Quantification of invasion of M1 GAS into primary human dermal endothelial cells (HDLEC) after varying time 
points. The graph represents mean values ± SD of one representative experiment out of three independent 
experiments.  
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4.7.2 Ex vivo infection of human endothelium with M1 GAS  
In order to verify the invasiveness of M1 GAS on endothelial cells within human tissue, 
human endothelium was infected with M1 GAS ex vivo. Therefore, human umbilical cord was 
collected directly post-delivery from the Hospital Celler Strasse in Braunschweig and the vein 
endothelium was infected with M1 GAS. After 4.5 h of infection the samples were washed 
and processed for electron microscopy.  
Figure 23a shows attachment of M1 GAS to the apical side of the endothelium 4.5 h post 
infection. M1 GAS was found to be closely associated with the endothelial cell lining of the 
vein within the umbilical cord (Figure 23b). However, analysis of the basal side of the 
endothelium did not reveal any streptococci. Further experiments are needed in order to 
demonstrate transmigration of M1 GAS in ex vivo derived endothelium. 
Taken together, the close association of M1 GAS with the human endothelium in the ex vivo 
experimental set up confirms that human endothelial cells represent potential target cells for 
M1 GAS invasion.   
 
 
Figure 23: Attachment of M1 GAS to ex vivo derived human endothelium 
Analysis of the invasion potential of M1 GAS on ex vivo derived vein endothelium of human umbilical cord by field 
emission scanning electron microscopy. Upon infection M1 GAS adheres to (a) and closely associates (b) with 
the human vein endothelium. Bars represent 2 µm (a, b). 
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5. Discussion 
5.1 Use of an in vitro EC barrier model to study serotype M1 S. pyogenes invasion 
S. pyogenes is an extremely versatile organism that causes mild and superficial infections 
but also severe invasive diseases such as necrotizing fasciitis and streptococcal toxic shock 
syndrome (Cunningham, 2000). Although antibiotic treatment of streptococcal infections with 
penicillin is still effective and to date no resistances have occurred, invasive diseases are still 
the cause for substantial morbidity and mortality worldwide (Kaplan, 1997, Horn et al., 1998, 
Macris et al., 1998, Carapetis et al., 2005). With over 500.000 deaths per year due to 
streptococcal infections S. pyogenes still represents a major public health problem 
(Carapetis et al., 2005). Although various serotypes of GAS have been associated with 
severe invasive infections, serotype M1 and M3 S. pyogenes are most frequently isolated 
from patients with necrotizing fasciitis and STSS (Stevens, 2001, Tart et al., 2007). Invasion 
into host cells represents one successful mechanism of S. pyogenes to circumvent host 
immune defences and to ensure streptococcal survival. Several studies have already shown 
that serotype M1 GAS triggers its uptake into various cell types, including epithelial cells and 
professional phagocytic cells e.g. macrophages and neutrophils and survives and persists 
intracellular (LaPenta et al., 1994, Medina et al., 2003, Staali et al., 2003, Staali et al., 2006, 
Hertzen et al., 2010). The ability of S. pyogenes to cause invasive diseases, however, 
implies the ability of GAS to reach the naturally sterile environment of deeper tissue layers, 
thus, being able to overwind tissue barriers. The observation that in a majority of the patients 
with invasive diseases no obvious port of entry is detectable led to the hypothesis that 
streptococcal spread into deeper tissue is associated with a transient bacteraemia originating 
from the oropharynx (Johansson et al., 2010). This suggests that blood endothelial cells 
lining the blood vessels might represent potential target cells for pathogenic streptococci and 
that internalization of S. pyogenes into cells of the vascular system might represent a first 
crucial step during the dissemination into deep tissue. A deeper understanding of the 
invasion mechanisms itself, as well as the host and bacterial factors involved, might aid in 
the development of new therapeutic strategies to combat streptococcal infections. The 
present study, thus, focusses on the invasive potential of one of the most common 
serotypes, serotype M1 S. pyogenes, on EC and, in particular, the mechanisms underlying 
the interaction of M1 GAS with the endothelial cells of the vascular system. 
Studies have already identified a role of invasion of EC in the pathogenesis of serotype M3 
GAS which triggers efficient and rapid internalization into EC (Nerlich et al., 2009, Amelung 
et al., 2011). Preliminary experiments of M1 GAS on EC using a standard infection assay, in 
which EC are grown and infected on glass coverslips, however suggested fundamental 
differences between M1 and M3 GAS. Unlike M3 GAS, all M1 clinical GAS isolates were 
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non-invasive in this standard infection assay (data not shown). These results seem 
contradictory to the general observation that M1 GAS represents one of the most invasive 
serotypes, suggesting that the standard infection model is not suitable to study the invasive 
potential of M1 GAS on EC. Therefore, an additional more complex in vitro transwell infection 
model was employed. In contrast to the standard infection assay, EC are grown on an 
artificial semi-permeable basement membrane of a transwell insert which allows the 
establishment of an artificial barrier representing the blood stream on the apical side and the 
tissue side on the basolateral side. Using this cultivation system allowed the formation of a 
confluent polarized endothelial cell layer, close to in vivo conditions, to study M1 GAS 
invasion (Figure 5b). Layer formation and polarization was determined by continuous 
measurement of the transendothelial resistance (TER) and the capacitance providing 
valuable parameters to assess the current state of the EC layer. Confluent polarized EC 
layers exhibit high TER values and low capacitance and were then used for infection assays 
with M1 GAS (Figure 5a). Following infection of confluent polarized EC layers, 
immunofluorescence analysis demonstrated the invasiveness of M1 GAS on EC. Upon 
infection, M1 GAS efficiently invade into EC and are localized within the perinuclear region of 
the cell (Figure 6). The confluence and polarity of the EC layer proofed to be absolutely 
essential for M1 GAS internalization and correlates with the invasion rates of M1 GAS. Thus, 
this artificial barrier model represents a suitable system to study the invasion process of M1 
GAS into EC in further detail. 
 
5.2 Serotype M1 GAS mediates zipper-like uptake into EC 
Invasion into non-phagocytic cells has been shown to represent a common mechanism of 
various bacterial pathogens to circumvent the host immune system (Alonso et al., 2004). In 
the case of classical intracellular pathogens two uptake mechanisms have been described 
and are depicted in Figure 24 (Finlay et al., 1997). Listeria and Yersinia species for example 
induce uptake by the zipper invasion mechanism. This is characterized by the initiation of 
intracellular signalling cascades which are normally involved in host cell processes like cell 
adhesion and cell migration. The initiation of these signalling cascades induces a 
rearrangement of the actin cytoskeleton as well as membrane reorganization, resulting in 
successive engulfment and subsequent internalization of bacteria by the host cell membrane 
(Alonso et al., 2004, Rottner et al., 2005). The second mechanism, the trigger invasion 
mechanism, on the other hand is characterized by drastic morphological alterations of the 
host cell cytoskeleton and membrane ruffling. Uptake by the trigger invasion mechanism has 
been described for Salmonella and Shigella species and is induced by the injection of 
bacterial effector proteins into the cytoplasm of the host cell which then directly target 
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regulatory host cell factors involved in actin polymerization and actin remodelling processes 
(Finlay et al., 1997, Alonso et al., 2004, Rottner et al., 2005).  
 
 
Figure 24: Mechanisms of bacterial invasion  
Taken from (Finlay et al., 1997) 
 
Also in the case of streptococci strain dependent morphological differences in the invasion 
process have been observed (Molinari et al., 2000). Some strains, such as M1-expressing 
strains and SfbI-negative strains, invade epithelial cells via a zipper-like mechanism, while 
other strains invade via membrane ruffling similar to the trigger mechanism of classical 
intracellular pathogens (Dombek et al., 1999, Molinari et al., 2000, Nitsche-Schmitz et al., 
2007). In addition, Rohde and colleagues have identified a third invasion mechanism 
employed by SfbI-expressing streptococci, namely caveolae-mediated endocytosis. This 
uptake mechanism is completely independent of cytoskeletal rearrangements. Instead, it 
comprises the accumulation of caveolae at the entry port and subsequent invasion of 
streptococci into the host cell by the formation of large membrane invaginations (Rohde et 
al., 2003).  
Although the internalization of serotype M1 GAS into epithelial cells is well established, 
nothing is known about the interaction of M1 GAS with endothelial cells. The results of this 
study clearly demonstrate that also blood endothelial cells represent target cells for M1 GAS 
invasion. Immunofluorescence analysis and subsequent quantification of internalization rates 
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show that M1 GAS efficiently triggers its own uptake into EC (Figure 6). A closer look on the 
internalization process itself reveals that M1 GAS triggers the formation of membrane 
protrusions that tightly attach to and engulf invading bacteria resulting in successive zipper-
like uptake of M1 GAS into EC (Figure 7). On the cellular level the formation of membrane 
protrusions is ascribed to a reorganization of the actin cytoskeleton. A key feature in all 
cytoskeletal remodelling processes is the de novo nucleation of actin filaments or site-
directed branching and elongation of existing actin fibres (Stradal et al., 2006). These 
processes are catalysed by the heptameric protein complex Arp2/3 which, by acting as a 
nucleation factor, promotes the formation and assembly of branched actin filaments. Arp2/3-
mediated actin polymerization is induced by the activation of signalling cascades involving 
small GTPases such as Rac and Cdc42. These act as molecular switches to relate signals to 
the Arp2/3 complex via the association of nucleation promoting factors, including members of 
the Wiskott-Aldrich Syndrome proteins (WASP) and WASP family verprolin-homologous 
(WAVE) proteins (Stradal et al., 2004, Vartiainen et al., 2004, Stradal et al., 2006). The 
Arp2/3 complex is not only a key component of all cellular processes involving actin 
dynamics, moreover, several bacterial pathogens e.g. Shilgella, Listeria and Rickettsia  
exploit the cellular actin cytoskeletal machinery for their own purposes. By specifically 
targeting the Arp2/3 complex these pathogens induce actin polymerization and actin tail 
formation, allowing rapid movement within the host cell and spread to adjacent cells 
(Goldberg, 2001, Gruenheid et al., 2003, Gouin et al., 2004, Alonso et al., 2004). Given the 
essential function of actin polymerization in the reorganization of the cytoskeleton, it is not 
surprising that uptake of serotype M1 GAS into EC also involves accumulation of F-actin at 
the entry port (Figure 8a). Moreover, immunofluorescence analysis of infected EC layers 
shows that actin accumulation is accompanied with an aggregation and recruitment of the 
Arp2/3 complex in the vicinity of invading streptococci (Figure 8b). Thus, serotype M1 GAS 
subverts cellular actin cytoskeletal dynamics possibly by inducing Arp2/3 dependent actin 
filament branching to trigger its uptake into EC.  
 
5.3 The M1 protein of GAS triggers internalization into EC via the engagement of β1-
integrins on the endothelial cell surface 
Internalization of bacterial pathogens by the zipper invasion mechanism is initiated by 
binding of bacterial ligands to a host cell surface receptor which than triggers intracellular 
signalling cascades leading to cytoskeletal rearrangements and engulfment of bacteria 
(Alonso et al., 2004). Previously, the fibronectin binding protein FbaB of serotype M3 GAS 
was identified as an invasin for endothelial cells driving rapid zipper-like uptake of serotype 
M3 GAS into EC (Amelung et al., 2011). However, since M1 GAS lacks FbaB on its cell 
surface, the bacterial factor driving M1 GAS internalization into EC remained so far unknown. 
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This study clearly identifies the M1 surface protein of serotype M1 GAS as the invasin driving 
M1 GAS internalization into EC. Using an isogenic M1 knock out mutant, which is deficient in 
invasion of EC, demonstrates that the M1 protein is absolutely essential for internalization. 
Complementation of the M1 knock out mutant by episomal expression of M1 restores the 
wild type phenotype (Figure 16a, b). Gain of function experiments using M1-coated latex 
beads as well as heterologous expression of M1 in naturally non-invasive L. lactis proof that 
the M1 protein is the sole factor which triggers the internalization process into EC (Figure 17, 
Figure 18). These findings add yet another role to this multifunctional protein which has 
already been identified as a major virulence factor of GAS, responsible for subverting various 
host immune responses thereby ensuring streptococcal survival (reviewed in (Oehmcke et 
al., 2010) and (Smeesters et al., 2010)). In addition to its well established role as an 
adhesin/invasin for epithelial cells and its antiphagocytic properties in non-immune human 
blood, the M1 protein has been described as a crucial factor mediating survival of 
S. pyogenes within neutrophils and macrophages (Bisno, 1979, Dombek et al., 1999, Staali 
et al., 2003, Staali et al., 2006, Hertzen et al., 2010). Given its antiphagocytic properties, it is 
quite remarkable that GAS uses the same factor to specifically initiate internalization into 
non-phagocytic cells. This adds to the extreme versatility of S. pyogenes, on the one hand 
preventing its internalization by professional phagocytes, while on the other hand specifically 
inducing its entry into non-phagocytic cells including epithelial and endothelial cells.  
S. pyogenes has evolved multiple pathways to efficiently invade host cells (Cue et al., 1998, 
Molinari et al., 2000, Rohde et al., 2003). Invasion into human lung epithelial cells for 
example involves binding of the M1 protein to components of the extracellular matrix such as 
fibronectin or laminin (Cue et al., 1998). Fibronectin bound to the M1 protein subsequently 
interacts with the major fibronectin binding receptor α5β1-integrins on the surface of lung 
epithelial cells and thereby triggers streptococcal uptake via cytoskeletal rearrangements 
(Cue et al., 1998, Dombek et al., 1999). The results of the present study clearly demonstrate 
that, similar to M1 GAS invasion into epithelial cells, efficient invasion into endothelial cells 
requires the engagement of subsets of the β1-integrin family on the host cell surface (Figure 
20). However, although in both cases binding of β1-integrins is required, efficient invasion into 
endothelial cells is highly dependent on a confluent cell layer. Blocking of the β1-integrin 
subunit on endothelial cells significantly reduces streptococcal invasion to 56%, proofing that 
β1-integrins are required for efficient internalization of serotype M1 GAS into EC (Figure 20a). 
Moreover, upon invasion an aggregation of β1-integrins in the vicinity of invading streptococci 
is detectable (Figure 20b). It is well known that integrin clustering is a prerequisite for 
triggering an outside to inside signal. Therefore, it is conceivable that, as in the case of 
invasion into epithelial cells, engagement of α5β1-integrin heterodimers is required for 
efficient M1-mediated invasion into endothelial cells. Further studies need to be performed to 
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address whether α5β1-integrins are indeed cell surface receptors for M1-mediated invasion 
into EC. Moreover, since pre-treatment of EC with an anti-β1-integrin antibody does not 
completely abolish M1 GAS invasion into EC, it is likely that the M1 protein targets an 
additional host cell surface receptor or receptors to ensure efficient entry. Indeed, membrane 
cofactor protein CD46 has been identified as a receptor for M protein (Okada et al., 1995). 
Later Rezcallah and colleagues demonstrated that, in addition to α5β1-integrins, CD46 is 
required for efficient M1-mediated internalization of GAS into epithelial cells and that invasion 
is dependent on the presence of serum or fibronectin (Rezcallah et al., 2005).  
The role of extracellular matrix components (e.g. fibronectin) in the invasion of M1 GAS into 
EC has also to be clarified in subsequent experiments. SfbI/PrtF1-mediated invasion has 
been shown to be highly dependent on binding to the host glycoprotein fibronectin (Molinari 
et al., 1997, Jadoun et al., 1998, Talay et al., 2000). However, little is known about the 
interaction of the M1 protein with fibronectin. Cue and colleagues suspected that the M1 
protein contains two independent binding sites for fibronectin, one present in the A and one 
in the B domain of the protein, since deletion of either of those significantly inhibited 
fibronectin binding and subsequent invasion into epithelial cells (Cue et al., 2001). Hence, it 
would be interesting to study the requirement of M1 protein-fibronectin interactions for 
efficient invasion into EC. But this question needs to be clarified in subsequent studies. 
 
5.4 M1 GAS exploits the phagocytic uptake machinery to gain access to EC 
The molecular basis for membrane remodelling and pseudopod extensions, as seen in M1 
GAS invasion into EC, is the initiation of intracellular signalling cascades which activate host 
cell molecules involved in actin remodelling (Alonso et al., 2004). Thus, it was of interest 
which signalling molecules are triggered during the internalization of M1 GAS into EC. 
Function interfering experiments using different chemicals specifically inhibiting single host 
cell signalling molecules were performed (Figure 21). These experiments identified 
phospholipase C (PLC), intracellular calcium and protein kinase C (PKC) as key signalling 
components involved in the uptake of M1 GAS into EC. Pre-treatment of HUVEC with 
edelfosine, interfering with the activation of phospholipase C, results in a reduction of 
invasion to 16%. Targeting protein kinase C by calphostin C also significantly reduces M1 
GAS invasion by 80%. In addition, intracellular calcium is also absolutely essential for M1 
GAS internalization as reducing its release from intracellular stores by the chelator BAPTA-
AM completely abolishes M1 GAS invasion into EC (Figure 21).  
F-actin accumulation and the formation of membrane protrusions, as seen in M1 GAS 
invasion, are major characteristics for phagocytic uptake processes. A comparison of the 
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signalling molecules involved highlights similarities between both processes. Classical 
receptor-mediated phagocytosis involves multiple ligand receptor interactions resulting in 
lateral receptor clustering, activation of multiple receptors by phosphorylation and 
subsequent recruitment of additional adaptor proteins to the activated signalling complex 
(Flannagan et al., 2012, Sarantis et al., 2012). Lipids, for example phosphatidylinositol-4,5-
bisphosphate (PI(4,5)P2), play an important role in signalling events during classical 
phagocytosis. PI(4,5)P2 is present in the inner leaflet of the cell membrane of resting 
phagocytes. During phagocytosis its amount first increases within the phagocytic cup but 
then abruptly decreases (Steinberg et al., 2008, Flannagan et al., 2012). The decrease in the 
concentration of PI(4,5)P2 is absolutely essential for efficient internalization of foreign 
particles, most likely by allowing actin disassembly. Phospholipase C γ, which is activated 
during phagocytosis, binds to PI(4,5)P2 and subsequently hydrolyzes it to yield diacylglycerol 
(DAG) and inositol-3,4,5-trisphosphate (IP3) (Steinberg et al., 2008, Flannagan et al., 2012, 
Sarantis et al., 2012). IP3 triggers the release of calcium from intracellular stores such as the 
endoplasmic reticulum (Nunes et al., 2010, Sarantis et al., 2012). Together with DAG, 
calcium promotes the recruitment of protein kinase C (PKC) (Steinberg et al., 2008). PKC is 
also a key component enhancing phagocytosis by activating downstream signalling events 
including the activation of small GTPases (e.g. Rac1 and Cdc42) which relate signals to the 
Arp2/3 complex promoting cytoskeletal rearrangements during phagocytosis (Botelho et al., 
2011, Flannagan et al., 2012).            
Taken together, the results of the present study demonstrate that internalization of M1 GAS 
into EC shows features of classical phagocytic uptake processes in particular ligand receptor 
binding, activation of calcium dependent intracellular signalling cascades including PLC and 
PKC, membrane remodelling and engulfment of streptococci. Thus, serotype M1 GAS 
exploits the phagocytic uptake machinery of the host cell to gain access to non-phagocytic 
cells, thereby facilitating protection from the immune system. In contrast to the findings of the 
present study, Purushothaman and colleagues have shown that protein kinase C is not 
required for M1 GAS invasion into epithelial cells since the inhibitor calphostin C fails to 
inhibit M1 GAS invasion in this study (Purushothaman et al., 2003). This demonstrates that, 
although M1 GAS apparently triggers similar internalization processes into both epithelial and 
endothelial cells, distinct signalling cascades are driving these processes. Hence, further 
experiments need to be performed to fully understand the signalling cascades generated 
during M1 GAS uptake into EC. Class I phosphatidylinositol-3-kinases (PI3K) might 
constitute yet other possible signalling components involved during M1 GAS invasion into EC 
as they are also known to hydrolyse PI(4,5)P2 into IP3 (Steinberg et al., 2008, Flannagan et 
al., 2012). Indeed, Wang and colleagues have previously shown an involvement of PI3K in 
the internalization of M1 GAS into epithelial cells. Upon association with integrins, M1 GAS 
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initiate the recruitment and phosphinositide 3-kinase (PI3K) dependent activation of the 
integrin linked kinase (ILK) and subsequent phosphorylation and assembly of paxillin and the 
focal adhesion kinase (FAK) at the port of entry (Purushothaman et al., 2003, Wang et al., 
2006, Wang et al., 2007). In contrast, Nerlich and colleagues could show that entry of 
serotype M3 GAS into EC is independent of PI3K (Nerlich et al., 2009).  
The small GTPases Rac1 and Cdc42 play also an essential role in processes involving 
cytoskeletal rearrangements. Both act as molecular switches that relate signals from the 
cellular receptor to effector proteins. Rac1 induces the formation of lamellipodia and Cdc42 
has been shown to mediate the formation of filopodia (Flannagan et al., 2012). Nerlich and 
colleagues have previously shown that Rac1 is essential to mediate internalization of 
serotype M3 GAS into EC (Nerlich et al., 2009). Therefore, it will be interesting to analyse the 
role of Rac1 and Cdc42 in M1 GAS invasion in future experiments. 
 
5.5 Serotype M1 GAS survival within EC is associated with phagolysosomal escape 
Following phagocytosis, intracellular bacteria are incorporated into membrane-bound 
vacuoles called phagosomes (Sarantis et al., 2012). The composition of the newly formed 
phagosome resembles in its composition the plasma membrane from which it is derived. 
However, membrane scission is followed by a series of biochemical modifications altering the 
composition of the phagosome and turning it into a highly microbicidal degradative organelle 
(Flannagan et al., 2012). These processes involve sequential fusion and fission events of the 
nascent phagosome with early and late endosomes and finally lysosomes (Sarantis et al., 
2012, Flannagan et al., 2012). Early phagosomes acquire the GTPase Rab5 which 
coordinates early phagosome biogenesis by mediating fusion of the nascent phagosome with 
early endosomes. Rab5 also recruits other effector proteins such as the early endosomal 
antigen 1 (EEA1) further facilitating vesical fusion events (Botelho et al., 2011). The transition 
of the early phagosome into a late phagosome is characterized by the loss of early 
endosomal markers (e.g. Rab5) but acquisition of other distinct biochemical markers 
including Rab7 and the lysosome-associated membrane proteins 1 and 2 (Lamp-1 and 
Lamp-2) (Botelho et al., 2011, Flannagan et al., 2012). Therefore, Rab7 and its effector 
proteins are essential for phagolysosomal fusion and acidification in the phagosome 
maturation process. The mature phagolysosome with a pH of 4.5 is rich in degradative 
enzymes including lysosomal hydrolases, nucleases, lipases, glycosidases, reactive oxygen 
species and antimicrobial peptides ensuring degradation of foreign material (Botelho et al., 
2011, Flannagan et al., 2012). Phagocytosis and subsequent phagosomal maturation, thus, 
represents one of the first lines of defence against invading pathogens (Flannagan et al., 
2012).  
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Given the importance of phagocytosis in combating infections, it is not surprising that various 
pathogens, including S. pyogenes, have evolved mechanisms to interfere with phagosome 
maturation and to alter the phagosome for their own benefit avoiding intracellular killing. 
These mechanisms include (i) the induction of phagosome maturation arrest, (ii) avoidance 
of fusion of phagosomes with lysosomes, (iii) complete segregation of membrane-bound 
compartments from the endocytic route and (iiii) escape from the phagosome (Alonso et al., 
2004). Chlamydia, Legionella and Brucella for example inhibit endocytic maturation and live 
within phagosomes segregated from the endocytic route (Meresse et al., 1999, Alonso et al., 
2004, Botelho et al., 2011). Mycobacterium tuberculosis again mediates an arrest in 
phagosome maturation by preventing fusion of the phagosome with lysosomes and Listeria 
lyses the phagosomal membrane to escape into the cytoplasm of the host cell (Meresse et 
al., 1999, Goldberg, 2001, Portnoy et al., 2002, Alonso et al., 2004, Botelho et al., 2011). 
Also in the case of S. pyogenes several evasion mechanisms have been described. 
Serotype M3 GAS, which triggers invasion by cytoskeletal rearrangements, is localized within 
phagosomes which traffic along the classical endocytic route and fuse with lysosomes 
(Amelung et al., 2011). Following transmigration within EC, M3 GAS induces its escape at 
the basolateral tissue associated membrane via lysosomal exocytosis (Talay, unpublished 
data). In contrast, SfbI-expressing S. pyogenes strains showing caveolae-mediated invasion 
reside within caveosomes and prevent fusion with lysosomes, thereby bypassing the 
endocytic machinery (Rohde et al., 2003). In the case of serotype M1 GAS, studies have 
described that survival within neutrophils and macrophages is mediated by an inhibition of 
fusion of phagosomes with azurophilic granules and late endosomal/lysosomal 
compartments (Staali et al., 2006, Hertzen et al., 2010). In contrast to these observations, 
the results of the present study give evidence that within EC M1 GAS containing 
phagosomes do travel along the classical endocytic route and fuse with terminal lysosomes 
(Figure 9, Figure 10, Figure 11). M1 GAS containing phagosomes acquire late endosomal 
lysosomal markers like Lamp-1. 1 h up to 5 h post infection the majority of intracellular 
streptococci is localized within Lamp-1 positive compartments (Figure 9). Co-localization of 
intracellular streptococci with gold loaded-lysosomes by electron microscopy demonstrates 
that phagosomes in the end fuse with terminal lysosomes, thus, further confirming 
endosomal/lysosomal intracellular trafficking of M1 GAS within EC (Figure 10, Figure 11). This 
intracellular pathway of M1 GAS shows parallels to M3 GAS trafficking in EC (Amelung et al., 
2011). However, although in both cases fusion events of phagosomes with lysosomes are 
detectable, differences can be observed. In contrast to M3 GAS which induces movement of 
gold-loaded lysosomes towards intracellular residing streptococci and the formation of large 
apertures in the host cells (Talay, unpublished data), the present study shows that serotype 
M1 GAS moves from the periphery of the cell towards lysosomes which are still localized in 
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the perinuclear region of the host cell (Figure 10). Furthermore, no formation of apertures is 
detectable. Most likely this difference between M1 serotype and M3 serotype can be 
attributed to the nature of subsequent trafficking steps which differ in both strains. Serotype 
M3 GAS is released at the basolateral side of the host cell by lysosomal exocytosis, a 
process which is characterized by fusion of the phagolysosomal membrane with the host cell 
membrane (Talay, unpublished data). Movement of lysosomes towards intracellular residing 
M3 GAS, thus, strongly supports the observation of streptococcal escape by lysosomal 
exocytosis. In contrast, the results of this study demonstrate that following fusion with 
lysosomes M1 GAS escapes from the phagolysosomal compartment into the cytoplasm of 
the host cell (Figure 13a, b). Visualization of cellular membranes by ferrocyanide-
thiocarbocyanide-osmium tetroxide staining confirmed the absence of any cellular membrane 
surrounding intracellular M1 GAS, further verifying its cytoplasmic localization (Figure 13c). 
Streptococcal escape from the phagolysosomes also correlates with the observation that 
after overnight infection the number of M1 GAS co-localized with the Lamp-1 positive late 
endosomal/lysosomal compartment declines to approximately 50% (Figure 9b). Escape from 
the phagosome has already been shown for Listeria, Shigella and Rickettsia. These 
pathogens secrete specific enzymes, e.g. the pore-forming toxin listeriolysine-O of Listeria, 
which lyses the phagosomal membrane releasing the bacteria into the host cytoplasm 
(Meresse et al., 1999, Alonso et al., 2004). Recruitment of actin to one pole facilitates 
movement within the host cell and spread to neighbouring cells (Goldberg, 2001). One can 
speculate that the streptococcal exotoxins streptolysin O and/or streptolysin S are 
responsible for M1 GAS phagolysosomal escape. Both belong to the group of pore-forming 
toxins and have been shown to exert cytolytic effects on various cell types and subcellular 
organelles (Nizet, 2002, Bisno et al., 2003). Experiments within the department are on the 
way to address this question.  
 
5.6 Survival of serotype M1 GAS within endothelial cells and its ability to overcome the 
endothelial cell barrier 
As described in the previous chapter, M1 GAS mediates its escape from the phagolysosomal 
compartment, thus, ensuring streptococcal survival within the nutrient-rich host cytoplasm. 
Bacterial viability staining and plating of intracellular streptococci confirm successful survival 
of intracellular streptococci up to 10 h post infection (Figure 12). Analysis of ultra-thin sections 
of infected EC layers also show that intracellular M1 GAS appears morphologically intact. In 
addition, signs of ongoing bacterial replication are visible, thus, giving further evidence for 
streptococcal viability (Figure 13). Although quantification of intracellular bacteria by plating of 
EC lysates also confirms streptococcal survival, bacterial counts are gradually declining over 
time (Figure 12b) which seems contradictory to the observations made by electron and 
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immunofluorescence microscopy (Figure 12a, Figure 13). Possible explanations for this 
discrepancy will be discussed below.   
The development of an invasive disease implies that, at some point, the pathogen is able to 
overcome cellular barriers e.g. the endothelial cell lining. As M1 GAS accounts for the 
majority of invasive infections, it was hypothesised that following phagolysosomal escape M1 
GAS transmigrates within EC and at some point emerges from the host cell at the basolateral 
side facilitating spread into deeper tissue. Plating of the medium within the lower transwell 
compartment underneath the EC layer reveals no streptococci even after longer infection 
times (up to 72 h post infection, Figure 14a). However, after removal of the infected EC layer 
and examination of the surface of the transwell membrane, M1 GAS was found to be 
attached to the transwell membrane itself, entangled within a mesh of extracellular matrix 
and gelatine (Figure 14c). The results of this experiment provide evidence that M1 GAS is 
indeed able to overcome the endothelial cell lining, a mechanism which potentially favours 
dissemination into deeper tissue. Due to the tight attachment of streptococci to the gelatine, 
which was used for coating of transwell membranes, it is not surprising that streptococci are 
unable to pass through the pores of the transwell membrane and this, therefore, explains the 
absence of streptococci within the lower transwell compartment (Figure 14a). Moreover, the 
escape from the host cell might account for the declining numbers of intracellular bacteria 
after plating of EC lysates (Figure 12b). Presumably, permeabilization and subsequent 
trypsination of infected EC are not sufficient to detach streptococci from the transwell 
membrane and, thus, these are not included in the bacterial counts obtained after plating of 
EC lysates.  
With progressive infection time increasing numbers of dead cells are detectable within the 
EC layer (Figure 14d). This gives reason for speculation that M1 GAS escape is accompanied 
by host cell lysis. In line with this observation is the study of Hertzén and colleagues also 
demonstrating morphological changes and cell lysis of macrophages infected with serotype 
M1 GAS (Hertzen et al., 2010). Whether EC lysis is due to the increasing amount of 
intracellular streptococci after prolonged infection times or caused by production of 
streptolysin O and/or streptolysin S remains to be addressed. The morphological changes of 
the EC layer as described above were only detected by electron microscopy, but not by 
examination of infected cell layers by immunofluorescence microscopy. This discrepancy 
highlights the limitations of immunofluorescence microscopy itself. In order to stain 
intracellular streptococci, all cells are treated with Triton-X-100, thus, all cells are 
permeabilized. Therefore, during immunofluorescence microscopic analysis, it is impossible 
to distinguish cells lysed as a consequence of streptococcal infection from those lysed due to 
Triton-X-100 treatment. Moreover, lysis of host cells implies release of intracellular 
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streptococci into the surrounding medium. During preparation of EC lysates for quantification 
of intracellular bacterial survival all extracellular streptococci, including those released during 
host cell lysis, are killed by the addition of penicillin and gentamycin, thus, impairing the 
actual viable intracellular bacterial counts. This would also explain the gradual decrease of 
the intracellular bacteria numbers over time (Figure 12b).  
 
5.7 Summary of the invasion process triggered by serotype M1 GAS  
In conclusion, the results of the present study show, for the first time, a direct interaction of 
M1 GAS, which is one of the most invasive serotypes, with human endothelial cells. Serotype 
M1 GAS efficiently mediates internalization into polarized EC and, moreover, possesses a 
strong potential to cross the endothelial cell lining separating the blood stream from the 
underlying tissue. The M1 surface protein of GAS was identified as a strong invasin which 
mediates the internalization process into EC. Binding of the M1 protein to β1-integrin host cell 
receptors triggers calcium dependent intracellular signalling cascades, involving 
phospholipase C and protein kinase C, which activate downstream signalling molecules 
including the Arp2/3 complex. The activation of these effector proteins results in actin 
recruitment to the port of entry, membrane remodelling and subsequent zipper-like uptake of 
M1 GAS into endothelial cells. Following internalization, intracellular streptococci, 
incorporated into phagosomes, traffic along the classical endosomal pathway and finally fuse 
with terminal lysosomes. With progressive infection time M1 S. pyogenes escapes from the 
phagolysosomal compartment into the cytoplasm of the host cell, subsequently crosses the 
endothelial cell barrier and is released at the basolateral side of the EC layer.   
In summary, the results presented in this study clearly demonstrate new major insights into 
serotype M1 S. pyogenes invasion: i) endothelial cells represent potential target cells for M1 
GAS invasion, ii) infection assays show successful invasion of M1 GAS into human umbilical 
cord, lung as well as human dermal endothelial cells, iii) these results are in favour for and 
strongly indicate that EC invasion possibly constitutes a general mechanism of M1 GAS to 
evade innate host immune defences and to reside and persist intracellular before 
transmigrating into underlying soft tissue, iv) these results give strong evidence about the 
mechanistic aspects why serotype M1 S. pyogenes is very often associated with invasive 
tissue infections like necrotizing fasciitis.  
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